WO2019101357A1 - Topical preparations - Google Patents
Topical preparations Download PDFInfo
- Publication number
- WO2019101357A1 WO2019101357A1 PCT/EP2018/000527 EP2018000527W WO2019101357A1 WO 2019101357 A1 WO2019101357 A1 WO 2019101357A1 EP 2018000527 W EP2018000527 W EP 2018000527W WO 2019101357 A1 WO2019101357 A1 WO 2019101357A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particles
- acid
- agents
- topical preparations
- skin
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 79
- 230000000699 topical effect Effects 0.000 title claims abstract description 69
- 239000002245 particle Substances 0.000 claims abstract description 123
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 35
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 33
- 239000000126 substance Substances 0.000 claims abstract description 31
- 230000008569 process Effects 0.000 claims abstract description 21
- 239000002253 acid Substances 0.000 claims abstract description 19
- 241001465754 Metazoa Species 0.000 claims abstract description 13
- 230000035876 healing Effects 0.000 claims abstract description 9
- 239000001993 wax Substances 0.000 claims description 61
- -1 flow regulators Substances 0.000 claims description 51
- 239000003795 chemical substances by application Substances 0.000 claims description 41
- 239000000203 mixture Substances 0.000 claims description 39
- 239000002674 ointment Substances 0.000 claims description 33
- 239000002105 nanoparticle Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 24
- 239000000499 gel Substances 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 23
- 239000002304 perfume Substances 0.000 claims description 22
- 241000792859 Enema Species 0.000 claims description 21
- 239000006071 cream Substances 0.000 claims description 21
- 239000007920 enema Substances 0.000 claims description 21
- 229940079360 enema for constipation Drugs 0.000 claims description 20
- 239000003921 oil Substances 0.000 claims description 20
- 239000003205 fragrance Substances 0.000 claims description 19
- 239000007921 spray Substances 0.000 claims description 19
- 239000000796 flavoring agent Substances 0.000 claims description 18
- 239000006210 lotion Substances 0.000 claims description 18
- 229920001864 tannin Polymers 0.000 claims description 18
- 239000001648 tannin Substances 0.000 claims description 18
- 235000018553 tannin Nutrition 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 17
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 16
- 239000006260 foam Substances 0.000 claims description 16
- 235000019634 flavors Nutrition 0.000 claims description 15
- 229920001046 Nanocellulose Polymers 0.000 claims description 13
- 239000000443 aerosol Substances 0.000 claims description 12
- 239000003245 coal Substances 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 12
- 239000004753 textile Substances 0.000 claims description 12
- 239000006196 drop Substances 0.000 claims description 11
- 239000007937 lozenge Substances 0.000 claims description 11
- 229910052615 phyllosilicate Inorganic materials 0.000 claims description 11
- 239000000049 pigment Substances 0.000 claims description 11
- 239000004094 surface-active agent Substances 0.000 claims description 11
- 239000004909 Moisturizer Substances 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 10
- 230000001333 moisturizer Effects 0.000 claims description 10
- 230000001698 pyrogenic effect Effects 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 235000006708 antioxidants Nutrition 0.000 claims description 9
- 235000010980 cellulose Nutrition 0.000 claims description 9
- 229920002678 cellulose Polymers 0.000 claims description 9
- 238000000197 pyrolysis Methods 0.000 claims description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 8
- 229920000426 Microplastic Polymers 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 8
- 229920002674 hyaluronan Polymers 0.000 claims description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000003242 anti bacterial agent Substances 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 229940041616 menthol Drugs 0.000 claims description 7
- 235000010755 mineral Nutrition 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- 238000000517 particles from gas-saturated solution Methods 0.000 claims description 7
- 239000000829 suppository Substances 0.000 claims description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 239000003610 charcoal Substances 0.000 claims description 6
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 claims description 6
- 239000007884 disintegrant Substances 0.000 claims description 6
- 239000003925 fat Substances 0.000 claims description 6
- 239000003112 inhibitor Substances 0.000 claims description 6
- 239000000419 plant extract Substances 0.000 claims description 6
- 239000013460 polyoxometalate Substances 0.000 claims description 6
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 5
- 229920002498 Beta-glucan Polymers 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 239000000571 coke Substances 0.000 claims description 5
- 239000003906 humectant Substances 0.000 claims description 5
- 150000002632 lipids Chemical class 0.000 claims description 5
- 239000000314 lubricant Substances 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 150000004804 polysaccharides Chemical class 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 239000011573 trace mineral Substances 0.000 claims description 5
- 235000013619 trace mineral Nutrition 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 108010088751 Albumins Proteins 0.000 claims description 4
- 102000009027 Albumins Human genes 0.000 claims description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical class OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000003113 alkalizing effect Effects 0.000 claims description 4
- 229940035676 analgesics Drugs 0.000 claims description 4
- 239000000730 antalgic agent Substances 0.000 claims description 4
- 230000000840 anti-viral effect Effects 0.000 claims description 4
- 229940088710 antibiotic agent Drugs 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 4
- 235000021466 carotenoid Nutrition 0.000 claims description 4
- 150000001747 carotenoids Chemical class 0.000 claims description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000003638 chemical reducing agent Substances 0.000 claims description 4
- 239000003398 denaturant Substances 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000003349 gelling agent Substances 0.000 claims description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- 239000000693 micelle Substances 0.000 claims description 4
- 108700005457 microfibrillar Proteins 0.000 claims description 4
- 230000003472 neutralizing effect Effects 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 239000003605 opacifier Substances 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 238000001046 rapid expansion of supercritical solution Methods 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 4
- 239000002699 waste material Substances 0.000 claims description 4
- 229940035674 anesthetics Drugs 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 235000007336 cyanidin Nutrition 0.000 claims description 3
- 239000000824 cytostatic agent Substances 0.000 claims description 3
- 230000001085 cytostatic effect Effects 0.000 claims description 3
- 230000001877 deodorizing effect Effects 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 235000013355 food flavoring agent Nutrition 0.000 claims description 3
- 238000000278 gas antisolvent technique Methods 0.000 claims description 3
- 239000003193 general anesthetic agent Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 239000006082 mold release agent Substances 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 239000003380 propellant Substances 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 claims description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 claims description 2
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 claims description 2
- 108090000695 Cytokines Proteins 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- 108090000288 Glycoproteins Proteins 0.000 claims description 2
- 102000003886 Glycoproteins Human genes 0.000 claims description 2
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 2
- 108091034117 Oligonucleotide Proteins 0.000 claims description 2
- 108090000526 Papain Proteins 0.000 claims description 2
- 241000241413 Propolis Species 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 241000124033 Salix Species 0.000 claims description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 2
- 239000004037 angiogenesis inhibitor Substances 0.000 claims description 2
- 230000002491 angiogenic effect Effects 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 239000012296 anti-solvent Substances 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 229940125715 antihistaminic agent Drugs 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 2
- 229960001948 caffeine Drugs 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 235000014633 carbohydrates Nutrition 0.000 claims description 2
- 108010015046 cell aggregation factors Proteins 0.000 claims description 2
- 230000024245 cell differentiation Effects 0.000 claims description 2
- 210000003022 colostrum Anatomy 0.000 claims description 2
- 235000021277 colostrum Nutrition 0.000 claims description 2
- 239000002872 contrast media Substances 0.000 claims description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 229940093496 esculin Drugs 0.000 claims description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 claims description 2
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 claims description 2
- 235000020776 essential amino acid Nutrition 0.000 claims description 2
- 239000003797 essential amino acid Substances 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 2
- 210000002744 extracellular matrix Anatomy 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000010437 gem Substances 0.000 claims description 2
- 229910001751 gemstone Inorganic materials 0.000 claims description 2
- 229920000876 geopolymer Polymers 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 239000003102 growth factor Substances 0.000 claims description 2
- 230000002439 hemostatic effect Effects 0.000 claims description 2
- 229940088597 hormone Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- 229940072221 immunoglobulins Drugs 0.000 claims description 2
- 239000002955 immunomodulating agent Substances 0.000 claims description 2
- 229940121354 immunomodulator Drugs 0.000 claims description 2
- 239000002858 neurotransmitter agent Substances 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 230000002188 osteogenic effect Effects 0.000 claims description 2
- 229940055729 papain Drugs 0.000 claims description 2
- 235000019834 papain Nutrition 0.000 claims description 2
- 229920001281 polyalkylene Polymers 0.000 claims description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 2
- 229940093914 potassium sulfate Drugs 0.000 claims description 2
- 235000011151 potassium sulphates Nutrition 0.000 claims description 2
- 229940069949 propolis Drugs 0.000 claims description 2
- 239000008262 pumice Substances 0.000 claims description 2
- 239000002516 radical scavenger Substances 0.000 claims description 2
- 229940109850 royal jelly Drugs 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- 229920001221 xylan Polymers 0.000 claims description 2
- 150000004823 xylans Chemical class 0.000 claims description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 1
- 244000186892 Aloe vera Species 0.000 claims 1
- 241000238017 Astacoidea Species 0.000 claims 1
- 235000002918 Fraxinus excelsior Nutrition 0.000 claims 1
- 235000006085 Vigna mungo var mungo Nutrition 0.000 claims 1
- 240000005616 Vigna mungo var. mungo Species 0.000 claims 1
- 239000004855 amber Substances 0.000 claims 1
- 239000002956 ash Substances 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 239000004081 narcotic agent Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 69
- 239000002537 cosmetic Substances 0.000 abstract description 47
- 239000003814 drug Substances 0.000 abstract description 32
- 210000004209 hair Anatomy 0.000 abstract description 29
- 229940079593 drug Drugs 0.000 abstract description 24
- 208000015181 infectious disease Diseases 0.000 abstract description 13
- 150000007513 acids Chemical class 0.000 abstract description 11
- 210000001508 eye Anatomy 0.000 abstract description 11
- 210000004400 mucous membrane Anatomy 0.000 abstract description 11
- 206010052428 Wound Diseases 0.000 abstract description 9
- 208000027418 Wounds and injury Diseases 0.000 abstract description 9
- 210000000214 mouth Anatomy 0.000 abstract description 9
- 239000003053 toxin Substances 0.000 abstract description 7
- 231100000765 toxin Toxicity 0.000 abstract description 7
- 108700012359 toxins Proteins 0.000 abstract description 7
- 208000032544 Cicatrix Diseases 0.000 abstract description 6
- 239000002585 base Substances 0.000 abstract description 6
- 210000005069 ears Anatomy 0.000 abstract description 6
- 231100000241 scar Toxicity 0.000 abstract description 6
- 230000037387 scars Effects 0.000 abstract description 6
- 201000004624 Dermatitis Diseases 0.000 abstract description 5
- 206010015150 Erythema Diseases 0.000 abstract description 5
- 208000010668 atopic eczema Diseases 0.000 abstract description 5
- 238000002512 chemotherapy Methods 0.000 abstract description 5
- 210000004087 cornea Anatomy 0.000 abstract description 5
- 210000004905 finger nail Anatomy 0.000 abstract description 5
- 230000003902 lesion Effects 0.000 abstract description 5
- 210000000088 lip Anatomy 0.000 abstract description 5
- 230000003449 preventive effect Effects 0.000 abstract description 5
- 210000004906 toe nail Anatomy 0.000 abstract description 5
- 208000007514 Herpes zoster Diseases 0.000 abstract description 3
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 2
- 201000006082 Chickenpox Diseases 0.000 abstract description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract description 2
- 201000005505 Measles Diseases 0.000 abstract description 2
- 208000005647 Mumps Diseases 0.000 abstract description 2
- 201000004681 Psoriasis Diseases 0.000 abstract description 2
- 241001303601 Rosacea Species 0.000 abstract description 2
- 206010046980 Varicella Diseases 0.000 abstract description 2
- 208000000260 Warts Diseases 0.000 abstract description 2
- 206010000496 acne Diseases 0.000 abstract description 2
- 208000010805 mumps infectious disease Diseases 0.000 abstract description 2
- 230000001473 noxious effect Effects 0.000 abstract description 2
- 238000011275 oncology therapy Methods 0.000 abstract description 2
- 201000004700 rosacea Diseases 0.000 abstract description 2
- 201000005404 rubella Diseases 0.000 abstract description 2
- 208000017520 skin disease Diseases 0.000 abstract description 2
- 201000010153 skin papilloma Diseases 0.000 abstract description 2
- 206010003645 Atopy Diseases 0.000 abstract 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 abstract 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 abstract 1
- 208000002375 Hand-Foot Syndrome Diseases 0.000 abstract 1
- 201000009053 Neurodermatitis Diseases 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 230000005722 itchiness Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 105
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 38
- 239000011859 microparticle Substances 0.000 description 24
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 24
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 22
- 159000000000 sodium salts Chemical class 0.000 description 22
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 16
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 16
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 15
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- 235000011187 glycerol Nutrition 0.000 description 15
- 235000002639 sodium chloride Nutrition 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 14
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 14
- 239000011325 microbead Substances 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 13
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 13
- 210000000282 nail Anatomy 0.000 description 13
- 229920001223 polyethylene glycol Polymers 0.000 description 13
- 229920000642 polymer Polymers 0.000 description 12
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 11
- 229910052708 sodium Inorganic materials 0.000 description 11
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 10
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 239000002202 Polyethylene glycol Substances 0.000 description 10
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 10
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- 229920005989 resin Polymers 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 9
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 235000013871 bee wax Nutrition 0.000 description 9
- 239000012166 beeswax Substances 0.000 description 9
- 239000007844 bleaching agent Substances 0.000 description 9
- 230000032050 esterification Effects 0.000 description 9
- 238000005886 esterification reaction Methods 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 239000010408 film Substances 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 9
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 9
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 9
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 229920002125 Sokalan® Polymers 0.000 description 8
- 235000021355 Stearic acid Nutrition 0.000 description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 description 8
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 8
- 230000001681 protective effect Effects 0.000 description 8
- 239000000341 volatile oil Substances 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 7
- 239000005711 Benzoic acid Substances 0.000 description 7
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 7
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 7
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 7
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 235000010233 benzoic acid Nutrition 0.000 description 7
- 239000001569 carbon dioxide Substances 0.000 description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 238000004140 cleaning Methods 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000001815 facial effect Effects 0.000 description 7
- 125000000524 functional group Chemical group 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 239000002207 metabolite Substances 0.000 description 7
- 239000012188 paraffin wax Substances 0.000 description 7
- 229960002477 riboflavin Drugs 0.000 description 7
- 150000004760 silicates Chemical class 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 6
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 6
- 150000001450 anions Chemical class 0.000 description 6
- 239000002246 antineoplastic agent Substances 0.000 description 6
- 235000019445 benzyl alcohol Nutrition 0.000 description 6
- 229960004217 benzyl alcohol Drugs 0.000 description 6
- 159000000007 calcium salts Chemical class 0.000 description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 235000017471 coenzyme Q10 Nutrition 0.000 description 6
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 229940127089 cytotoxic agent Drugs 0.000 description 6
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 6
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 6
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 6
- 229960004063 propylene glycol Drugs 0.000 description 6
- 235000013772 propylene glycol Nutrition 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000010703 silicon Substances 0.000 description 6
- 229910052710 silicon Inorganic materials 0.000 description 6
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 6
- AOSFMYBATFLTAQ-UHFFFAOYSA-N 1-amino-3-(benzimidazol-1-yl)propan-2-ol Chemical compound C1=CC=C2N(CC(O)CN)C=NC2=C1 AOSFMYBATFLTAQ-UHFFFAOYSA-N 0.000 description 5
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 5
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 5
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 5
- 241000207840 Jasminum Species 0.000 description 5
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 244000044822 Simmondsia californica Species 0.000 description 5
- 235000004433 Simmondsia californica Nutrition 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 235000010443 alginic acid Nutrition 0.000 description 5
- 229920000615 alginic acid Polymers 0.000 description 5
- 239000001099 ammonium carbonate Substances 0.000 description 5
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 5
- 239000000440 bentonite Substances 0.000 description 5
- 229910000278 bentonite Inorganic materials 0.000 description 5
- 229940092782 bentonite Drugs 0.000 description 5
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 239000006229 carbon black Substances 0.000 description 5
- 229940081733 cetearyl alcohol Drugs 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 230000007803 itching Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 5
- 235000005152 nicotinamide Nutrition 0.000 description 5
- 239000011570 nicotinamide Substances 0.000 description 5
- 230000000474 nursing effect Effects 0.000 description 5
- BCTWNMTZAXVEJL-UHFFFAOYSA-N phosphane;tungsten;tetracontahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.P.[W].[W].[W].[W].[W].[W].[W].[W].[W].[W].[W].[W] BCTWNMTZAXVEJL-UHFFFAOYSA-N 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 5
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000019260 propionic acid Nutrition 0.000 description 5
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 229910052709 silver Inorganic materials 0.000 description 5
- 239000004332 silver Substances 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 235000010199 sorbic acid Nutrition 0.000 description 5
- 229960004793 sucrose Drugs 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- 239000004408 titanium dioxide Substances 0.000 description 5
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 5
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 5
- 235000012141 vanillin Nutrition 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 4
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 4
- ALKCLFLTXBBMMP-UHFFFAOYSA-N 3,7-dimethylocta-1,6-dien-3-yl hexanoate Chemical compound CCCCCC(=O)OC(C)(C=C)CCC=C(C)C ALKCLFLTXBBMMP-UHFFFAOYSA-N 0.000 description 4
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 4
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 4
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 4
- 244000144927 Aloe barbadensis Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 4
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 4
- 240000007575 Macadamia integrifolia Species 0.000 description 4
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 4
- 239000000020 Nitrocellulose Substances 0.000 description 4
- 244000025272 Persea americana Species 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 4
- 238000004630 atomic force microscopy Methods 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 239000003139 biocide Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 4
- 229940067596 butylparaben Drugs 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 4
- 239000002734 clay mineral Substances 0.000 description 4
- 229940110767 coenzyme Q10 Drugs 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 229940086555 cyclomethicone Drugs 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 4
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 4
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 4
- 230000029142 excretion Effects 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 235000019256 formaldehyde Nutrition 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 4
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 4
- 208000005005 intertrigo Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 229920001220 nitrocellulos Polymers 0.000 description 4
- 235000019645 odor Nutrition 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 235000011837 pasties Nutrition 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 238000001907 polarising light microscopy Methods 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 229920006324 polyoxymethylene Polymers 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 4
- 229960003415 propylparaben Drugs 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 229940083037 simethicone Drugs 0.000 description 4
- 239000001540 sodium lactate Substances 0.000 description 4
- 235000011088 sodium lactate Nutrition 0.000 description 4
- 229940005581 sodium lactate Drugs 0.000 description 4
- 229940001584 sodium metabisulfite Drugs 0.000 description 4
- 235000010262 sodium metabisulphite Nutrition 0.000 description 4
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 4
- 239000004334 sorbic acid Substances 0.000 description 4
- 229940075582 sorbic acid Drugs 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 229960003500 triclosan Drugs 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000007762 w/o emulsion Substances 0.000 description 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 3
- OWEGWHBOCFMBLP-UHFFFAOYSA-N 1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one Chemical compound C1=CN=CN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 OWEGWHBOCFMBLP-UHFFFAOYSA-N 0.000 description 3
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- KOZZOZYINRDZOU-UHFFFAOYSA-N 2-octadecoxyethyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOCCOC(=O)C(C)=C KOZZOZYINRDZOU-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 3
- LVDKZNITIUWNER-UHFFFAOYSA-N Bronopol Chemical compound OCC(Br)(CO)[N+]([O-])=O LVDKZNITIUWNER-UHFFFAOYSA-N 0.000 description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 3
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 3
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 3
- 208000004434 Calcinosis Diseases 0.000 description 3
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 3
- 235000004310 Cinnamomum zeylanicum Nutrition 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 235000004866 D-panthenol Nutrition 0.000 description 3
- 239000011703 D-panthenol Substances 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 3
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 3
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 235000010254 Jasminum officinale Nutrition 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 125000005250 alkyl acrylate group Chemical group 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 3
- ZZTCCAPMZLDHFM-UHFFFAOYSA-N ammonium thioglycolate Chemical compound [NH4+].[O-]C(=O)CS ZZTCCAPMZLDHFM-UHFFFAOYSA-N 0.000 description 3
- 230000000118 anti-neoplastic effect Effects 0.000 description 3
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 3
- 235000021302 avocado oil Nutrition 0.000 description 3
- 239000008163 avocado oil Substances 0.000 description 3
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 3
- KYZHGEFMXZOSJN-UHFFFAOYSA-N benzoic acid isobutyl ester Natural products CC(C)COC(=O)C1=CC=CC=C1 KYZHGEFMXZOSJN-UHFFFAOYSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 235000011132 calcium sulphate Nutrition 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- QDOXWKRWXJOMAK-UHFFFAOYSA-N dichromium trioxide Chemical compound O=[Cr]O[Cr]=O QDOXWKRWXJOMAK-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 229960002949 fluorouracil Drugs 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 210000004392 genitalia Anatomy 0.000 description 3
- 229960000587 glutaral Drugs 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 159000000003 magnesium salts Chemical class 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000004200 microcrystalline wax Substances 0.000 description 3
- 235000019808 microcrystalline wax Nutrition 0.000 description 3
- 229910052750 molybdenum Inorganic materials 0.000 description 3
- 239000011733 molybdenum Substances 0.000 description 3
- 229910052901 montmorillonite Inorganic materials 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 231100001143 noxa Toxicity 0.000 description 3
- 229960002446 octanoic acid Drugs 0.000 description 3
- 230000000771 oncological effect Effects 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 239000001688 paprika extract Substances 0.000 description 3
- 235000012658 paprika extract Nutrition 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- AVFBYUADVDVJQL-UHFFFAOYSA-N phosphoric acid;trioxotungsten;hydrate Chemical compound O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O AVFBYUADVDVJQL-UHFFFAOYSA-N 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 229920001456 poly(acrylic acid sodium salt) Polymers 0.000 description 3
- 229920002689 polyvinyl acetate Polymers 0.000 description 3
- 239000011118 polyvinyl acetate Substances 0.000 description 3
- 235000010408 potassium alginate Nutrition 0.000 description 3
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 3
- 239000011164 primary particle Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 3
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 3
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristoyl-sn-glycerol Natural products CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 3
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000010937 tungsten Substances 0.000 description 3
- 229910052720 vanadium Inorganic materials 0.000 description 3
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 2
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 2
- GBNVXYXIRHSYEG-UHFFFAOYSA-N 1-chloro-2-ethylsulfanylethane Chemical compound CCSCCCl GBNVXYXIRHSYEG-UHFFFAOYSA-N 0.000 description 2
- LIPRCTSGLFLUNJ-UHFFFAOYSA-N 1-chloro-2-ethylsulfinylethane Chemical compound CCS(=O)CCCl LIPRCTSGLFLUNJ-UHFFFAOYSA-N 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- WSWCOQWTEOXDQX-UHFFFAOYSA-N 2,4-Hexadienoic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 2
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- KWIPUXXIFQQMKN-UHFFFAOYSA-N 2-azaniumyl-3-(4-cyanophenyl)propanoate Chemical compound OC(=O)C(N)CC1=CC=C(C#N)C=C1 KWIPUXXIFQQMKN-UHFFFAOYSA-N 0.000 description 2
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 description 2
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- BXCRLBBIZJSWNS-UHFFFAOYSA-N 2-hydroxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCO BXCRLBBIZJSWNS-UHFFFAOYSA-N 0.000 description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- GCZLBHOAHLBGEA-UHFFFAOYSA-N 3-butyl-1,2-benzothiazole 1-oxide Chemical compound C1=CC=C2C(CCCC)=NS(=O)C2=C1 GCZLBHOAHLBGEA-UHFFFAOYSA-N 0.000 description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- YXVSKJDFNJFXAJ-UHFFFAOYSA-N 4-cyclohexyl-2-methylbutan-2-ol Chemical compound CC(C)(O)CCC1=CC=CC=C1 YXVSKJDFNJFXAJ-UHFFFAOYSA-N 0.000 description 2
- 229940046305 5-bromo-5-nitro-1,3-dioxane Drugs 0.000 description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 235000021537 Beetroot Nutrition 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 235000002568 Capsicum frutescens Nutrition 0.000 description 2
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 235000009088 Citrus pyriformis Nutrition 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- LIKYNOPXHGPMIH-UHFFFAOYSA-N Dillapiole Chemical compound C=CCC1=C(OC)C(OC)=C2OCOC2=C1 LIKYNOPXHGPMIH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- 241000183672 Echium plantagineum Species 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 240000009088 Fragaria x ananassa Species 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 102000006992 Interferon-alpha Human genes 0.000 description 2
- 108010047761 Interferon-alpha Proteins 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- FEXQDZTYJVXMOS-UHFFFAOYSA-N Isopropyl benzoate Chemical compound CC(C)OC(=O)C1=CC=CC=C1 FEXQDZTYJVXMOS-UHFFFAOYSA-N 0.000 description 2
- 239000002310 Isopropyl citrate Substances 0.000 description 2
- XBLJCYOUYPSETL-UHFFFAOYSA-N Isopropyl citrate Chemical compound CC(C)O.CC(=O)CC(O)(C(O)=O)CC(O)=O XBLJCYOUYPSETL-UHFFFAOYSA-N 0.000 description 2
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 108010000817 Leuprolide Proteins 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 241000208467 Macadamia Species 0.000 description 2
- MQHWFIOJQSCFNM-UHFFFAOYSA-L Magnesium salicylate Chemical compound [Mg+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O MQHWFIOJQSCFNM-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 244000042664 Matricaria chamomilla Species 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 235000008673 Persea americana Nutrition 0.000 description 2
- 235000011236 Persea americana var americana Nutrition 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920001131 Pulp (paper) Polymers 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 240000007651 Rubus glaucus Species 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000004904 UV filter Substances 0.000 description 2
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229940090948 ammonium benzoate Drugs 0.000 description 2
- 235000012501 ammonium carbonate Nutrition 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 229940075861 ammonium thioglycolate Drugs 0.000 description 2
- 230000000340 anti-metabolite Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 229940100197 antimetabolite Drugs 0.000 description 2
- 239000002256 antimetabolite Substances 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- XJMWHXZUIGHOBA-UHFFFAOYSA-N azane;propanoic acid Chemical compound N.CCC(O)=O XJMWHXZUIGHOBA-UHFFFAOYSA-N 0.000 description 2
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- UDEWPOVQBGFNGE-UHFFFAOYSA-N benzoic acid n-propyl ester Natural products CCCOC(=O)C1=CC=CC=C1 UDEWPOVQBGFNGE-UHFFFAOYSA-N 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- YKGYQYOQRGPFTO-UHFFFAOYSA-N bis(8-methylnonyl) hexanedioate Chemical compound CC(C)CCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC(C)C YKGYQYOQRGPFTO-UHFFFAOYSA-N 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- XVBRCOKDZVQYAY-UHFFFAOYSA-N bronidox Chemical compound [O-][N+](=O)C1(Br)COCOC1 XVBRCOKDZVQYAY-UHFFFAOYSA-N 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- XSIFPSYPOVKYCO-UHFFFAOYSA-N butyl benzoate Chemical compound CCCCOC(=O)C1=CC=CC=C1 XSIFPSYPOVKYCO-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010331 calcium propionate Nutrition 0.000 description 2
- 239000004330 calcium propionate Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 235000013736 caramel Nutrition 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 239000004203 carnauba wax Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 2
- 229960004926 chlorobutanol Drugs 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 229960003993 chlorphenesin Drugs 0.000 description 2
- 229960003344 climbazole Drugs 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000011258 core-shell material Substances 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- 239000011928 denatured alcohol Substances 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 238000004851 dishwashing Methods 0.000 description 2
- 235000019820 disodium diphosphate Nutrition 0.000 description 2
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229960004679 doxorubicin Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229940043259 farnesol Drugs 0.000 description 2
- 229930002886 farnesol Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 2
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 2
- 229960001915 hexamidine Drugs 0.000 description 2
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 235000013847 iso-butane Nutrition 0.000 description 2
- 235000019300 isopropyl citrate Nutrition 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 2
- 229960004338 leuprorelin Drugs 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 239000008206 lipophilic material Substances 0.000 description 2
- 239000012263 liquid product Substances 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- PJJZFXPJNUVBMR-UHFFFAOYSA-L magnesium benzoate Chemical compound [Mg+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 PJJZFXPJNUVBMR-UHFFFAOYSA-L 0.000 description 2
- CQQJGTPWCKCEOQ-UHFFFAOYSA-L magnesium dipropionate Chemical compound [Mg+2].CCC([O-])=O.CCC([O-])=O CQQJGTPWCKCEOQ-UHFFFAOYSA-L 0.000 description 2
- 229940072082 magnesium salicylate Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- KZMACGJDUUWFCH-UHFFFAOYSA-O malvidin Chemical compound COC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 KZMACGJDUUWFCH-UHFFFAOYSA-O 0.000 description 2
- 239000008204 material by function Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- JPMIIZHYYWMHDT-UHFFFAOYSA-N octhilinone Chemical compound CCCCCCCCN1SC=CC1=O JPMIIZHYYWMHDT-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000010292 orthophenyl phenol Nutrition 0.000 description 2
- 229940070805 p-chloro-m-cresol Drugs 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- LQPLDXQVILYOOL-UHFFFAOYSA-I pentasodium;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)CC([O-])=O LQPLDXQVILYOOL-UHFFFAOYSA-I 0.000 description 2
- 239000010702 perfluoropolyether Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229940106026 phenoxyisopropanol Drugs 0.000 description 2
- FCJSHPDYVMKCHI-UHFFFAOYSA-N phenyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OC1=CC=CC=C1 FCJSHPDYVMKCHI-UHFFFAOYSA-N 0.000 description 2
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 2
- 230000001699 photocatalysis Effects 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229940068965 polysorbates Drugs 0.000 description 2
- 239000000737 potassium alginate Substances 0.000 description 2
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 description 2
- 235000010235 potassium benzoate Nutrition 0.000 description 2
- 239000004300 potassium benzoate Substances 0.000 description 2
- 229940103091 potassium benzoate Drugs 0.000 description 2
- 239000001508 potassium citrate Substances 0.000 description 2
- 229960002635 potassium citrate Drugs 0.000 description 2
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 2
- 235000011082 potassium citrates Nutrition 0.000 description 2
- BWILYWWHXDGKQA-UHFFFAOYSA-M potassium propanoate Chemical compound [K+].CCC([O-])=O BWILYWWHXDGKQA-UHFFFAOYSA-M 0.000 description 2
- 235000010332 potassium propionate Nutrition 0.000 description 2
- 239000004331 potassium propionate Substances 0.000 description 2
- FRMWBRPWYBNAFB-UHFFFAOYSA-M potassium salicylate Chemical compound [K+].OC1=CC=CC=C1C([O-])=O FRMWBRPWYBNAFB-UHFFFAOYSA-M 0.000 description 2
- 229960003629 potassium salicylate Drugs 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 238000001350 scanning transmission electron microscopy Methods 0.000 description 2
- 238000004574 scanning tunneling microscopy Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 2
- 235000019254 sodium formate Nutrition 0.000 description 2
- 239000000176 sodium gluconate Substances 0.000 description 2
- 235000012207 sodium gluconate Nutrition 0.000 description 2
- 229940005574 sodium gluconate Drugs 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 2
- 235000010334 sodium propionate Nutrition 0.000 description 2
- 239000004324 sodium propionate Substances 0.000 description 2
- 229960003212 sodium propionate Drugs 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 235000019250 sodium sorbate Nutrition 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- 238000004627 transmission electron microscopy Methods 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 229960001325 triclocarban Drugs 0.000 description 2
- 239000001069 triethyl citrate Substances 0.000 description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 2
- 235000013769 triethyl citrate Nutrition 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- HOFQVRTUGATRFI-XQKSVPLYSA-N vinblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1N=C1[C]2C=CC=C1 HOFQVRTUGATRFI-XQKSVPLYSA-N 0.000 description 2
- 229960003048 vinblastine Drugs 0.000 description 2
- 229920003176 water-insoluble polymer Polymers 0.000 description 2
- 238000007704 wet chemistry method Methods 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 2
- 229960002555 zidovudine Drugs 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011576 zinc lactate Substances 0.000 description 2
- 235000000193 zinc lactate Nutrition 0.000 description 2
- 229940050168 zinc lactate Drugs 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- ZXFNOEJFYLQUSB-UHFFFAOYSA-N (2-methyl-4-phenylbutan-2-yl) acetate Chemical compound CC(=O)OC(C)(C)CCC1=CC=CC=C1 ZXFNOEJFYLQUSB-UHFFFAOYSA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 1
- GVOIABOMXKDDGU-XRODXAHISA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Chemical compound O=C([C@@]1(C)C(C[C@H](O)C1)(C)C)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C GVOIABOMXKDDGU-XRODXAHISA-N 0.000 description 1
- GVOIABOMXKDDGU-LOFNIBRQSA-N (3S,3'S,5R,5'R)-3,3'-dihydroxy-kappa,kappa-carotene-6,6'-dione Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)C1(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C GVOIABOMXKDDGU-LOFNIBRQSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IFSYJVQRVQMRKN-ONEGZZNKSA-N (E)-hept-5-en-2-ol Chemical compound C\C=C\CCC(C)O IFSYJVQRVQMRKN-ONEGZZNKSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- YDDUMTOHNYZQPO-UHFFFAOYSA-N 1,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,5-dihydroxycyclohexanecarboxylic acid Natural products OC1C(O)CC(C(O)=O)(OC(=O)C=CC=2C=C(O)C(O)=CC=2)CC1OC(=O)C=CC1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-UHFFFAOYSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- ZQCIPRGNRQXXSK-UHFFFAOYSA-N 1-octadecoxypropan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCOCC(C)O ZQCIPRGNRQXXSK-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VCRZAKVGPJFABU-UHFFFAOYSA-N 10-phenoxarsinin-10-yloxyphenoxarsinine Chemical compound C12=CC=CC=C2OC2=CC=CC=C2[As]1O[As]1C2=CC=CC=C2OC2=CC=CC=C21 VCRZAKVGPJFABU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QAQJMLQRFWZOBN-UHFFFAOYSA-N 2-(3,4-dihydroxy-5-oxo-2,5-dihydrofuran-2-yl)-2-hydroxyethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)C1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-UHFFFAOYSA-N 0.000 description 1
- RFIMISVNSAUMBU-UHFFFAOYSA-N 2-(hydroxymethyl)-2-(prop-2-enoxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC=C RFIMISVNSAUMBU-UHFFFAOYSA-N 0.000 description 1
- USPWZHPEKZNJMB-UHFFFAOYSA-N 2-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]propanedioic acid Chemical compound COC1=CC(C=C(C(O)=O)C(O)=O)=CC(OC)=C1O USPWZHPEKZNJMB-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-O 2-ammonio-3-(1H-imidazol-3-ium-4-yl)propanoate Chemical compound [O-]C(=O)C([NH3+])CC1=C[NH+]=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-O 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- FSAMVJAGJWGWTQ-UHFFFAOYSA-N 2-hexadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCOCCO FSAMVJAGJWGWTQ-UHFFFAOYSA-N 0.000 description 1
- FEWFXBUNENSNBQ-UHFFFAOYSA-N 2-hydroxyacrylic acid Chemical class OC(=C)C(O)=O FEWFXBUNENSNBQ-UHFFFAOYSA-N 0.000 description 1
- DUAYDERMVQWIJD-UHFFFAOYSA-N 2-n,2-n,6-trimethyl-1,3,5-triazine-2,4-diamine Chemical compound CN(C)C1=NC(C)=NC(N)=N1 DUAYDERMVQWIJD-UHFFFAOYSA-N 0.000 description 1
- KDTZBYPBMTXCSO-UHFFFAOYSA-N 2-phenoxyphenol Chemical class OC1=CC=CC=C1OC1=CC=CC=C1 KDTZBYPBMTXCSO-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- WHBKVWBGTBULQY-UHFFFAOYSA-N 2-propylheptyl octanoate Chemical compound CCCCCCCC(=O)OCC(CCC)CCCCC WHBKVWBGTBULQY-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XORSRAGWEHXCIR-UHFFFAOYSA-N 3-(8,8-dichlorooctyl)-1,2-thiazol-4-one Chemical compound ClC(Cl)CCCCCCCC1=NSCC1=O XORSRAGWEHXCIR-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 1
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 1
- MKNQNPYGAQGARI-UHFFFAOYSA-N 4-(bromomethyl)phenol Chemical compound OC1=CC=C(CBr)C=C1 MKNQNPYGAQGARI-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- MSLKMRUEVOYOOZ-VBYMZDBQSA-L 519-62-0 Chemical compound [Mg+2].[N-]1C2=C(C=3[C@H]([C@H](C)C(=CC=4C(=C(C=C)C(=C5)N=4)C)N=3)CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@@H](C(=O)OC)C([O-])=C2C(C)=C1C=C1C(CC)=C(C=O)C5=N1 MSLKMRUEVOYOOZ-VBYMZDBQSA-L 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000004910 After sun product Substances 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 241001520764 Betula pubescens Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 101100042649 Bombyx mori Siwi gene Proteins 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241001131796 Botaurus stellaris Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- WDSYLXCAQXWZTN-UHFFFAOYSA-L C(C1=CC=CC=C1)(=O)[O-].[Ca+2].C(CCC)OC(C1=CC=C(C=C1)O)=O.C(C1=CC=CC=C1)(=O)[O-] Chemical compound C(C1=CC=CC=C1)(=O)[O-].[Ca+2].C(CCC)OC(C1=CC=C(C=C1)O)=O.C(C1=CC=CC=C1)(=O)[O-] WDSYLXCAQXWZTN-UHFFFAOYSA-L 0.000 description 1
- AHCRHXQRAZBRFR-UHFFFAOYSA-L C(C=1C(O)=CC=CC1)(=O)[O-].[Ca+2].C(CC)(=O)O.C(C=1C(O)=CC=CC1)(=O)[O-] Chemical compound C(C=1C(O)=CC=CC1)(=O)[O-].[Ca+2].C(CC)(=O)O.C(C=1C(O)=CC=CC1)(=O)[O-] AHCRHXQRAZBRFR-UHFFFAOYSA-L 0.000 description 1
- ZCTLCGANNMQEOS-UHFFFAOYSA-N C(CCCCCCCCCC)[N+](C[C-]1C=CC=C1)(C)C.[CH-]1C=CC=C1.[Fe+2] Chemical compound C(CCCCCCCCCC)[N+](C[C-]1C=CC=C1)(C)C.[CH-]1C=CC=C1.[Fe+2] ZCTLCGANNMQEOS-UHFFFAOYSA-N 0.000 description 1
- MAIMIZSGBCBYMI-UHFFFAOYSA-N C(CCCCCCCCCCCCCC)[N+](C[C-]1C=CC=C1)(C)C.[CH-]1C=CC=C1.[Fe+2] Chemical compound C(CCCCCCCCCCCCCC)[N+](C[C-]1C=CC=C1)(C)C.[CH-]1C=CC=C1.[Fe+2] MAIMIZSGBCBYMI-UHFFFAOYSA-N 0.000 description 1
- MUXXJYUJQMPUIX-UHFFFAOYSA-N C(CCCCCCCCCCCCCCCCC)(=O)OCC(C)OC(CCCCCCCCCCCCCCCCC)=O.C(CCCCCCCCCCCCCCCCC)(=O)OCC(C)OC(CCCCCCCCCCCCCCCCC)=O Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)OCC(C)OC(CCCCCCCCCCCCCCCCC)=O.C(CCCCCCCCCCCCCCCCC)(=O)OCC(C)OC(CCCCCCCCCCCCCCCCC)=O MUXXJYUJQMPUIX-UHFFFAOYSA-N 0.000 description 1
- KFTDQZGVWCRMGQ-QMFOHGQOSA-L C(\C=C\C=C\C)(=O)[O-].[Ca+2].C(C=1C(O)=CC=CC1)(=O)O.C(\C=C\C=C\C)(=O)[O-] Chemical compound C(\C=C\C=C\C)(=O)[O-].[Ca+2].C(C=1C(O)=CC=CC1)(=O)O.C(\C=C\C=C\C)(=O)[O-] KFTDQZGVWCRMGQ-QMFOHGQOSA-L 0.000 description 1
- 241000117451 Camellia euryoides Species 0.000 description 1
- 101100188540 Candida albicans (strain SC5314 / ATCC MYA-2876) OBPA gene Proteins 0.000 description 1
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 1
- GVOIABOMXKDDGU-SUKXYCKUSA-N Capsorubin Natural products O=C(/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/C(=O)[C@@]1(C)C(C)(C)C[C@H](O)C1)\C)/C)\C)/C)[C@@]1(C)C(C)(C)C[C@H](O)C1 GVOIABOMXKDDGU-SUKXYCKUSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000871264 Cardiospermum halicacabum Species 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000021512 Cinnamomum verum Nutrition 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000016649 Copaifera officinalis Species 0.000 description 1
- 239000004859 Copal Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000003393 Curcuma xanthorrhiza Nutrition 0.000 description 1
- 244000164418 Curcuma xanthorrhiza Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- SITQVDJAXQSXSA-CEZRHVESSA-N Cynarin Natural products O[C@@H]1C[C@@](C[C@H](O)[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)(OC(=O)C=Cc3cccc(O)c3O)C(=O)O SITQVDJAXQSXSA-CEZRHVESSA-N 0.000 description 1
- YDDUMTOHNYZQPO-RVXRWRFUSA-N Cynarine Chemical compound O([C@@H]1C[C@@](C[C@H]([C@@H]1O)O)(OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C(O)=O)C(=O)\C=C\C1=CC=C(O)C(O)=C1 YDDUMTOHNYZQPO-RVXRWRFUSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 206010061619 Deformity Diseases 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- WSWCOQWTEOXDQX-MQQKCMAXSA-N E-Sorbic acid Chemical compound C\C=C\C=C\C(O)=O WSWCOQWTEOXDQX-MQQKCMAXSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241001070947 Fagus Species 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000020061 Hand, Foot and Mouth Disease Diseases 0.000 description 1
- 208000025713 Hand-foot-and-mouth disease Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 235000010702 Insulata Nutrition 0.000 description 1
- 244000165077 Insulata Species 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 241000208473 Macadamia ternifolia Species 0.000 description 1
- HQLLRHCTVDVUJB-OBHOOXMTSA-N Marrubiin Chemical compound C([C@]1(O)[C@@]2(C)CCC[C@]3(C)C(=O)O[C@@H]([C@H]23)C[C@H]1C)CC=1C=COC=1 HQLLRHCTVDVUJB-OBHOOXMTSA-N 0.000 description 1
- HQLLRHCTVDVUJB-UHFFFAOYSA-N Marrubiin Natural products CC1CC(C23)OC(=O)C3(C)CCCC2(C)C1(O)CCC=1C=COC=1 HQLLRHCTVDVUJB-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- GLQBQXYLMFHHIA-UHFFFAOYSA-N N.S(=O)(O)O.C(C1=CC=CC=C1)(=O)O Chemical compound N.S(=O)(O)O.C(C1=CC=CC=C1)(=O)O GLQBQXYLMFHHIA-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DEEBSFQUBNJYAC-UHFFFAOYSA-H O.O.O.O.O.O.O.P(=O)([O-])([O-])[O-].[Mn+2].P(=O)([O-])([O-])[O-].[Mn+2].[Mn+2] Chemical compound O.O.O.O.O.O.O.P(=O)([O-])([O-])[O-].[Mn+2].P(=O)([O-])([O-])[O-].[Mn+2].[Mn+2] DEEBSFQUBNJYAC-UHFFFAOYSA-H 0.000 description 1
- NXPRVMLOWWEISE-UHFFFAOYSA-N O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1.C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 Chemical compound O1[SiH2]O[SiH2]O[SiH2]O[SiH2]O[SiH2]1.C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 NXPRVMLOWWEISE-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033553 Palmar-plantar erythrodysaesthesia syndrome Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000008582 Pinus sylvestris Nutrition 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Chemical group 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 206010062106 Respiratory tract infection viral Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000004828 Rosa odorata Nutrition 0.000 description 1
- 240000002289 Rosa odorata Species 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HRKAMJBPFPHCSD-UHFFFAOYSA-N Tri-isobutylphosphate Chemical compound CC(C)COP(=O)(OCC(C)C)OCC(C)C HRKAMJBPFPHCSD-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 229940122803 Vinca alkaloid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003776 Vitamin B4 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- GCSPRLPXTPMSTL-IBDNADADSA-N [(2s,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[C@@]1([C@]2(CO)[C@H]([C@H](O)[C@@H](CO)O2)O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GCSPRLPXTPMSTL-IBDNADADSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- QMSISMSXLXRDKS-UHFFFAOYSA-I [O-]P([O-])(=O)OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[O-]P(O)(=O)OP(=O)(O)O.[Na+].[Na+] Chemical compound [O-]P([O-])(=O)OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[O-]P(O)(=O)OP(=O)(O)O.[Na+].[Na+] QMSISMSXLXRDKS-UHFFFAOYSA-I 0.000 description 1
- XGXZPVHXOMQSIT-UHFFFAOYSA-N [W].O[Si](O)(O)O Chemical compound [W].O[Si](O)(O)O XGXZPVHXOMQSIT-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000003655 absorption accelerator Substances 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 229910052768 actinide Inorganic materials 0.000 description 1
- 150000001255 actinides Chemical class 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 108700025316 aldesleukin Proteins 0.000 description 1
- 229960005310 aldesleukin Drugs 0.000 description 1
- 239000003619 algicide Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 230000002152 alkylating effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000012935 ammoniumperoxodisulfate Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000010828 animal waste Substances 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000798 anti-retroviral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-O argininium(1+) Chemical compound NC(=[NH2+])NCCCC([NH3+])C([O-])=O ODKSFYDXXFIFQN-UHFFFAOYSA-O 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229940098396 barley grain Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 229960003872 benzethonium Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 229920000704 biodegradable plastic Polymers 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- NUHCTOLBWMJMLX-UHFFFAOYSA-N bromothymol blue Chemical compound BrC1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=C(Br)C(O)=C(C(C)C)C=2)C)=C1C NUHCTOLBWMJMLX-UHFFFAOYSA-N 0.000 description 1
- 229960003168 bronopol Drugs 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- SKKTUOZKZKCGTB-UHFFFAOYSA-N butyl carbamate Chemical compound CCCCOC(N)=O SKKTUOZKZKCGTB-UHFFFAOYSA-N 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000281 calcium bentonite Inorganic materials 0.000 description 1
- NSQPPSOSXWOZNH-UHFFFAOYSA-L calcium benzoate Chemical compound [Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 NSQPPSOSXWOZNH-UHFFFAOYSA-L 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- AVVIDTZRJBSXML-UHFFFAOYSA-L calcium;2-carboxyphenolate;dihydrate Chemical compound O.O.[Ca+2].OC1=CC=CC=C1C([O-])=O.OC1=CC=CC=C1C([O-])=O AVVIDTZRJBSXML-UHFFFAOYSA-L 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 1
- 235000018889 capsanthin Nutrition 0.000 description 1
- 235000009132 capsorubin Nutrition 0.000 description 1
- 229910021387 carbon allotrope Inorganic materials 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- YAYRGNWWLMLWJE-UHFFFAOYSA-L carboplatin Chemical compound O=C1O[Pt](N)(N)OC(=O)C11CCC1 YAYRGNWWLMLWJE-UHFFFAOYSA-L 0.000 description 1
- 229960004562 carboplatin Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 229960005243 carmustine Drugs 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229960003431 cetrimonium Drugs 0.000 description 1
- 229960002788 cetrimonium chloride Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical compound OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 description 1
- 208000002849 chondrocalcinosis Diseases 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- CYYGBBNBGCVXEL-UHFFFAOYSA-N chromium(3+);oxygen(2-);dihydrate Chemical compound O.O.[O-2].[O-2].[O-2].[Cr+3].[Cr+3] CYYGBBNBGCVXEL-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011335 coal coke Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 229910052607 cyclosilicate Inorganic materials 0.000 description 1
- YDDUMTOHNYZQPO-BKUKFAEQSA-N cynarine Natural products O[C@H]1C[C@@](C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)(OC(=O)C=Cc3ccc(O)c(O)c3)C(=O)O YDDUMTOHNYZQPO-BKUKFAEQSA-N 0.000 description 1
- 229950009125 cynarine Drugs 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- LTXHKPDRHPMBKA-UHFFFAOYSA-N dialuminum;cobalt(2+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Co+2] LTXHKPDRHPMBKA-UHFFFAOYSA-N 0.000 description 1
- ONCZQWJXONKSMM-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4].[Si+4].[Si+4].[Si+4] ONCZQWJXONKSMM-UHFFFAOYSA-N 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- QQJDHWMADUVRDL-UHFFFAOYSA-N didodecyl(dimethyl)azanium Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC QQJDHWMADUVRDL-UHFFFAOYSA-N 0.000 description 1
- SWSFKKWJEHRFFP-UHFFFAOYSA-N dihexadecyl(dimethyl)azanium Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC SWSFKKWJEHRFFP-UHFFFAOYSA-N 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- SIYLLGKDQZGJHK-UHFFFAOYSA-N dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 SIYLLGKDQZGJHK-UHFFFAOYSA-N 0.000 description 1
- CJBMLKNLJXFFGD-UHFFFAOYSA-N dimethyl-di(tetradecyl)azanium Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCC CJBMLKNLJXFFGD-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- AYBSICMEDZIQTK-UHFFFAOYSA-K dipotassium sodium phosphoric acid phosphate Chemical compound [Na+].[K+].[K+].OP(O)(O)=O.[O-]P([O-])([O-])=O AYBSICMEDZIQTK-UHFFFAOYSA-K 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229940038485 disodium pyrophosphate Drugs 0.000 description 1
- CEGDCUKGIQDKKW-UHFFFAOYSA-L disodium;2-hydroxypropane-1,2,3-tricarboxylic acid;carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O CEGDCUKGIQDKKW-UHFFFAOYSA-L 0.000 description 1
- 229960003668 docetaxel Drugs 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940045811 echinacea purpurea extract Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000012183 esparto wax Substances 0.000 description 1
- 229940052296 esters of benzoic acid for local anesthesia Drugs 0.000 description 1
- XLNZHTHIPQGEMX-UHFFFAOYSA-N ethane propane Chemical compound CCC.CCC.CC.CC XLNZHTHIPQGEMX-UHFFFAOYSA-N 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- GHUOUGGZZJXPRM-UHFFFAOYSA-N ethyl 2-amino-5-(4-chlorophenyl)-1,3-thiazole-4-carboxylate Chemical compound N1=C(N)SC(C=2C=CC(Cl)=CC=2)=C1C(=O)OCC GHUOUGGZZJXPRM-UHFFFAOYSA-N 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- YEQFXLJGRXZCFU-UHFFFAOYSA-N formaldehyde;4-methylbenzenesulfonamide Chemical compound O=C.CC1=CC=C(S(N)(=O)=O)C=C1 YEQFXLJGRXZCFU-UHFFFAOYSA-N 0.000 description 1
- QFKPPROZZUZXSO-UHFFFAOYSA-N formaldehyde;phenylmethanesulfonamide Chemical compound O=C.NS(=O)(=O)CC1=CC=CC=C1 QFKPPROZZUZXSO-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 230000001408 fungistatic effect Effects 0.000 description 1
- 239000006221 furniture coating Substances 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229960002687 ganciclovir sodium Drugs 0.000 description 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 1
- 229960005277 gemcitabine Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229940087073 glycol palmitate Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229950000038 interferon alfa Drugs 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- UETZVSHORCDDTH-UHFFFAOYSA-N iron(2+);hexacyanide Chemical compound [Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] UETZVSHORCDDTH-UHFFFAOYSA-N 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- QGPQTSCLUYMZHL-UHFFFAOYSA-N iron(3+);oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Fe+3].[Fe+3] QGPQTSCLUYMZHL-UHFFFAOYSA-N 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000012182 japan wax Substances 0.000 description 1
- 150000004715 keto acids Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- VJQAFLAZRVKAKM-QQUHWDOBSA-N lactucin Chemical compound O[C@@H]1CC(C)=C2C(=O)C=C(CO)[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 VJQAFLAZRVKAKM-QQUHWDOBSA-N 0.000 description 1
- VJQAFLAZRVKAKM-UHFFFAOYSA-N lactucine Natural products OC1CC(C)=C2C(=O)C=C(CO)C2C2OC(=O)C(=C)C21 VJQAFLAZRVKAKM-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229910052667 lazurite Inorganic materials 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940087875 leukine Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-O lysinium(1+) Chemical compound [NH3+]CCCCC([NH3+])C([O-])=O KDXKERNSBIXSRK-UHFFFAOYSA-O 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009584 malvidin Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
- OLXYLDUSSBULGU-UHFFFAOYSA-N methyl pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC=C1 OLXYLDUSSBULGU-UHFFFAOYSA-N 0.000 description 1
- HUZVOFBJZJVUBY-UHFFFAOYSA-N methyl(trioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCC HUZVOFBJZJVUBY-UHFFFAOYSA-N 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000005078 molybdenum compound Substances 0.000 description 1
- 150000002752 molybdenum compounds Chemical class 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000010935 mono and diglycerides of fatty acids Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- 230000001069 nematicidal effect Effects 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- OSTGTTZJOCZWJG-UHFFFAOYSA-N nitrosourea Chemical class NC(=O)N=NO OSTGTTZJOCZWJG-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229950004864 olamine Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000012168 ouricury wax Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000012187 peat wax Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- HKUHOPQRJKPJCJ-UHFFFAOYSA-N pelargonidin Natural products OC1=Cc2c(O)cc(O)cc2OC1c1ccc(O)cc1 HKUHOPQRJKPJCJ-UHFFFAOYSA-N 0.000 description 1
- 235000006251 pelargonidin Nutrition 0.000 description 1
- YPVZJXMTXCOTJN-UHFFFAOYSA-N pelargonidin chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C(C(=C1)O)=[O+]C2=C1C(O)=CC(O)=C2 YPVZJXMTXCOTJN-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- IZUPBVBPLAPZRR-UHFFFAOYSA-N pentachlorophenol Chemical compound OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl IZUPBVBPLAPZRR-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 229930015721 peonidin Natural products 0.000 description 1
- 235000006404 peonidin Nutrition 0.000 description 1
- OGBSHLKSHNAPEW-UHFFFAOYSA-N peonidin chloride Chemical compound [Cl-].C1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 OGBSHLKSHNAPEW-UHFFFAOYSA-N 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- WCNLCIJMFAJCPX-UHFFFAOYSA-N pethidine hydrochloride Chemical compound Cl.C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 WCNLCIJMFAJCPX-UHFFFAOYSA-N 0.000 description 1
- 229930015717 petunidin Natural products 0.000 description 1
- 235000006384 petunidin Nutrition 0.000 description 1
- QULMBDNPZCFSPR-UHFFFAOYSA-N petunidin chloride Chemical compound [Cl-].OC1=C(O)C(OC)=CC(C=2C(=CC=3C(O)=CC(O)=CC=3[O+]=2)O)=C1 QULMBDNPZCFSPR-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000005496 phosphonium group Chemical group 0.000 description 1
- PDDXOPNEMCREGN-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum;hydrate Chemical compound O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O PDDXOPNEMCREGN-UHFFFAOYSA-N 0.000 description 1
- 239000011941 photocatalyst Substances 0.000 description 1
- 238000005424 photoluminescence Methods 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000001839 pinus sylvestris Substances 0.000 description 1
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 1
- 229940081510 piroctone olamine Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920013639 polyalphaolefin Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Chemical group 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- HFTYFFXNUVBSII-UHFFFAOYSA-M potassium;4-ethoxycarbonylphenolate Chemical compound [K+].CCOC(=O)C1=CC=C([O-])C=C1 HFTYFFXNUVBSII-UHFFFAOYSA-M 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 229940078491 ppg-15 stearyl ether Drugs 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- YLQLIQIAXYRMDL-UHFFFAOYSA-N propylheptyl alcohol Chemical compound CCCCCC(CO)CCC YLQLIQIAXYRMDL-UHFFFAOYSA-N 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000008132 rose water Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 108010038379 sargramostim Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- ZLVSYODPTJZFMK-UHFFFAOYSA-M sodium 4-hydroxybenzoate Chemical compound [Na+].OC1=CC=C(C([O-])=O)C=C1 ZLVSYODPTJZFMK-UHFFFAOYSA-M 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000280 sodium bentonite Inorganic materials 0.000 description 1
- 229940080314 sodium bentonite Drugs 0.000 description 1
- 235000010268 sodium methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- DJDYMAHXZBQZKH-UHFFFAOYSA-M sodium;1-amino-4-(cyclohexylamino)-9,10-dioxoanthracene-2-sulfonate Chemical compound [Na+].C1=2C(=O)C3=CC=CC=C3C(=O)C=2C(N)=C(S([O-])(=O)=O)C=C1NC1CCCCC1 DJDYMAHXZBQZKH-UHFFFAOYSA-M 0.000 description 1
- JJICLMJFIKGAAU-UHFFFAOYSA-M sodium;2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate Chemical compound [Na+].NC1=NC([O-])=C2N=CN(COC(CO)CO)C2=N1 JJICLMJFIKGAAU-UHFFFAOYSA-M 0.000 description 1
- OGBHACNFHJJTQT-UHFFFAOYSA-M sodium;4-butoxycarbonylphenolate Chemical compound [Na+].CCCCOC(=O)C1=CC=C([O-])C=C1 OGBHACNFHJJTQT-UHFFFAOYSA-M 0.000 description 1
- QYNMSPKSYXPZHG-UHFFFAOYSA-M sodium;4-ethoxycarbonylphenolate Chemical compound [Na+].CCOC(=O)C1=CC=C([O-])C=C1 QYNMSPKSYXPZHG-UHFFFAOYSA-M 0.000 description 1
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 description 1
- IXMINYBUNCWGER-UHFFFAOYSA-M sodium;4-propoxycarbonylphenolate Chemical compound [Na+].CCCOC(=O)C1=CC=C([O-])C=C1 IXMINYBUNCWGER-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 229940070720 stearalkonium Drugs 0.000 description 1
- 125000005502 stearalkonium group Chemical group 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium group Chemical group [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical class OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000013460 sweaty Diseases 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 229910052645 tectosilicate Inorganic materials 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- 150000004685 tetrahydrates Chemical class 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229960004906 thiomersal Drugs 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910001428 transition metal ion Inorganic materials 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical compound OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 210000002396 uvula Anatomy 0.000 description 1
- 229940117960 vanillin Drugs 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000008979 vitamin B4 Nutrition 0.000 description 1
- 239000011579 vitamin B4 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000021468 vitamin B8 Nutrition 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000010803 wood ash Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940100530 zinc ricinoleate Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Definitions
- the present invention relates to topical preparations.
- the present invention relates to a process for the preparation of topical preparations.
- the present invention relates to the use of the topical preparations.
- the present invention relates to cosmetics, care products, products for saunas and steam baths, powders, solids, gels, creams, ointments, lotions, drops, sprays, metered aerosols, gargles, lozenges, enemas, enemas, foams, coatings on textile fabrics, face masks, Gauze, patches and medical devices and components of release materials containing or consisting of the topical preparations.
- Topical medicines or care products are understood in medicine and cosmetics to mean all those medicines or care products that are not taken or injected, but applied locally. Since local application of the drug is brought directly to the site of action, this can often reduce the dose as much as possible and thus reduce the risk of side effects. All superficial organs, ie the skin and mucous membranes of the respiratory tract, the digestive tract and the external eye are accessible to local treatment or care. But also an injection into a joint is a topical (local, intraarticular) treatment.
- Antibiotics can also be used topically, for example for bacterial skin infections. Sulfonamides are mainly used here.
- care products means, for example, products for hair care, for skin care, oral care and / or nail care.
- a very good example are care products for the sauna.
- a sauna product is used, which is applied to the skin and includes, among other things, black amber.
- the skin is often rubbed with salt before the sauna session. This is to help the body with the purification.
- Cleaning preparations for the skin and / or the hair contain surfactants, activated carbon having a particle size of 0.5 to 60 ⁇ m, pearlescing agents and / or at least one structural agent selected from the group of acrylate copolymers and alkoxylated thickeners, and also sodium chloride.
- an absorbent fire ointment which contains activated carbon powder of a particle size ⁇ 50 pm, an absorbent ointment matrix and an isotonic regulator.
- the activated carbon is added to an aqueous solution of sodium chloride, after which the water is evaporated.
- the burn ointment can effectively eliminate the burn wound toxins and prevent the growth of harmful bacteria in the wound. It promotes wound healing and cell proliferation in the wound tissue.
- the US patent application US 2013/0259913 A1 discloses particles which are not suitable for oral ingestion and contain at least two incompatible hydrophilic and lipophilic substances, the particles being produced by PGSS (Particles from Gas Saturated Solutions). Paraffin and microcrystalline wax may be considered as lipophilic material in addition to numerous other materials. Further information on the waxes are not made.
- the particles may be used in the manufacture of consumer products such as shampoos, personal cleansers, laundry detergents, dishwashing detergents, non-aqueous liquid products, soap bars, paper products, cosmetics, lotions or skin-care agents. From the US patent application US 2012/0258150 A1 particles are known which are produced by the PGSS process.
- the particles have a size of 1 nm to 1 mm, preferably 1 nm to 500 pm and contain a water-insoluble polymer and a volatile material, in particular a perfume or a raw material for perfume.
- a water-insoluble polymer and a volatile material in particular a perfume or a raw material for perfume.
- a water-insoluble polymer in particular a perfume or a raw material for perfume.
- paraffin and microcrystalline wax may be considered in addition to numerous other materials. Further information on the waxes are not made.
- the particles may be used in the manufacture of consumer products such as shampoos, personal cleansers, laundry detergents, dishwashing detergents, non-aqueous liquid products, soap bars, paper products, cosmetics, lotions or skin-care agents.
- a cosmetic composition which contains a combination of a film-forming polymers with 'a wax microdispersion.
- the wax particles preferably have average dimensions of less than 1 ⁇ m and preferably less than 0.5 ⁇ m.
- organic waxes are used.
- the cosmetic composition may contain alkali salts of organic bases and alkylsulfuric acids and alkylsulfonic acids as surfactants and organic pigments such as carbon black.
- German Patent DE 699 17 690 T3 discloses the use of a microdispersion of wax in a cosmetic or dermatological composition. Among other things, organic waxes are used. The microdispersion of wax is used as an active ingredient for the prevention and / or treatment of the appearance of wrinkles and / or wrinkles.
- German Offenlegungsschrift 10 2008 021 007 A1 discloses a microdispersion of waxes which contains inorganic particles of carbon allotropes, in particular carbon nanotubes.
- the microdispersion is used in cosmetics, especially nail varnishes.
- German published patent application DE 10 2012 214 662 A1 discloses a cosmetic composition with delayed release of active ingredient.
- the cosmetic composition contains, based in each case on the particle weight, 30 to 90% by weight of polyalphaolefin waxes and 10 to 70% by weight of one or more cosmetic active ingredients.
- European patent EP 1 235 546 B1 discloses the use of nanoscale waxes with particle diameters of 10 to 300 nm, which are encased by a protective colloid, for the production of surface-active preparations, such as hair treatment compositions.
- Protective colloids used are gelatin, casein, gum arabic, lysalbinic acid, starch, polyvinyl alcohols, polyvinylpyrrolidones, polyalkylene glycols and polyacrylates.
- the cosmetic preparations may also contain sodium chloride.
- a wax beeswax or sunflower wax is used.
- crystalline nanocellulose can be used in antiviral ointments.
- US Patent Application US 2015/0367024 A1 discloses the use of hydrogels of nanofibrillar cellulose for preventing and controlling the disfigurement of scars in wound healing or tissue repair.
- US Patent Application US 2017/0000903 A1 discloses the use of gels of crystalline cellulose in the field of cosmetics.
- the gels act as surfactants and can stabilize emulsions.
- US Patent Application US 2014/0083416 describes processes for producing microcrystalline and nanocrystalline cellulose. It is only cursory that the products can be used in food, cosmetics or medicine.
- microplastics or microbeads that are not biodegraded, for example as exfoliating particles.
- Microplasticity is released into the environment, especially in rivers, lakes and seas, where it accumulates in the food chain.
- the cosmetic industry is now anxious to find substitutes for microplastics.
- materials such as alumina, silica or ground nutshells are suggested as alternatives.
- shampoos containing phyllosilicates are already common products.
- European Patent Application EP 0 563 876 A2 proposes biodegradable microbeads for use in cosmetics and pharmaceuticals. These microbeads can be made by the reaction of glyceraldehyde with natural proteins such as gelatin, albumin and casein.
- US Patent Application US 2014/0026916 A1 proposes a process for the reduction of environmental pollution in aqueous systems, in which the use of polyhydroxyalkanoate microbeads in personal care products is proposed.
- the polyhydroxyalkanoate microbeads are said to rapidly sink in aqueous systems.
- microbeads based on biodegradable, starch-based thermoplastic polymers as described in the European patent EP 2 493 975 B1. These products are commercially available under the trademark Solanyl®.
- biocides are listed by way of example:
- biocides are 10,10'-oxybisphenoxoarsine (OBPA), octylisothiazolinone (OIT), dichloroctylisothiazolinone (DCOIT), butylbenzisothiazolinone (BBIT), iodocarb (3-iodo-2-propynylbutylcabamate), zinc pyrithione (zinc salt of pyridine-2-one).
- thiol-1-oxide trichlosan (polychlorinated phenoxyphenols), silver ions and silver, especially in the form of silver nanoparticles.
- the known biocides have disadvantages such as a narrow range of applications, a comparatively high toxicity, the tendency to cause resistance and cross-resistance and a still largely unexplained ecological long-term effect.
- Polyoxometalates are inorganic polyacids with - in contrast to isopolyacids - at least two different central atoms.
- the second central atom may also be actinide or lanthanide;
- the tungsten heteropolyacids are thermally much more stable than the analogous molybdenum compounds.
- E eg, boron, silicon, zinc
- the heterohexametallate type [(E0 6 ) M 6 O 18 ] ni 2 (Anderson-Evans anions) is frequently found [cf. Römpp Online, Version 3.47 "Heteropolyacids"].
- US Pat. Nos. 5,824,706 and 6,020,369 disclose the prevention and treatment of respiratory viral infections in which a POM-containing aerosol spray is applied to the lungs.
- topical POM-containing compositions with the aid of which pollutants, in particular warfare agents, are removed from the environment. Additionally, the topical compositions may still contain cerium, silver, gold, or platinum compounds. In particular, perfluoropolyethers (PFPE) can be used as the carrier.
- PFPE perfluoropolyethers
- CEES 2-chloroethylethyl sulfide
- CEESO 2-chloroethylethyl sulfoxide
- a bleaching agent which contains peroxide and an activator.
- the activator may be tungsten silicic acid.
- the bleach can remove mold and fungus from tiles and curtains.
- Japanese Unexamined Patent Publication JP 002005281299 A discloses the use of potassium salt of 12-silicotungstic acid as an antibacterial and antifungal agent for use in furniture coating compositions.
- polymers functionalized with reactive polyoxometalates which serve to decontaminate harmful compounds.
- German laid-open specification DE 10 2015 000 812 A1 discloses hydrous cleansing and personal care products having a biocidal action which contain polyoxometalates as a biocidal constituent.
- German Patent Application DE 10 2015 000 813 A1 discloses a method for destroying medicaments and toxins and their metabolites with the aid of polyoxometalate micro and / or nanoparticles.
- the present invention was based on the object cosmetics, toiletries, products for saunas and steam baths, powders, solids, gels, creams, ointment lotions, drops, sprays, metered aerosols gargles, lozenges, enemas, enemas, suppositories, Foams providing toilet utensils, textile fabrics, face masks, envelopes, sanitary napkins, tampons, gauze, plasters, medical devices, and release materials that function, inter alia, as a moisture regulator and / or water storage, inorganic and / or organic matter based on, in and / or under the human or animal skin, bind, absorb and / or render harmless, suppress the formation of unpleasant odors and / or inhibit unhealthy bacteria and promote healthy bacteria.
- the aforementioned products are said to be of advantage as medical, especially oncological and dermatological, cosmetics and care products, products for saunas and steam baths and for the care of the skin, mucous membranes, especially mucous membranes in the mouth, on and in the genitals and in the intestine, eyes, ears , Mouth, lips, fingernails, toenails, cornea, warts and scars, in excretions of noxa, drugs, toxins, drugs, acids and bases over the skin, in lesions, itching, burning, intertrigo, infections and redness, for preventive protection, to be used to assist healing processes in existing infections, wounds or burns, in decorative cosmetics, in cosmetic facial care, in hair care and in the personal care of humans and animals.
- the resulting homogenised mixture is processed into powders, solids, gels, creams, ointments, lotions, drops, sprays, metered aerosols, gargles, lozenge enemas, enemas, suppositories or foams and / or on and / or in textile fabrics, face masks, Gauze, envelopes, bandages, tampons, plasters, medical devices and / or release materials applied, and which is hereinafter referred to as "inventive method".
- topical preparations as medical and decorative cosmetics, care products and products for saunas and steam baths and for the care of skin, mucous membranes, eyes, ears, mouth, lips, fingernails, toenails, cornea, warts and scars, in excretions of noxious substances, drugs, toxins, medicines, acids and bases via the skin, in the case of lesions, itching, burning, intertrigo, infections and redness, for preventive protection, to support healing processes in existing infections, wounds or burns, in decorative cosmetics, in the cosmetic facial care, in the hair care and in the personal care of humans and animals, which is referred to below as "inventive use”.
- the medical and decorative cosmetics, toiletries, products for saunas and steam baths, powders, solids, gels, creams, ointment lotions, drops, sprays, metered aerosols gargle solutions, lozenges, enemas, enemas, suppositories, foams toilet utensils, textile Tissues, facemasks, envelopes, sanitary napkins, tampons, gauze, plasters, medical devices and release materials have functioned well as moisture regulators and / or water storages, inorganic and / or organic substances located on, in and / or under human or animal skin , bind, absorb and / or render harmless, suppress the formation of unpleasant odors and / or inhibit unhealthy bacteria and promote healthy bacteria.
- the products according to the invention could advantageously be used as medical, in particular oncological and dermatological, cosmetics and care products, products for saunas and steam baths and for the care of skin, mucous membranes, in particular mucous membranes in the mouth, on and in the genitals and in the intestine, eyes, ears, Mouth, lips, fingernails, toenails, cornea, warts and scars, in excretions of noxa, drugs, toxins, medicines, acids and bases over the skin, in lesions, itching, burning, intertrigo, infections and redness, for preventive protection, for Assist healing processes in existing infections, wounds or burns, in decorative cosmetics, in cosmetic facial care, in hair care and in the personal care of humans and animals.
- topical preparations according to the invention and the products according to the invention could be prepared in a simple and very reproducible manner by the method according to the invention.
- topical preparations according to the invention were tolerable for allergy sufferers and / or for all skin types.
- they were bacteriostatic and had an antiviral, fungicidal or fungistatic and nematicidal action.
- the charcoal particles (A) may consist of charcoal and / or their screenings and / or wood ash, activated carbon, hard coal, animal charcoal, animal waste coal, pyrogenic carbon of different pyrolysis degree, functionalized carbon and / or functionalized coal, pretreated coal, washed coal, coal with different degrees of charring, Extracted coal coke, natural coke and incompletely outgassed coke and / or obtained by a pyrolysis process in a mobile or stationary pyrolysis of predominantly lignin-rich, organic materials such as wood, plant stems, leaves, fruit pits, nut shells and / or bones. Bones have the advantage that they are particularly phosphorus-containing.
- the pyrolysis process is operated under oxygen exclusion at about 1000 ° C.
- the person skilled in the art understands how to adapt the pyrolysis conditions to the particular circumstances, such as the type of pyrolysis plant, the ambient pressure and / or the amount of the type and nature of the pyrolysis product. These materials are customary and known and are evident, for example, from German Patent Application DE 10 2015 010 041 A1, paragraphs [0055] to [0064].
- the coal produced by various processes has intramolecular carbon structures, e.g. can be influenced by the pyrolysis conditions. Thereby, the properties of the carbon used for the process according to the invention can be adapted in view of a high nutrient and water storage capacity.
- the carbon particles (A) can have a wide variety of morphologies and geometric shapes, so that they can be excellently adapted to the other constituents of the topical preparations according to the invention.
- cavities can be different in size.
- spherical carbon particles (A) may have pointed outgrowths in the form of cones. Furthermore, their surface may have depressions so that the carbon particles (A) have a strawberry or raspberry morphology.
- the dumbbell, tori, needles or plates can be bent in at least one direction of the room. They can be freely selectable in any form.
- the mean particle size dso of the carbon particles (A) varies between the limits given above.
- the carbon particles (A) may be monodisperse, oligodisperse and / or polydisperse and therefore be excellently adapted to the particular intended use of the topical preparations according to the invention.
- the mean particle size co can be measured by transmission electron microscopy (TEM), scanning electron microscopy (SEM), scanning transmission electron microscopy (RTEM), atomic force microscopy (AFM) or scanning tunneling microscopy (TRM). It can be set to the desired value using standard and well-known screening methods.
- the carbon particles (A) have largely free or completely free surfaces.
- the amounts of carbon particles (A) used in the topical preparations according to the invention can vary very widely and depend mainly on their intended use.
- the amounts used are from 0.01 to 20 wt .-%, preferably 0.05 to 18 wt .-% and in particular 0.1 to 15 wt .-%, each based on the total amount of a given inventive topical preparations. For special applications, higher dosages can also be used.
- Particularly advantageous topical preparations according to the invention comprise particles (B) having an average particle size dso equal to 10 nm to ⁇ 1000 pm, preferably 20 nm to 1000 nm, preferably 30 nm to 800 nm and in particular 40 nm to 600 nm. Containing particles (B) and / or consist of at least one, in particular one, type of nanocrystalline and / or microcrystalline natural waxes and / or semi-synthetic waxes based on natural waxes and / or biodegradable microplastics.
- wax is a phenomenology term for a series of naturally or synthetically or synthetically obtained substances, which generally have the following properties: kneadable at 20 ° C, solid to brittle-hard, coarse to fine crystalline, translucent to opaque, non-glassy, melting above 40 ° C without decomposition, but already slightly above the melting point relatively low viscosity and generally or advantageously not stringy, have a strong temperature-dependent consistency and solubility and are polishable under light pressure. If more than one of the above-mentioned properties is not met, this substance is not wax according to the DGF (German Society for Fat Science) (see DGF unit method Ml 1 (75)).
- Waxes differ from similar synthetic or natural products such as resins, plastic masses, metal soaps, etc. mainly in that they generally in the molten, low-viscosity state between about 50 ° C and 90 ° C, in exceptional cases up to about 200 ° C. pass over and virtually free of ash-forming Connections are. Waxes form pastes or gels and usually burn with a sooting flame.
- a wax (B) which contains polar functional groups, in particular groups which contain heteroatoms from the group of oxygen, nitrogen and / or sulfur, preferably oxygen, particularly preferably hydroxyl groups, polyether groups, in particular polyethylene oxide groups, and / or carboxyl groups.
- suitable natural waxes are vegetable waxes such as candelilla wax, carnauba wax, Japan wax, esparto wax wax, cork wax, guaruma wax, rice germ oil wax, sugarcane wax, ouricury wax, montan wax, absolute flower waxes, cuba palm wax, cotton wax, flax wax, peat wax, rose wax, jasmine wax, peethawax, myrtle wax and waxy wax ,
- suitable natural waxes are animal waxes such as spermaceti, wool wax, shellac, china wax, beeswax and ragwort wax.
- suitable natural waxes are mineral waxes such as ceresin and ozokerite.
- modified natural waxes are hard waxes, montan ester waxes, Sasol waxes, hydrogenated jojoba waxes, wool wax alcohols (Eucerit), and modified beeswaxes (Cerabellina).
- the wax particles (B) of natural and semi-synthetic waxes using the gas antisolvent recrystallization (GAS), the PCA (Precipitation with a Compressed Fluid Antisolvent) method, the PGSS method (Particles from Gas Saturated Solutions) or the RESS process (Rapid Expansion of Supercritical Solutions) (see, for example, US Patent Applications US 2012/0258150 A1 and US 2013/0259913 A1).
- GAS gas antisolvent recrystallization
- PCA Precipitation with a Compressed Fluid Antisolvent
- PGSS method Particles from Gas Saturated Solutions
- RESS process Rapid Expansion of Supercritical Solutions
- the topical preparations according to the invention may contain biodegradable and non-degradable microplastics or microbeads, which, however, is less preferred according to the invention. If non-biodegradable microplastics is used, their amount should be kept as low as possible.
- Suitable biodegradable microbeads are known for example from US patent application 2014/0026916 A1. They have a mean particle size dso ⁇ 400 pm and consist of polyhydroxyalkanoates. Polyhydroxyalkanoates (PHA) or polyhydroxy-fatty acids (PHF) are naturally occurring water-insoluble and linear polyesters, which are formed by many bacteria as a reserve for carbon and energy. In nature, they are made by fermenting sugar or fats. These biopolymers are biodegradable and are used to make bioplastics. It has the advantage that they sink to the bottom in water and biodegrade.
- PHA polyhydroxyalkanoates
- PHF polyhydroxy-fatty acids
- biodegradable microbeads are known for example from US patent application US 2010/0278882 A1. They consist of cross-linked proteins, such as silk proteins, and have an average particle size d.sub.50 of from 0.1 .mu.m to 100 .mu.m.
- biodegradable microbeads are furthermore known from European patent application EP 0 563 876 A2. They are made by cross-linking natural proteins such as gelatin, albumin and casein with glyceraldehyde as a cross-linking agent.
- the average particle size dso of the wax particles (B) and / or of the biodegradable microbeads (B) can vary widely and thus be perfectly adapted to the requirements of the individual case.
- the average particle size d 50 is preferably between 1 ⁇ m and ⁇ 1000 ⁇ m, preferably 10 ⁇ m to 700 ⁇ m, more preferably 50 ⁇ m to 500 ⁇ m and in particular 100 ⁇ m to 300 ⁇ m.
- the wax particles (B) and / or the biodegradable microbeads (B) can be protected by protective colloids from aggregation or agglomeration.
- Protective colloids are usually water-soluble, preferably biodegradable, polymers such as partially saponified polyvinyl acetate, polyvinyl alcohol, polyvinylpyrrolidone, cellulose ethers (Tylose) such as methylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, starch, proteins, alginates, pectins and gelatin.
- polymers such as partially saponified polyvinyl acetate, polyvinyl alcohol, polyvinylpyrrolidone, cellulose ethers (Tylose) such as methylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, starch, proteins, alginates, pectins and gelatin.
- the content of the topical formulations according to the invention on wax particles and / or biodegradable microbeads (B) can vary widely and can thus be adapted excellently to the respective intended use.
- a given topical preparation according to the invention based on its total amount, contains 0.1% by weight to 50% by weight, 0.5% to 45% by weight and in particular 1% by weight to 40% by weight of wax particles (B).
- Further advantageous topical preparations according to the invention comprise particles (C) of an average particle size d 50 of from 10 nm to ⁇ 1000 nm, preferably 300 nm to 900 nm, preferably 650 ⁇ 200 nm and in particular 650 ⁇ 100 nm. They contain at least one type and / or consist of at least one type of nanocrystalline, nanofibrillar, microcrystalline and / or microfibrillar polysaccharides.
- CNF cellulose nanofibers
- MFC microfibrillar celluloses
- MCC microcrystalline celluloses
- NFP nanofibrillary polysaccharides
- NC nanocrystalline celluloses
- BNC bacterial nanocelluloses
- a given topical preparation according to the invention contains, based on its total amount, from 0.01% by weight to 10% by weight, preferably from 0.02% by weight to 9% by weight and in particular from 0.03 to 8% by weight. -%.
- Still further advantageous topical preparations according to the invention contain (D): heteropolyacids and isopolyacids and their isomers, defect structures and substructures, collectively called polyoxometalates (POM), in the form of their molecules having a largest molecular diameter ⁇ 2 nm, preferably ⁇ 1, 5 nm and in particular ⁇ 1 nm, collectively called POM molecules and in the form of microparticles and nanoparticles having an average particle size of 1 nm to ⁇ 1000 pm, preferably 2 nm to 500 pm, preferably 5 nm to 250 pm, more preferably 5 nm to 150 pm and in particular 5 nm to 100 pm.
- POM polyoxometalates
- the data ⁇ 2 nm, ⁇ 1, 5 nm and ⁇ 1 nm do not include a molecular diameter of 0 nm, but that the lower limit of the molecular diameter is equal to the largest diameter of the smallest existing POM molecule.
- the mean particle size of the POM microparticles to be used according to the invention and POM nanoparticles measured by transmission electron microscopy (TEM), scanning electron microscopy (SEM), scanning transmission electron microscopy (RTEM), atomic force microscopy (AFM) or scanning tunneling microscopy (TRM) can vary very widely and meet the requirements of the invention To be adjusted individually.
- the POM microparticles and POM nanoparticles can have a wide variety of morphologies and geometric shapes, so that they can also be perfectly adapted to the requirements of the individual case in this respect.
- they can be compact and have at least one cavity and / or a core-shell structure, wherein the core and the shell can be constructed of different materials. They may also have different geometric shapes such as spheres, ellipsoids, cubes, cuboids, pyramids, cones, cylinders, rhombuses, dodecahedra, truncated dodecahedra, icosahedra, truncated icosahedra, dumbbells, tori, platelets or needles with circular, oval, elliptical, square, triangular , quadrangular, pentagonal, hexagonal, heptagonal, octagonal, or star-shaped (tri-quad, quadrilateral, pentagonal, or polygonal) outline.
- geometric shapes such as spheres, ellipsoids, cubes, cuboids, pyramids, cones, cylinders, rhombuses, dodecahedra, truncated dodecahedra, ico
- POM microparticles and / or POM nanoparticles of different morphology and / or geometric form may have pointed outgrowths in the form of cones.
- two or three cylindrical POM microparticles and / or POM nanoparticles may assemble to form a T-shaped or Y-shaped particle.
- their surface may have pits so that the POM microparticles and / or POM nanoparticles have a strawberry, raspberry or blackberry morphology.
- the dumbbells, tori, needles or plates can be bent in at least one direction of the room.
- the diameter of the POM microparticles and POM nanoparticles can vary widely and therefore be perfectly adapted to the requirements of the individual case.
- the diameter of the POM microparticles and / or POM nanoparticles to be used according to the invention, which have no spherical shape, is equal to the longest distance traveled by the respective POM microparticles and POM nanoparticles.
- the diameter of the nanoparticles preferred according to the invention is preferably 1 nm to ⁇ 1000 pm, preferably 2 nm to 500 pm, preferably 5 nm to 250 pm, more preferably 5 nm to 150 pm and in particular 5 nm to 100 pm.
- the elemental composition and structure of the POM can also vary very widely.
- n-prime number here is an integer from 3 to 20 denoting the valence of an anion that varies depending on the variables X and M.
- TM is a divalent or trivalent transition metal ion such as Mn 2+ , Fe 2+ , Fe 3+ , Co 2+ , Co 3+ , Ni 2+ , Cu 2+ and Zn 2+ .
- the superscript t is an integer and denotes the valence of an anion, which varies depending on the significance of the variable TM.
- variable A stands for phosphorus, silicon or germanium and the index x stands for 0 or for an integer from 1 to 40.
- the index y stands for an integer from 1 to 10
- the index a stands for one integer from 1 to 8
- the index b is an integer from 15 to 150.
- the z factor varies depending on the nature and the degree of oxidation of the variable A.
- the aqua complexes and the active fragments of the POM XIII are also suitable.
- y is preferably 6-a, where the index a is an integer of 1 to 5 and the index b is 19.
- variable A is silicon or germanium
- the index x is 2
- the index y is 18
- the index a is 6
- the index b is 77.
- the index x is 2 or 4
- the index y is 12, 15, 17 or 30
- the index a is 1, 3 or 6
- the index b is 62 or 123.
- the isomers of POM come into consideration.
- the keggin structure has five isomers, the alpha, beta, gamma, delta, and epsilon structure.
- defect structures or lacunary structures as well as partial structures can be considered.
- the anions I to XIII are applied in the form of salts with cations which are approved for cleansing and personal care and pharmaceutical use.
- Suitable cations are H + , Na + , K + and NH 4 + ,
- Mono-, di-, tri- or tetra- (C 1 -C 20 -alkylammonium) such as pentadecyldimethyl-ferrocenylmethylammonium, undecyldimethylferrocenylmethylammonium,
- HISH + histidinium
- ARGFT argininium
- LYSH + lysinium
- oligomers and polymers bearing primary, secondary, tertiary and quaternary ammonium groups, primary, secondary and tertiary sulfonium groups and / or primary, secondary and tertiary phosphonium groups.
- Synthetic oligomers and polymers are common and well known and are used, for example, in electrodeposition paints.
- natural cationic oligomers and polymers are polyamino-saccharides such as polyglucosamines, especially chitosan.
- n number in particular integer, from 1 to 50.
- suitable POM are disclosed in US Pat. No. 7,097,858 B2, column 14, line 56, to column 17, line 19, and from TABLE 8a, col. 22, line 41, to col. 23, line 28, compounds number 1-53, and TABLE 8b, column 23, line 30, to column 25, line 34, compounds number 1 to 150.
- the molecular POMs to be used according to the invention can be prepared by means of customary and known wet-chemical processes, such as, for example, precipitation processes.
- the POM microparticles and POM nanoparticles to be used according to the invention can be prepared by customary and known wet-chemical processes. However, it is also possible to dissolve the POM in water and to spray the resulting solution against a warm stream of air. In addition, it is possible to evaporate the solution under vacuum, being irradiated with IR radiation. Furthermore, it is possible to prepare solutions, in particular aqueous, solutions of POM on cold surfaces, such as frozen, smooth metal surfaces, dry ice, cryogenic organic solvents and liquefied gases, such as methane, ethane propane, butane, methylcyclohexane or benzine, liquid nitrogen or liquid helium spray on and evaporate the dry ice or the liquid substances.
- solutions, in particular aqueous, solutions of POM on cold surfaces such as frozen, smooth metal surfaces, dry ice, cryogenic organic solvents and liquefied gases, such as methane, ethane propane, butane, methylcyclohexane or benzine
- the molecular POM, POM microparticles and / or POM nanoparticles described above are unchanged, oxygen-substituted, functionalized, aggregated, agglomerated and / or supported. For example, they may be functionalized, agglomerated and supported. But they can also not be functionalized and not aggregated.
- They may be dissolved, suspended, lipophilized and / or fluidized with organic groups and / or in and / or on compact and / or porous as acid, salt, soft oxometalate (SOMS), coating and / or polyoxometalate nanocomposite and / or molecular disperse Particles, films, fibers and / or sponges, in hydrogels, in micelles, in vesicles, in microcapsules, in gels, in powders, in and on coatings, in and on plastics, in and on tablets, in creams, lotions, ointments and / or foams and / or in mixtures and / or in conjunction with functional materials, antibiotics and / or biocidal materials.
- SOMS soft oxometalate
- the unaltered POMs are the POMs that arise during their manufacture without further functionalization or modification.
- terminal oxide centers are replaced by other ligands, such as sulfide ions, bromide ions, amino groups, nitrosyl groups, and / or alkoxy groups.
- ligands such as sulfide ions, bromide ions, amino groups, nitrosyl groups, and / or alkoxy groups.
- the sulfur-containing POM are also called polyoxothiometalates.
- the aggregates are loose aggregates of particles that are held together by cohesion and can not be distributed by conventional and known dispersion methods. Their inner surface is smaller than the sum of the surfaces of the primary particles.
- the agglomerates are aggregates of primary particles and their aggregates, which are bridged over edges and corners. Their inner surface corresponds approximately to the sum of the surfaces of the primary particles.
- the molecular POM, POM microparticles and POM nanoparticles to be used according to the invention can be present "naked". That is, their surface is not surrounded by a shell and / or is not functionalized.
- the molecular POM, POM microparticles and POM nanoparticles to be used according to the invention can be surrounded by a shell and / or carry at least one functional group.
- the material of the shells may be the functional groups or the functional groups may be present directly on the surface of the molecular POM, the POM microparticles, and the POM nanoparticles.
- the material of the shell and / or the functional groups can be selected so that the molecular POM, POM microparticles and POM nanoparticles to be used according to the invention are particularly rapidly and homogeneously in an organic and / or inorganic, solid or liquid matrix, in particular a distribute and / or modify the physical and / or chemical properties of the molecular POM, POM microparticles, and POM nanoparticles in a particular desired manner, and / or modify the physical and / or chemical properties of the organic and / or inorganic polymeric matrix or inorganic ceramic matrix acting as a support material and / or binder mask.
- the shells and / or the functional groups may be attached to the surface of the molecular POM, POM microparticles and POM nanoparticles via covalent and / or ionic bonds and / or electrostatic and / or van der Waals forces.
- the bond between the surface of the molecular POM, POM microparticles and POM nanoparticles and the shell and / or the functional groups can be permanently or reversibly, i. be solvable again.
- the shells may be constructed of organic, inorganic and organometallic, polymeric, oligomeric and low molecular weight materials or combinations of at least two of these materials.
- the topical preparations according to the invention may contain at least one ingredient (E) commonly used for topical preparations, selected from the group consisting of water, phyllosilicates, ground clays, bolus americus clays, healing earth, nut shells, willow bark, lapacho healing cortices, siliceous earth, pumice stones, Geopolymers, amines, gemstones, trace elements and neutral inorganic salts, beta-glucans, glutathione, albumin, xylan, phytates, complexing agents, antioxidants, radical scavengers, menthol, caffeine, teein, papain, esculin hemihydrate, carotenoids, lecithins, abscinic acid, cyanidin, guanidine, Urea, thiourea, fillers, solvents, humectants, solubilizers, nonionic wetting agents, buffers, thickeners, binders, coating agents, disintegrants
- Cell differentiation reagents analgesics, anesthetics, anesthetics, contrast agents, enzymes, cytokines, antihistamines, immunomodulators, hemostatic reagents, hormones, angiogenic and antiangiogenic agents, neurotransmitters, therapeutic oligonucleotides, viral particles, growth factors, retinoids, cell adhesion factors, extracellular matrix glycoproteins, osteogenic factors, antibodies, antigens , Steroids, analgesics, potassium sulfate, royal jelly, propolis, encapsulated perfumes, nutrients hexahydroxycyclohexanehexaphosphoric acid ester salt nanoparticles, especially salts of phytic acid, and surfactants, in effective amounts.
- suitable ingredients are in particular phyllosilicates, which are particularly preferred as nanoparticles and / or microparticles having an average particle size dso of 1 nm to ⁇ 1000 pm, preferably 10 nm to 900 pm, preferably 300 nm to 1000 nm, particularly preferably 650 ⁇ 200 nm preferably 650 ⁇ 150 nm and in particular 650 ⁇ 100 nm
- the elemental composition and the structure of the layered silicate micro- and / or nanoparticles can also vary widely.
- classification of the silicates into the following structures is known:
- Phyllosilicates are silicates whose silicates consist of layers of corner-sharing S1O 4 tetrahedra. These layers and / or bilayers are not further linked to one another.
- the technically important and in sedimentary rocks widespread clay minerals are also phyllosilicates.
- the layered structure of these minerals determines the shape and properties of the crystals. They are usually tabular to leafy with good to perfect cleavage parallel to the layers.
- the number of rings that make up the silicate layers often determines the symmetry and shape of the crystals. Between the layers, water molecules, large cations and / or lipids can be stored.
- bentonite from the group of montmorillonites ((Na, Ca) o .3 (Al, Mg) 2 Si 4 0io (OH) 2 -nH 2 0).
- Bentonite is a mixture of various clay minerals and contains montmorillonite as its main constituent.
- sodium bentonite absorbs water, it can absorb a variety of its own dry weight.
- calcium bentonite can absorb fats and / or oils.
- the layered silicate micro- and / or nanoparticles described above are functionalized, non-functionalized, aggregated, non-aggregated, agglomerated, non-agglomerated, supported and / or unsupported.
- they may be functionalized, agglomerated and supported. But they can also not be functionalized and aggregated.
- Polyethylene glycols (macrogols, PEG); Polyethylene oxides (PEO) (tablets, ointments, creams);
- Emulsifiers cetylstearyl alcohol, glycerol monostearate, lecithin, fatty acid esters of sorbitan, polyoxyethylene sorbitan (polysorbates), polyoxyethylene, polyoxyethylene fatty alcohol ethers (emulsions, creams), methyl glucose, sesquistearates, stearic acid and derivatives thereof, acrylate-based emulsifiers, e.g. Acrylates / C 10-330 Alkyl Acrylate Crosspolymer
- Solubilizers and / or wetting agents polyethylene glycols (PEG, macrogols), polyethylene oxides (PEO, PolyOx), polysorbates (solutions, suspensions) • buffer: dipotassium hydrogen phosphate sodium dihydrogen phosphate,
- Thickeners and binders starches, guar gum, xanthan gum, alginate, carrageenan, pectin, tragacanth, polyacrylic acids, polyvinylpyrrolidone (granules, tablets); fumed silica, substituted cellulose ethers (methylcellulose, ethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose) (tablets, gels, viscous solutions), Butyrospermum Parkii Butter, MAGNESIUM SULFATE
- sucrose sucrose (sugar dragee); Gelatin (capsules);
- Gelatin polysuccinate (“soft capsules”), polyacrylates, ethylcellulose, methylcellulose (filmcoating: film capsules, film-coated tablets, pellets)
- disintegrants and / or disintegrants starches (tablets, tabs);
- Croscarmellosis tablettes, capsules, granules
- Sodium bicarbonate in combination with citric acid effervescent tablets
- Lubricants and / or mold release agents polyethylene glycols (PEG, macrogols), polyethylene oxides (PEO), talc, magnesium stearate (tableting)
- Flow control agent fumed silica (powders, granules)
- Antioxidants butylated hydroxytoluene, all-rac-a-tocopherol
- Sweeteners, flavoring agents sucrose, sorbitol, sweeteners such as saccharin sodium and cyclamate
- Ammonium bicarbonate ammonium bicarbonate • AMMONIUM CARBONATE
- Citric acid citric acid
- Vitamin C Ascorbic acid
- vitamin E alpha tocopheryl acetate
- Anthocyanins (cyanidin, peonidin, malvidin, delphinidin, petunidin, pelargonidin)
- Curcumin curcumin; 1, 7-bis (4-hydroxy-3-methoxyphenyl) hepta-1, 6-diene-3,5-dione carmine; carminic
- chlorophyll Chlorophyll a / b; Trisodium (2S-trans) - [18-carboxy-20- (carboxymethyl) -13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H, 23H-porphine 2-propionato (5)
- cyclomethicone Composed of octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5) and dodecamethylcyclohexasiloxane (D6)
- Lactic acid 2-hydroxypropionic acid, 2-hydroxypropanoic acid y-6
- Ammonium benzoate, ammonium salt of benzoic acid AMMONIUM BISULFITE
- Butyl paraben (potassium salt); 4-hydroxybenzoic acid butyl ester (potassium salt)
- Ethyl paraben (potassium salt); 4-hydroxybenzoic acid ethyl ester (potassium salt)
- Methylparaben (potassium salt); 4-hydroxybenzoic acid methyl ester (potassium salt)
- Butyl paraben (sodium salt); 4-Hydroxybenzoic acid butyl ester (sodium salt) SODIUM ETHYLPARABEN
- Methylparaben sodium salt
- 4-Hydroxybenzoic acid methyl ester sodium salt
- Triclocarban 1- (4-chlorophenyl) -3- (3,4-dichlorophenyl) urea
- alkyl acrylates C10-C30
- acrylic acid methacrylic acid and / or other alkyl acrylates
- Cetearyl alcohol mixture of 1-hexadecanol (cetyl alcohol) and 1-octadecanol (stearyl alcohol)
- Potassium alginate potassium salt of alginic acid
- Palmitic acid glycol esters 2-Hydroxyethylpalmitat
- Propylene glycol stearate Ester of stearic acid and propylene glycol (1: 1) containing sodium or potassium stearate *
- Cetearyl isononanoate esters of isononanoic acid and cetearyl alcohol
- Vitamins include Vitamin A, Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B4, Vitamin B5, Vitamin B6, Vitamin B7, Vitamin B8, Vitamin B9, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, Vitamin K
- Substances that are usually added to surfactant preparations in order to counteract their degreasing character are substances which are also called moisturizers and / or moisturizers.
- moisturizing substances are used.
- the list below is exemplary and not exhaustive. The person skilled in the art, on the basis of his general knowledge, can easily name further possible refatting substances.
- Glyceryl trimyristate Esterification product of glycerine and myristic acid (1: 3)
- Glyceryl tripalmitate Esterification product of glycerol and palmitic acid (1: 3)
- Oils are a collective term for different liquid fatty substances. These include, inter alia, mineral oils, silicone oils and / or oils of natural origin, such as vegetable oils and / or essential oils. These are often characterized by monounsaturated and / or polyunsaturated fatty acids. Oils of animal origin are usually referred to as fats. In addition, many oil components used in cosmetics are based on natural starting materials synthetically produced. Just like the lubricating substances, oil components prevent the premature drying of the skin and / or hair. In the list below, the oils are listed by example and not by definition. The person skilled in the art, on the basis of his general knowledge, can easily name further possible oils.
- Cetearyl alcohol mixture of 1-hexadecanol (cetyl alcohol) and 1-octadecanol (stearyl alcohol)
- cyclomethicone Composed of octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5) and dodecamethylcyclohexasiloxane (D6)
- Glycerol stearate glycerol monostearate, stearic acid-glycerol ester
- Macadamia ; Macadamia nut, genuine; macadamia nut oil
- Macadamia trifoliate; macadamia nut oil
- avocado oil avocado oil
- Essential oils are volatile, intense-smelling mixtures of oily consistency that are sparingly soluble in water. They are usually obtained from vegetable raw materials by steam distillation. They can also be obtained by synthesis, extraction or by squeezing. Herbal substances such as menthol, cineole, vanillin and / or thymol are also referred to as essential oils. In medicine, they are used depending on the oil for the treatment of numerous complaints, u. a. Muscle and joint pain, infectious diseases, colds and discomfort in the gastrointestinal tract. Furthermore, they are used in cosmetics especially for perfuming.
- Flavors are products that are added to foods, for example, to give them a special smell and / or taste.
- An aroma can consist of numerous flavors, aroma extracts, thermally derived reaction aromas, smoke flavors and / or aroma precursors. Most flavors are used industrially in food production, and some flavors are also available in retail stores. Flavorings are chemically defined substances with taste-giving properties (aroma properties), which are used for the production of flavors. There are different natural, nature-identical and / or artificial flavorings.
- fragrances used in cosmetics are organic compounds from the animal and plant kingdoms. Furthermore, fragrances are compounds that are synthetic can be produced. The purpose of the fragrances in cosmetic products is to mask the odor of a drug and continue to trigger pleasant sensations in the consumer. Perfumes in the narrower sense are fragrances and fragrance mixtures that are supposed to change or mask the body odor.
- anisalcohol Anisyl alcohol, 4-methoxybenzyl alcohol
- Lactic acid 2-hydroxypropionic acid, 2-hydroxypropanoic acid
- Vitamin C Ascorbic acid
- avocado oil avocado oil
- Zinc lactate (zinc salt of lactic acid)
- Steareth-20-methacrylate is an ester of methacrylic acid with polyethylene glycol (avg. 20 units -CH 2 -CH 2 -O-)
- T ololsulphonamide-formaldehyde resin • PHTHALIC ANHYDRIDE / TRIMELLITIC ANHYDRIDE / GLYCOLS COPOLYMER
- Tanning agents, tanning agents and / or tannin extracts are tanning agents and / or tannin extracts:
- tannins are chemicals used to tan animal skins. By treating with tannins the animal skins are converted into leather, which among other things prevents the rot. Furthermore, there are naturally occurring, ie natural, as well as artificially produced, ie synthetic tannins.
- Tanning agents are plant parts and / or mixtures containing one and / or more tannins. The terms tanning agent and / or tanning agent are often used as synonyms.
- a tannin extract is an extract of a Tanning agent. After extraction, the tanning agent is in a higher concentration, without any interfering constituents of the starting material. Vegetable tannins, also called tannins, are also used in medicine. Furthermore, tannins are known as taste components of wine and tea.
- Synthetic tanning agents Synthetic tanning agents (Syntans) based on phenol derivatives
- Bittern refers to all chemical compounds that have a bitter taste. They are not a chemically unified group, but are characterized only by the fact that they taste bitter. The following bitter substances are only exemplary and not fully listed. The person skilled in the art, on the basis of his general knowledge, can easily name other possible bitter substances.
- Dyes, colored pigments, white pigments, fluorescent pigments and phosphorescent pigments (phosphorus) can be added in many different ways to the topical preparations according to the invention. Preference is given to chalk, talc, montmorillonite, Clay minerals, papers, paper-like materials and / or titanium dioxide, also black titanium dioxide.
- Plant extracts are extracts of plants used in cosmetics.
- the following list of plant extracts is exemplary and not exhaustive. The person skilled in the art can easily name further possible plant extracts.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Topische Zubereitungen Topical preparations
Gebiet der Erfindung Field of the invention
Die vorliegende Erfindung betrifft topische Zubereitungen. The present invention relates to topical preparations.
Des Weiteren betrifft die vorliegende Erfindung ein Verfahren zur Herstellung von topischen Zubereitungen. Furthermore, the present invention relates to a process for the preparation of topical preparations.
Ferner betrifft die vorliegende Erfindung die Verwendung der topischen Zubereitungen. Furthermore, the present invention relates to the use of the topical preparations.
Nicht zuletzt betrifft die vorliegende Erfindung Kosmetika, Pflegeprodukte, Produkte für Saunen und Dampfbäder, Pulver, Festkörper, Gele, Cremes, Salben, Lotionen, Tropfen, Sprays, Dosieraerosole Gurgellösungen, Lutschtabletten, Einläufe, Klistiere, Schäume, Beschichtungen auf textilen Geweben, Gesichtsmasken, Verbandsmull, Pflastern und medizinischen Geräten und Bestandteile von Releasematerialien, die die topischen Zubereitungen enthalten oder hieraus bestehen. Last but not least, the present invention relates to cosmetics, care products, products for saunas and steam baths, powders, solids, gels, creams, ointments, lotions, drops, sprays, metered aerosols, gargles, lozenges, enemas, enemas, foams, coatings on textile fabrics, face masks, Gauze, patches and medical devices and components of release materials containing or consisting of the topical preparations.
Stand der Technik State of the art
Der in der vorliegenden Anmeldung zitierte Stand der Technik wird durch Bezugnahme Bestandteil der vorliegenden Anmeldung. The prior art cited in the present application is incorporated by reference into the present application.
Unter topischen Arzneimitteln oder Pflegeprodukte versteht man in der Medizin und der Kosmetik alle diejenigen Medikamente oder Pflegeprodukte, die nicht eingenommen oder gespritzt, sondern lokal angewendet werden. Da bei örtlicher Anwendung der Wirkstoff direkt an den Wirkungsort gebracht wird, kann hierbei oft die Dosis weitestgehend verringert und somit das Nebenwirkungsrisiko vermindert werden. Einer örtlichen Behandlung oder Pflege zugänglich sind alle an der Oberfläche liegenden Organe, also die Haut und die Schleimhäute der Atemwege, des Verdauungstraktes und des äußeren Auges. Aber auch eine Injektion in ein Gelenk stellt eine topische (lokale, intraartikuläre) Behandlung dar. Topical medicines or care products are understood in medicine and cosmetics to mean all those medicines or care products that are not taken or injected, but applied locally. Since local application of the drug is brought directly to the site of action, this can often reduce the dose as much as possible and thus reduce the risk of side effects. All superficial organs, ie the skin and mucous membranes of the respiratory tract, the digestive tract and the external eye are accessible to local treatment or care. But also an injection into a joint is a topical (local, intraarticular) treatment.
Besonders in der Dermatologie spielen topische Arzneimittel und Pflegeprodukte eine große Rolle, daneben in der Ophthalmologie (Augenheilkunde) und in der Urologie. Zur Anwendung kommen unter anderem: Particularly in dermatology, topical medicines and care products play a major role, as well as in ophthalmology (ophthalmology) and urology. Among others:
1 1
BESTÄTIGUNGSKOPIE • an der Haut: Salben, Cremes und Lotionen CONFIRMATION COPY • on the skin: ointments, creams and lotions
• an der Nase: Nasentropfen, -sprays und -salben • on the nose: nose drops, sprays and ointments
• an der Mundschleimhaut: Gurgellösungen und Lutschtabletten • on the oral mucosa: gargles and lozenges
• an den Atemwegen: Dosieraerosole, Vernebelung mit UV-Licht und Pulverinhalatoren • in the respiratory tract: metered aerosols, nebulization with UV light and powder inhalers
• am Darm: Einläufe und Klistiere • on the intestine: enemas and enemas
• an den Bindehäuten der Augen: Tropfen, Salben und Sprays • on the conjunctiva of the eyes: drops, ointments and sprays
Auch Antibiotika können topisch angewendet werden, etwa bei bakteriellen Hautinfektionen. Zum Einsatz kommen hier vor allem Sulfonamide. Antibiotics can also be used topically, for example for bacterial skin infections. Sulfonamides are mainly used here.
Heutzutage gibt es viele verschiedene Pflegeprodukte. Unter dem Begriff Pflegeprodukte versteht man beispielsweise Produkte für die Haarpflege, für die Hautpflege, Mundpflege und/oder Nagelpflege. Ein sehr gutes Beispiel sind Pflegeprodukte für die Sauna. In der türkischen Sauna, auch Hamam genannt, wird ein Saunaprodukt benutzt, welches auf die Haut aufgetragen wir und unter anderem auch schwarzen Bernstein beinhaltet. Des Weiteren wird sehr oft vor dem Saunagang die Haut mit Salz eingerieben. Dies soll dem Körper bei der Entschlackung helfen. Nowadays there are many different care products. The term "care products" means, for example, products for hair care, for skin care, oral care and / or nail care. A very good example are care products for the sauna. In the Turkish sauna, also called Hamam, a sauna product is used, which is applied to the skin and includes, among other things, black amber. Furthermore, the skin is often rubbed with salt before the sauna session. This is to help the body with the purification.
In der nachstehenden Liste sind die einzelnen Stoffkomponenten aufgelistet, die bekanntermaßen in den einzelnen Produktgruppen enthalten sind. The list below lists the individual substance components that are known to be included in each product group.
Basisbestandteile Basic components
• Emulgatoren • emulsifiers
• Filmbildner • film-maker
• Gelbildner • gelling agent
• Lösungsmittel • solvents
• Ölkomponenten • oil components
• Seifenbasis • soap base
• Tenside • surfactants
• Verdickungsregler und/oder Konsistenzregler • Thickener and / or consistency regulator
• Wachse • waxes
Haarpflege • Antischuppen-Wirkstoffe hair care • anti-dandruff agents
• Haarbleichmittel und/oder Bleichverstärker • Hair bleach and / or bleach enhancer
• Haarfarbstoffe • hair dyes
• Haarfestigende Polymere • Hair-setting polymers
• Haarpflegestoffe und/oder Konditioniermittel Hair care and / or conditioners
Hautpflege skin care
• Antibakterielle Wirkstoffe • Antibacterial agents
• Antioxidantien • antioxidants
• Antitranspirantwirkstoffe und/oder Adstringentien • antiperspirant active substances and / or astringents
• Desodorierende Wirkstoffe • Deodorizing agents
• Hautbleichende Wirkstoffe • Skin bleaching agents
• Kühlende Wirkstoffe • Cooling agents
• Moisturizer und/oder Feuchtigkeitsspender • Moisturizer and / or moisturizer
• Putzkörper, Abrasivmittel und/oder Poliermittel • Cleaning body, abrasive and / or polish
• Rückfettende Substanzen • Refatting substances
• Selbstbräunende Wirkstoffe • Self-tanning active ingredients
• Sonnenschutz- und/oder UV-Filter • Sunscreen and / or UV filters
• Wirkstoffe für die Hautpflege • Active ingredients for skin care
• Wirkstoffe zur chemischen Haarentfernung und/oder Depilation • active ingredients for chemical hair removal and / or depilation
Mundpflege oral care
• Antibakterielle Wirkstoffe • Antibacterial agents
• Bleichmittel für die Zähne • bleach for the teeth
• Kühlende Wirkstoffe • Cooling agents
• Putzkörper, Abrasivmittel und/oder Poliermittel • Cleaning body, abrasive and / or polish
• Wirkstoffe gegen empfindliche Zähne • Active ingredients against sensitive teeth
• Wirkstoffe gegen Zahnbelag und/oder Karies • active ingredients against dental plaque and / or tooth decay
Nagelpflege nail care
• Nagelhärter • nail hardener
• Nagelserum Hilfsstoffe • Nagelserum excipients
• Alkalisierungsmittef, Säuren und/oder Neutralisierungsmittel• Alkalizing agents, acids and / or neutralizing agents
• Antioxidantien • antioxidants
• Bindemittel • binder
• Farbstoffe/Farbpigmente • Dyes / color pigments
• Feuchthaltemittel • Humectants
• Harze • Resins
• Konservierungsmittel • preservative
• Oxidationsmittel • oxidizing agent
• Reduktionsmittel • Reducing agent
• Stabilisatoren • stabilizers
• T reibgase für Sprays • T friction gases for sprays
• Trübungsmittel/Perlglanzstoffe • opacifiers / pearlescent substances
• Vergällungsmittel • Denaturants
• Weichmacher • plasticizer
Aromen und/oder Duftstoffe Flavors and / or fragrances
• Ätherische Öle • Essential oils
• Aromen • flavors
• Parfüm/Duftstoffe • perfume / fragrances
Anwendungsgebiete application areas
• Dekorative Kosmetik • Decorative cosmetics
• Gesichtspflege • Facial care
• Haarpflege • Hair care
• Körperpflege • Personal hygiene
• Sonnenschutz • sunscreen
• Zahn- und Mundpflege Die Anwendungen von Kohle sind breit gefächert und längst nicht mehr auf die Landwirtschaft beschränkt. In immer mehr neuen Anwendungsfeldern wird Kohle integriert und ihre positiven Eigenschaften genutzt. • Dental and oral care The uses of coal are broad and no longer limited to agriculture. More and more new fields of application are integrating coal and using its positive properties.
In seinem Artikel »55 Anwendungen von Pflanzenkohle« im Ithaka Journal, 1/2012, Seiten 92 bis 102, beschreibt H.-P. Schmidt die Vorteile von Pflanzenkohle und gibt eine detaillierte Beschreibung der Anwendungsfelder von Biokohle an. Hierbei wird deutlich, dass die Anwendungen nicht limitiert sind auf 55 Anwendungen von Biokohle, sondern vielmehr die ganzen Anwendungsgebiete und Möglichkeiten verdeutlicht sind. In his article »55 applications of biochar« in the Ithaka Journal, 1/2012, pages 92 to 102, H.-P. Schmidt discusses the benefits of biochar and gives a detailed description of biochar applications. Here it becomes clear that the applications are not limited to 55 applications of biochar, but rather the entire application areas and possibilities are clarified.
Die Gebrauchsmusterschrift DE 20 2014 010 286 U1 offenbart kosmetischeThe utility model DE 20 2014 010 286 U1 discloses cosmetic
Reinigungszubereitungen für die Haut und/oder die Haare. Diese Produkte enthalten Tenside, Aktivkohle mit einer Korngröße von 0,5 bis 60 pm, Perlglanzmittel und/oder mindestens einen Strukturanten, der aus der Gruppe der Acrcylatcopolymere und alkoxylierten Verdicker ausgewählt ist, sowie Natriumchlorid. Cleaning preparations for the skin and / or the hair. These products contain surfactants, activated carbon having a particle size of 0.5 to 60 μm, pearlescing agents and / or at least one structural agent selected from the group of acrylate copolymers and alkoxylated thickeners, and also sodium chloride.
Aus der chinesischen Patentanmeldung CN 1306825A ist eine absorbierende Brandsalbe bekannt, die Aktivkohlepulver einer Teilchengröße <50 pm, eine absorbierende Salbenmatrix und einen isotonischen Regler enthält. Zur Herstellung wird die Aktivkohle zu einer wässrigen Lösung von Natriumchlorid gegeben, wonach das Wasser verdampft wird. Die Brandsalbe kann die Brandwundentoxine effektiv beseitigen und das Wachstum von schädlichen Bakterien in der Wunde verhindern. Sie fördert die Wundheilung und die Zellvermehrung in dem Wundgewebe. From the Chinese patent application CN 1306825A an absorbent fire ointment is known, which contains activated carbon powder of a particle size <50 pm, an absorbent ointment matrix and an isotonic regulator. For preparation, the activated carbon is added to an aqueous solution of sodium chloride, after which the water is evaporated. The burn ointment can effectively eliminate the burn wound toxins and prevent the growth of harmful bacteria in the wound. It promotes wound healing and cell proliferation in the wound tissue.
Aus der amerikanischen Patentanmeldung US 2013/0259913 A1 sind nicht zur oralen Einnahme geeignete Partikel aus mindestens zwei miteinander unverträglichen hydrophilen und lipophilen Stoffen bekannt wobei die Partikel durch das PGSS(Particles from Gas Saturated Solutions, Partikel aus gasgesättigten Lösungen)-Verfahren hergestellt werden. Als lipophiles Material kommen neben zahlreichen anderen Materialien Paraffin und mikrokristallines Wachs in Betracht. Weitere Angaben zu den Wachsen werden nicht gemacht. Die Partikel können für die Herstellung von Produkten für den Endverbraucher verwendet werden, wie beispielsweise Shampoos, Körperwaschmittel, Detergentien für die Wäsche, Detergentien für Geschirrwaschmittel, nichtwässrige flüssige Produkte, Seifenstücke, Papierprodukte, Kosmetika, Lotionen oder Hautbehandlungsmittel. Aus der amerikanischen Patentanmeldung US 2012/0258150 A1 sind Partikel bekannt, die nach dem PGSS-Verfahren hergestellt werden. Die Partikel haben eine Größe von 1 nm bis 1 mm, bevorzugt 1 nm bis 500 pm und enthalten ein wasserunlösliches Polymer und ein flüchtiges Material, insbesondere ein Parfüm oder ein Rohmaterial für Parfüm. Als lipophiles Material oder wasserunlösliches Polymer kommen neben zahlreichen anderen Materialien Paraffin und mikrokristallines Wachs in Betracht. Weitere Angaben zu den Wachsen werden nicht gemacht. Die Partikel können für die Herstellung von Produkten für den Endverbraucher verwendet werden, wie beispielsweise Shampoos, Körperwaschmittel, Detergentien für die Wäsche, Detergentien für Geschirrwaschmittel, nichtwässrige flüssige Produkte, Seifenstücke, Papierprodukte, Kosmetika, Lotionen oder Hautbehandlungsmittel. The US patent application US 2013/0259913 A1 discloses particles which are not suitable for oral ingestion and contain at least two incompatible hydrophilic and lipophilic substances, the particles being produced by PGSS (Particles from Gas Saturated Solutions). Paraffin and microcrystalline wax may be considered as lipophilic material in addition to numerous other materials. Further information on the waxes are not made. The particles may be used in the manufacture of consumer products such as shampoos, personal cleansers, laundry detergents, dishwashing detergents, non-aqueous liquid products, soap bars, paper products, cosmetics, lotions or skin-care agents. From the US patent application US 2012/0258150 A1 particles are known which are produced by the PGSS process. The particles have a size of 1 nm to 1 mm, preferably 1 nm to 500 pm and contain a water-insoluble polymer and a volatile material, in particular a perfume or a raw material for perfume. As lipophilic material or water-insoluble polymer, paraffin and microcrystalline wax may be considered in addition to numerous other materials. Further information on the waxes are not made. The particles may be used in the manufacture of consumer products such as shampoos, personal cleansers, laundry detergents, dishwashing detergents, non-aqueous liquid products, soap bars, paper products, cosmetics, lotions or skin-care agents.
Aus der deutschen Patentschrift DE 697 04 925 T2 ist eine kosmetische Zusammensetzung bekannt, die eine Kombination eines filmbildenden Polymeren mit ' einer Wachs- Mikrodispersion enthält. Die Wachspartikel weisen vorzugsweise mittlere Abmessungen unter 1 pm und bevorzugt unter 0,5 pm auf. Es werden unter anderem Biowachse verwendet. Darüber hinaus kann die kosmetische Zusammensetzung Alkalisalze von organischen Basen und Alkylschwefelsäuren und Alkylsulfonsäuren als Tenside und organische Pigmente wie Ruß enthalten. From the German patent DE 697 04 925 T2 a cosmetic composition is known which contains a combination of a film-forming polymers with 'a wax microdispersion. The wax particles preferably have average dimensions of less than 1 μm and preferably less than 0.5 μm. Among other things, organic waxes are used. In addition, the cosmetic composition may contain alkali salts of organic bases and alkylsulfuric acids and alkylsulfonic acids as surfactants and organic pigments such as carbon black.
Aus der deutschen Patentschrift DE 699 17 690 T3 ist die Verwendung einer Mikrodispersion von Wachs in einer kosmetischen oder dermatologischen Zusammensetzung bekannt. Es werden unter anderem Biowachse verwendet. Die Mikrodispersion von Wachs wird als Wirkstoff zur Vorbeugung und/oder zur Behandlung des Auftretens von Falten und/oder Fältchen verwendet. German Patent DE 699 17 690 T3 discloses the use of a microdispersion of wax in a cosmetic or dermatological composition. Among other things, organic waxes are used. The microdispersion of wax is used as an active ingredient for the prevention and / or treatment of the appearance of wrinkles and / or wrinkles.
Aus der deutschen Offenlegungsschrift 10 2008 021 007 A1 ist eine Mikrodispersion von Wachsen bekannt, die anorganische Partikel aus Kohlenstoffallotropen, insbesondere Kohlenstoffnanoröhrchen enthält. Die Mikrodispersion wird in Kosmetika, insbesondere Nagellacke, verwendet. German Offenlegungsschrift 10 2008 021 007 A1 discloses a microdispersion of waxes which contains inorganic particles of carbon allotropes, in particular carbon nanotubes. The microdispersion is used in cosmetics, especially nail varnishes.
Aus der deutschen Offenlegungsschrift DE 10 2012 214 662 A1 ist eine kosmetische Zusammensetzung mit zeitverzögerte Wirkstofffreisetzung bekannt. Die kosmetische Zusammensetzung enthält, jeweils bezogen auf das Partikelgewicht, 30 bis 90 Gew.-% Polyalphaolefinwachse und 10 bis 70 Gew.-% eines oder mehrerer kosmetischer Wirkstoffe. Aus dem europäischen Patent EP 1 235 546 B1 ist die Verwendung von nanoskaligen Wachsen mit Teilchendurchmessern von 10 bis 300 nm, die von einem Schutzkolloid ummantelt sind, zur Herstellung von oberflächenaktiven Zubereitungen wie Haarbehandlungsmittel bekannt. Als Schutzkolloide werden Gelatine, Casein, Gummi Arabicum, Lysalbinsäure, Stärke, Polyvinylalkohole, Polyvinylpyrrolidone, Polyalkylenglykole und Polyacrylate verwendet. Die kosmetischen Zubereitungen können auch Natriumchlorid enthalten. Als Wachs wird unter anderem Bienenwachs oder Sonnenblumenwachs verwendet. In der amerikanischen Patentanmeldung US 2017/0027168 A1 , die nanokristallinen Produkte betrifft, die Mischungen von nanokristalliner Cellulose, nanokristallinen Polymeren und nanokristallinen Kunststoffen enthalten, wird kursorisch darauf hingewiesen, dass kristalline Nanocellulose in antiviralen Salben verwendet werden kann. German published patent application DE 10 2012 214 662 A1 discloses a cosmetic composition with delayed release of active ingredient. The cosmetic composition contains, based in each case on the particle weight, 30 to 90% by weight of polyalphaolefin waxes and 10 to 70% by weight of one or more cosmetic active ingredients. European patent EP 1 235 546 B1 discloses the use of nanoscale waxes with particle diameters of 10 to 300 nm, which are encased by a protective colloid, for the production of surface-active preparations, such as hair treatment compositions. Protective colloids used are gelatin, casein, gum arabic, lysalbinic acid, starch, polyvinyl alcohols, polyvinylpyrrolidones, polyalkylene glycols and polyacrylates. The cosmetic preparations may also contain sodium chloride. As a wax, beeswax or sunflower wax is used. In the US patent application US 2017/0027168 A1, which relates to nanocrystalline products containing mixtures of nanocrystalline cellulose, nanocrystalline polymers and nanocrystalline plastics, it is pointed out cursory that crystalline nanocellulose can be used in antiviral ointments.
Aus der amerikanischen Patentanmeldung US 2015/0367024 A1 ist die Verwendung von Hydrogelen von nanofibrillärer Cellulose zur Vermeidung und Kontrolle der Verunstaltung von Narben bei der Wundheilung oder Gewebeinstandsetzung bekannt. US Patent Application US 2015/0367024 A1 discloses the use of hydrogels of nanofibrillar cellulose for preventing and controlling the disfigurement of scars in wound healing or tissue repair.
Aus der amerikanischen Patentanmeldung US 2017/0000903 A1 ist die Verwendung von Gelen von kristalliner Cellulose auf dem Gebiet der Kosmetik bekannt. Dabei wirken die Gele als oberflächenaktive Mittel und können Emulsionen stabilisieren. US Patent Application US 2017/0000903 A1 discloses the use of gels of crystalline cellulose in the field of cosmetics. The gels act as surfactants and can stabilize emulsions.
In der amerikanischen Patentanmeldung US 2014/0083416 werden Verfahren zur Herstellung von mikro- und nanokristalliner Cellulose beschrieben. Es wird lediglich kursorisch darauf hingewiesen, dass die Produkte in Nahrungsmitteln, Kosmetika oder der Medizin verwendet werden können. US Patent Application US 2014/0083416 describes processes for producing microcrystalline and nanocrystalline cellulose. It is only cursory that the products can be used in food, cosmetics or medicine.
Zahlreiche Kosmetika und Pflegeprodukte enthalten noch Mikroplastik oder Microbeads, das biologisch nicht abgebaut wird, zum Beispiel als Peelingpartikel. Mikroplastik gelangt in die Umwelt, insbesondere in Flüsse, Seen und Meere, wo es sich in der Nahrungskette ansammelt. (Vgl. Umweltbundesamt, Texte 32 - 2016 Mikroplastik - Entwicklung eines Umweltbewertungskonzeptes; Umweltbundesamt, Texte 63 - 2015 Quellen für Mikroplastik mit Relevanz für den Meeresschutz). Die kosmetische Industrie ist inzwischen bestrebt, Ersatzstoffe für Mikroplastik zu finden. Beispielsweise werden Stoffe wie Tonerde, Kieselerde oder gemahlene Nussschalen als Alternativen vorgeschlagen. So sind Shampoos, die Schichtsilikate enthalten, bereits gängige Produkte. Des Weiteren werden in der europäischen Patentanmeldung EP 0 563 876 A2 biologisch abbaubare Microbeads zur Verwendung in Kosmetika und Arzneimitteln vorgeschlagen. Diese Microbeads können durch die Reaktion von Glycerinaldehyd mit natürlichen Proteinen wie Gelatine, Albumin und Casein hergestellt werden. Numerous cosmetics and care products still contain microplastics or microbeads that are not biodegraded, for example as exfoliating particles. Microplasticity is released into the environment, especially in rivers, lakes and seas, where it accumulates in the food chain. (See Umweltbundesamt, Texte 32 - 2016 Microplastics - Development of an Environmental Assessment Concept, Federal Environmental Agency, Texts 63 - 2015 Sources of Microplastics Relevant to Marine Conservation). The cosmetic industry is now anxious to find substitutes for microplastics. For example, materials such as alumina, silica or ground nutshells are suggested as alternatives. For example, shampoos containing phyllosilicates are already common products. Furthermore, European Patent Application EP 0 563 876 A2 proposes biodegradable microbeads for use in cosmetics and pharmaceuticals. These microbeads can be made by the reaction of glyceraldehyde with natural proteins such as gelatin, albumin and casein.
In der amerikanischen Patentanmeldung US 2010/0278882 A1 werden ebenfalls Protein- Microbeads als Bestandteile von Kosmetika vorgeschlagen. In the US patent application US 2010/0278882 A1 also protein microbeads are proposed as components of cosmetics.
Aus der amerikanischen Patentanmeldung US 2014/0026916 A1 wird ein Verfahren zur Reduktion von Umweltverschmutzung in wässrigen Systemen vorgeschlagen, bei dem die Verwendung von Polyhydroxyalkanoat-Microbeads in persönlichen Pflegeprodukten vorgeschlagen werden. Die Polyhydroxyalkanoat-Microbeads sollen in wässrigen Systemen rasch absinken. US Patent Application US 2014/0026916 A1 proposes a process for the reduction of environmental pollution in aqueous systems, in which the use of polyhydroxyalkanoate microbeads in personal care products is proposed. The polyhydroxyalkanoate microbeads are said to rapidly sink in aqueous systems.
Denkbar ist auch die Verwendung von Microbeads auf der Basis von biologisch abbaubaren, auf Stärke basierenden thermoplastischen Polymeren, wie sie in dem europäischen Patent EP 2 493 975 B1 beschrieben wird. Diese Produkte sind unter der Marke Solanyl® im Handel erhältlich. Also conceivable is the use of microbeads based on biodegradable, starch-based thermoplastic polymers, as described in the European patent EP 2 493 975 B1. These products are commercially available under the trademark Solanyl®.
Um zu verhindern, dass sich Bakterien und somit auch Krankheitserreger verbreiten, werden Reinigungsmittel, Desinfektionsmittel und Körperpflegemittel mit Bioziden versetzt. Folgende Biozide sind beispielhaft aufgelistet: In order to prevent bacteria and thus pathogens from spreading, cleaning agents, disinfectants and personal care products are mixed with biocides. The following biocides are listed by way of example:
- Akarizide gegen Milben, - acaricides against mites,
- Algizide gegen Algen, - algicides against algae,
- Fungizide gegen Pilze, - fungicides against fungi,
- mikrobiozide Ausrüstung gegen Keime, - microbiocidal equipment against germs,
- Natriumhypochlorit für Haut-/Schleimhaut gegen Viren, Keime, Pilze und Bakterien - Sodium hypochlorite for skin / mucosa against viruses, germs, fungi and bacteria
- Nematizide gegen Fadenwürmer und - Nematicides against roundworms and
- Viruzide gegen Viren. - Viruzide against viruses.
Beispiele bekannter Biozide sind 10,10‘-0xybisphenoxoarsin (OBPA), Octylisothiazolinon (OIT), Dichlorctylisothiazolinon (DCOIT), Butylbenzisothiazolinon (BBIT), lodocarb (3-lod-2- propinylbutylcabamat), Zink-Pyrithion (Zinksalz von Pyridin-2-thiol-1 -oxyd), Trichlosan (polychlorierte Phenoxyphenole), Silberionen und Silber, insbesondere in der Form von Silbernanopartikeln. Examples of known biocides are 10,10'-oxybisphenoxoarsine (OBPA), octylisothiazolinone (OIT), dichloroctylisothiazolinone (DCOIT), butylbenzisothiazolinone (BBIT), iodocarb (3-iodo-2-propynylbutylcabamate), zinc pyrithione (zinc salt of pyridine-2-one). thiol-1-oxide), trichlosan (polychlorinated phenoxyphenols), silver ions and silver, especially in the form of silver nanoparticles.
Die bekannten Biozide weisen Nachteile wie ein enges Anwendungsspektrum, eine vergleichsweise hohe Toxizität, die Neigung, Resistenzen und Kreuzresistenzen hervorzurufen und eine noch weitgehend ungeklärte ökologische Langzeitwirkung auf. The known biocides have disadvantages such as a narrow range of applications, a comparatively high toxicity, the tendency to cause resistance and cross-resistance and a still largely unexplained ecological long-term effect.
Polyoxometallate (POM) sind anorganische Polysäuren mit - im Gegensatz zu Isopolysäuren - mindestens zwei verschiedenen Zentralatomen. Heteropolysäuren entstehen aus jeweils schwachen, mehrbasischen Oxosäuren eines Metalls (meist Chrom, Molybdän, Vanadium oder Wolfram) und eines Nichtmetalls (meist Arsen, lod, Phosphor, Selen, Silicium oder Tellur) als partielle gemischte Anhydride wie zum Beispiel H3[PMi204o], insbesondere 12- Molybdatophosphoräure (M=Mo) bzw. 12-Wolframatophosphorsäure (M=W). Als zweites Zentralatom könne auch Actinoide oder Lanthanoide fungieren; dabei sind die Wolfram- Heteropolysäuren thermisch wesentlich stabiler als die analogen Molybdän-Verbindungen. Als Keggin-Säuren bezeichnet man gelegentlich Heteropolysäuren der allgemeinen Formulierung [(E04)M12036]h-8 mit n = Wertigkeit des tetraedisch koordinierten Elements E (z.B. Bor, Silicium, Zink). Mit oktaedrisch koordiniertem Heteroatom findet man häufig den Heterohexametallat-Typ [(E06)M6018]n-i2 (Anderson-Evans-Anionen) [vgl. Römpp Online, Version 3.47 »Heteropolysäuren«]. Polyoxometalates (POM) are inorganic polyacids with - in contrast to isopolyacids - at least two different central atoms. Heteropolyacids are formed from weak, polybasic oxo acids of a metal (usually chromium, molybdenum, vanadium or tungsten) and a non-metal (usually arsenic, iodine, phosphorus, selenium, silicon or tellurium) as partial mixed anhydrides such as H 3 [PMi 2 0 4 o], in particular 12-molybdophosphoric acid (M = Mo) or 12-tungstophosphoric acid (M = W). The second central atom may also be actinide or lanthanide; The tungsten heteropolyacids are thermally much more stable than the analogous molybdenum compounds. As Keggin acids occasionally called heteropolyacids of the general formulation [(E0 4 ) M 12 0 36 ] h- 8 with n = valency of the tetrahedral coordinated element E (eg, boron, silicon, zinc). With octahedrally coordinated heteroatom, the heterohexametallate type [(E0 6 ) M 6 O 18 ] ni 2 (Anderson-Evans anions) is frequently found [cf. Römpp Online, Version 3.47 "Heteropolyacids"].
In ihrem Artikel »Fabrication and Characterization of Antibacterial-active Multilaer Films Based on Keggin Polyoxometalates and Methylene Blue«, in Z. Naturforsch. 2010, 65b, Seiten 140 bis 146, beschreiben Dan Chen, Jun Peng, Haijun Pang, Pengpeg Zhang, Yuan Chen, Yan Shen, Chanyung Chen und Huiyuan Ma, mehrschichtige Filme auf der Basis der Kegging Polyoxymetallate alpha-[SiWi204o]4-/alpha-[PMoi2040]3_, die antibakterielle Wirkung gegen Escherichia coli zeigen. In her article "Fabrication and Characterization of Antibacterial-active Multilayer Films Based on Keggin Polyoxometalates and Methylene Blue", in Z. Naturforsch. 2010, 65b, pages 140-146, describe Dan Chen, Jun Peng, Haijun Pang, Pengpeg Zhang, Yuan Chen, Yan Shen, Chanyung Chen, and Huiyuan Ma, multi-layer films based on the kegging polyoxymetalates alpha [SiWi 2 O 4 o ] 4- / alpha [PMoi 2 O 40 ] 3_ , which show antibacterial activity against Escherichia coli.
In ihrem Artikel »Antibacterial activity of highly negative charged polyoxotungsstates, K27(KAS4W40O140) and K18(KSb9W21086), and Keggin-structural polyoxotungstates against Heliobacter pylori«, in Journal of Inorganic Biochemistry, 99 (2005), Seiten 1023 bis 1031 , beschreiben Miyao Inoue, Keiko Segawa, Sae Matsunaga, Obuhiro Matsmoto, Mayumi Oda undToshihiro Yamase die antibakterielle Aktivität dieses Polyoxymetallate (POM) auf der Basis der Bestimmung der minimalen inhibitorischen Konzentration (MIC) und der fraktionellen inhibitorischen Konzentration (FIK), des Todeszeitpunktes der Bakterien, der bakteriellen Morphologie und der Aufnahme der POM in den Bakterienzellen. Aus dem amerikanischen Patent US 6,91 1 ,470 B1 sind POM mit antiretroviraler Aktivität bekannt. In their article "Antibacterial activity of highly negatively charged polyoxotentates, K 27 (KAS 4 W 40 O 140 ) and K 18 (KSb 9 W 21 0 86 ), and Keggin-structural polyoxotungstates against Helicobacter pylori", in Journal of Inorganic Biochemistry, 99 (2005), pages 1023 to 1031, Miyao Inoue, Keiko Segawa, Sae Matsunaga, Obuhiro Matsmoto, Mayumi Oda and Toshihiro Yamase describe the antibacterial activity of this polyoxymetalate (POM) based on determination of minimum inhibitory concentration (MIC) and fractional inhibitory concentration (FIK), the time of death of the bacteria, the bacterial morphology and the uptake of POM in the bacterial cells. US Pat. No. 6,911 1,470 B1 discloses POMs with antiretroviral activity.
Aus den amerikanischen Patenten US 5,824,706 und US 6,020,369 sind die Prävention und die Behandlung von viralen Infektionen der Atemwege bekannt, bei dem ein POM-haltiges Aerosolspray in die Lungen appliziert wird. US Pat. Nos. 5,824,706 and 6,020,369 disclose the prevention and treatment of respiratory viral infections in which a POM-containing aerosol spray is applied to the lungs.
Aus der amerikanischen Patentanmeldung US 2008/0187601 A1 und den amerikanischen Patenten US 6,723,349 B2 und US 7,097,858 B2 sind topische POM-haltige Zusammensetzungen bekannt, mit deren Hilfe Schadstoffe, insbesondere Kampfstoffe, aus der Umwelt entfernt werden. Zusätzlich können die topische Zusammensetzungen noch Cer- , Silber-, Gold-, oder Platinverbindungen enthalten. Als Träger können insbesondere Perfluorpolyether (PFPE) verwendet werden. So kann der Kampfstoff 2-Chlorethylethylsulfid (CEES) quantitativ zu 2-Chlorethylethylsulfoxid (CEESO) oxidiert werden. Diese bekannten topischen Zusammensetzungen weisen den Nachteil auf, dass sie sich nicht durch Wasser von der Haut entfernen lassen. American patent application US 2008/0187601 A1 and US patents US Pat. No. 6,723,349 B2 and US Pat. No. 7,097,858 B2 disclose topical POM-containing compositions with the aid of which pollutants, in particular warfare agents, are removed from the environment. Additionally, the topical compositions may still contain cerium, silver, gold, or platinum compounds. In particular, perfluoropolyethers (PFPE) can be used as the carrier. Thus, the warfare agent 2-chloroethylethyl sulfide (CEES) can be quantitatively oxidized to 2-chloroethylethyl sulfoxide (CEESO). These known topical compositions have the disadvantage that they can not be removed from the skin by water.
Aus dem amerikanischen Patent US 5,904,734 ist ein Bleichmittel bekannt, das Peroxid und einen Aktivator enthält. Bei dem Aktivator kann es sich um Siliciumwolframsäure (tungstosilicic acid) handeln. Durch das Bleichmittel können Schimmel und Pilzbefall von Fliesen und Durchvorhängen entfernt werden. From the US patent US 5,904,734 a bleaching agent is known which contains peroxide and an activator. The activator may be tungsten silicic acid. The bleach can remove mold and fungus from tiles and curtains.
Aus der japanischen Offenlegungsschrift JP 002005281299 A ist die Verwendung von Kaliumsalz der 12-Siliciumwolframsäure als antibakterielles und antimykotisches Mittel zur Verwendung in Beschichtungsmitteln für Möbel bekannt. Japanese Unexamined Patent Publication JP 002005281299 A discloses the use of potassium salt of 12-silicotungstic acid as an antibacterial and antifungal agent for use in furniture coating compositions.
In dem Artikel von Eunyoung Bae, Jae Won Lee, Byeong Hee Wang, Jiman Yeo, Jecong Yoon, Hyung Joon Cha und Wonyong Choi „Photocatalytic bacterial inactivation by polyoxometalates“, in Chemosphere 72 (2008), 174-181 , wird die fotokatalytische Inaktivierung von gramnegativen und grampositiven Bakterien beschrieben. Dazu wurden wässrige Suspensionen der Bakterien, die H4S1W12O40 oder H3PW12O40 enthalten, mit UV-Licht bestrahlt. Die Autoren ziehen den Schluss, dass die Polyoxometallate als Fotokatalysatoren wirken. Aus der amerikanischen Patentanmeldung US 2009/0004124 A1 sind kosmetische Zusammensetzung bekannt, die fluidisierte Partikel wie H3PW12O40 enthalten. Die Fluidisierung der Partikel erfolgt durch Reste aus langen Kohlenstoffketten, die mit den Partikeln verknüpft sind. In the article by Eunyoung Bae, Jae Won Lee, Byeong Hee Wang, Jiman Yeo, Jecong Yoon, Hyung Joon Cha and Wonyong Choi "Photocatalytic bacterial inactivation by polyoxometalates", in Chemosphere 72 (2008), 174-181, the photocatalytic inactivation becomes of Gram-negative and Gram-positive bacteria. For this purpose, aqueous suspensions of the bacteria containing H4S1W12O40 or H3PW12O40 were irradiated with UV light. The authors conclude that the polyoxometalates act as photocatalysts. US Patent Application US 2009/0004124 A1 discloses cosmetic compositions which contain fluidized particles such as H3PW12O40. The fluidization of the particles is carried out by residues of long carbon chains, which are linked to the particles.
Aus der amerikanischen Patentanmeldung US 2009/0012204 A1 sind mit reaktiven Polyoxometallaten funktionalisierte Polymere bekannt, die der Dekontamination schädlicher Verbindungen dienen. Als Polyoxometallate können solche vom Keggin-Typ der allgemeinen Formel (Rm+)y[Xn+Mi204o](8 n) , worin m und n ganze Zahlen sind, y = (8-n)/m, X = Phosphor oder Silizium und M = Molybdän, Wolfram, Vanadium und Mischungen hiervon, O = Sauerstoff und R = Wasserstoff, Silber, Ammonium, quaternäres Ammonium und Mischungen hiervon, verwendet werden. From US patent application US 2009/0012204 A1, polymers functionalized with reactive polyoxometalates are known, which serve to decontaminate harmful compounds. As polyoxometalates, those of the Keggin type of the general formula (R m + ) y [X n + Mi 2 O 4 o] (8 n) , wherein m and n are integers, y = (8-n) / m, X = Phosphorus or silicon and M = molybdenum, tungsten, vanadium and mixtures thereof, O = oxygen and R = hydrogen, silver, ammonium, quaternary ammonium and mixtures thereof.
Aus der amerikanischen Patentanmeldung US 2009/0022645 A1 ist die Verwendung von K4[a- S1W12O40] als Aktivator für eine Bleiche bekannt. US Patent Application US 2009/0022645 A1 discloses the use of K4 [a-S1W12O40] as an activator for bleaching.
Aus der deutschen Offenlegungsschrift DE 10 2015 000 812 A1 sind wasserhaltige Reinigung- und Körperpflegemittel mit biozider Wirkung bekannt, die Polyoxometallate als bioziden Bestandteil enthalten. German laid-open specification DE 10 2015 000 812 A1 discloses hydrous cleansing and personal care products having a biocidal action which contain polyoxometalates as a biocidal constituent.
Dis Weiteren ist aus der deutschen Offenlegungsschrift DE 10 2015 000 813 A1 ein Verfahren zur Vernichtung von Medikamenten und Giftstoffen und ihren Metaboliten mithilfe von Polyoxometallat-Mikro und/oder - Nanopartikeln bekannt. Furthermore, German Patent Application DE 10 2015 000 813 A1 discloses a method for destroying medicaments and toxins and their metabolites with the aid of polyoxometalate micro and / or nanoparticles.
In der Publikation„Hair follicles as a target structure for nanoparticles“ von J. Lademann, F. Knorr, H. Richter, S. Jung, M. C. Meinke, E. Rühl, U. Alexiev, M. Calderon und A. Patzelt, Journal of Innovative Optical Health Sciences, Band 8, Nr. 4 (2015) 1530004, untersuchen die Autoren die Penetration von Titandioxid-Nanopartikeln in Haarfollikel. Sie kommen zu dem Ergebnis, dass Titandioxid-Nanopartikeln einer mittleren Teilchengröße d5o von 643 nm die größte Eindringtiefe zwischen 1100 pm und 1200 pm haben. In the publication "Hair follicles as a target structure for nanoparticles" by J. Lademann, F. Knorr, H. Richter, S. Jung, MC Meinke, E. Rühl, U. Alexiev, M. Calderon and A. Patzelt, Journal of Innovative Optical Health Sciences, Vol. 8, No. 4 (2015) 1530004, the authors study the penetration of titanium dioxide nanoparticles into hair follicles. They conclude that titanium dioxide nanoparticles with a mean particle size d5o of 643 nm have the highest penetration depth between 1100 pm and 1200 pm.
Aufgabe der vorliegenden Erfindung Object of the present invention
Der vorliegenden Erfindung lag die Aufgabe zu Grunde, Kosmetika, Pflegeprodukte, Produkte für Saunen und Dampfbäder, Pulver, Festkörper, Gele, Cremes, Salben Lotionen, Tropfen, Sprays, Dosieraerosole Gurgellösungen, Lutschtabletten, Einläufe, Klistiere, Zäpfchen, Schäume Toilettenutensilien, textilen Gewebe, Gesichtsmasken, Umschläge, Binden, Tampons, Verbandsmull, Pflaster, medizinische Geräte und Releasematerialien bereit zu stellen, die unter anderem als Feuchtigkeitsregulator und/oder als Wasserspeicher fungieren, anorganische und/oder organische Stoffe, die sich auf, in und/oder unter der menschlichen oder tierischen Haut befinden, binden, absorbieren und/oder unschädlich machen, die Bildung unangenehmer Gerüche unterdrücken und/oder ungesunde Bakterien hemmen und gesunde Bakterien fördern. The present invention was based on the object cosmetics, toiletries, products for saunas and steam baths, powders, solids, gels, creams, ointment lotions, drops, sprays, metered aerosols gargles, lozenges, enemas, enemas, suppositories, Foams providing toilet utensils, textile fabrics, face masks, envelopes, sanitary napkins, tampons, gauze, plasters, medical devices, and release materials that function, inter alia, as a moisture regulator and / or water storage, inorganic and / or organic matter based on, in and / or under the human or animal skin, bind, absorb and / or render harmless, suppress the formation of unpleasant odors and / or inhibit unhealthy bacteria and promote healthy bacteria.
Die vorstehend genannten Produkte sollen sich mit Vorteil als medizinische, insbesondere onkologische und dermatologische, Kosmetika und Pflegeprodukte, Produkte für Saunen und Dampfbäder und zur Pflege von Haut, Schleimhäuten, insbesondere Schleimhäute im Mund, an und in den Genitalien und im Darm, Augen, Ohren, Mund, Lippen, Fingernägel, Zehennägel, Hornhaut, Warzen und Narben, bei Ausscheidungen von Noxen, Drogen, Toxinen, Medikamenten, Säuren und Basen über die Haut, bei Läsionen, Juckreiz, Brennen, Intertrigo, Infektionen und Rötungen, zum vorbeugenden Schutz, zur Unterstützung von Heilungsprozessen bei bestehenden Infektionen, Wunden oder Verbrennungen, in der dekorativen Kosmetik, in der kosmetischen Gesichtspflege, in der Haarpflege und in der Körperpflege von Mensch und Tier verwenden lassen. The aforementioned products are said to be of advantage as medical, especially oncological and dermatological, cosmetics and care products, products for saunas and steam baths and for the care of the skin, mucous membranes, especially mucous membranes in the mouth, on and in the genitals and in the intestine, eyes, ears , Mouth, lips, fingernails, toenails, cornea, warts and scars, in excretions of noxa, drugs, toxins, drugs, acids and bases over the skin, in lesions, itching, burning, intertrigo, infections and redness, for preventive protection, to be used to assist healing processes in existing infections, wounds or burns, in decorative cosmetics, in cosmetic facial care, in hair care and in the personal care of humans and animals.
Des Weiteren sollen die vorstehend genannten Produkte die Umwelt nicht schädigen und sich insbesondere nicht in der marinen Nahrungskette in Organismen ansammeln. Furthermore, the above-mentioned products should not harm the environment and in particular do not accumulate in the marine food web in organisms.
Außerdem ist es Aufgabe der vorliegenden Erfindung, ein Verfahren zur Herstellung der vorstehend genannten Produkte zu finden. In addition, it is an object of the present invention to find a process for the preparation of the aforementioned products.
Erfindungsgemäße Lösung Inventive solution
Demgemäß wurden die topischen Zubereitungen, enthaltend Accordingly, the topical preparations containing
(A) mindestens einen Typ von Kohlenstoffpartikeln einer mittleren Teilchengröße von dso = 650 ± 200 nm, gefunden, die im Folgenden als »erfindungsgemäße topische Zubereitungen« bezeichnet werden. Außerdem wurde das Verfahren zur Herstellung der erfindungsgemäßen topischen Zubereitungen gefunden, bei dem man (A) at least one type of carbon particles having an average particle size of dso = 650 ± 200 nm, which are referred to below as "topical preparations according to the invention". In addition, the process for the preparation of the topical preparations according to the invention was found in which
(I) mindestens einen Typ von Partikeln (A) mit mindestens einem weiteren Bestandteil vermischt und die resultierende Mischung homogenisiert und (I) at least one type of particles (A) mixed with at least one further component and the resulting mixture homogenized and
(II) die resultierende homogenisierte Mischung zu Pulvern, Festkörpern, Gelen, Cremes, Salben, Lotionen, Tropfen, Sprays, Dosieraerosolen, Gurgellösungen, Lutschtabletten Einläufen, Klistieren, Zäpfchen oder Schäumen verarbeitet und/oder auf und/oder in textile Gewebe, Gesichtsmasken, Verbandsmull, Umschläge, Binden, Tampons, Pflaster, medizinische Geräte und/oder Releasematerialien appliziert, und das im Folgenden als »erfindungsgemäßes Verfahren« bezeichnet wird. (II) the resulting homogenised mixture is processed into powders, solids, gels, creams, ointments, lotions, drops, sprays, metered aerosols, gargles, lozenge enemas, enemas, suppositories or foams and / or on and / or in textile fabrics, face masks, Gauze, envelopes, bandages, tampons, plasters, medical devices and / or release materials applied, and which is hereinafter referred to as "inventive method".
Des Weiteren wurde die Verwendung der erfindungsgemäßen topischen Zubereitungen als medizinische und dekorative Kosmetika, Pflegeprodukte und Produkte für Saunen und Dampfbäder und zur Pflege von Haut, Schleimhäuten, Augen, Ohren, Mund, Lippen, Fingernägel, Zehennägel, Hornhaut, Warzen und Narben, bei Ausscheidungen von Noxen, Drogen, Toxinen, Medikamenten, Säuren und Basen über die Haut, bei Läsionen, Juckreiz, Brennen, Intertrigo, Infektionen und Rötungen, zum vorbeugenden Schutz, zur Unterstützung von Heilungsprozessen bei bestehenden Infektionen, Wunden oder Verbrennungen, in der dekorativen Kosmetik, in der kosmetischen Gesichtspflege, in der Haarpflege und in der Körperpflege von Mensch und Tier gefunden, die im Folgenden als »erfindungsgemäße Verwendung« bezeichnet wird. Furthermore, the use of the topical preparations according to the invention as medical and decorative cosmetics, care products and products for saunas and steam baths and for the care of skin, mucous membranes, eyes, ears, mouth, lips, fingernails, toenails, cornea, warts and scars, in excretions of noxious substances, drugs, toxins, medicines, acids and bases via the skin, in the case of lesions, itching, burning, intertrigo, infections and redness, for preventive protection, to support healing processes in existing infections, wounds or burns, in decorative cosmetics, in the cosmetic facial care, in the hair care and in the personal care of humans and animals, which is referred to below as "inventive use".
Nicht zuletzt wurden die medizinischen und dekorativen Kosmetika, Pflegeprodukte, Produkte für Saunen und Dampfbäder, Pulver, Festkörper, Gele, Cremes, Salben, Lotionen, Tropfen, Sprays, Dosieraerosole Gurgellösungen, Lutschtabletten, Einläufe, Klistiere, Zäpfchen, Schäume und Toilettenutensilien, textile Gewebe, Gesichtsmasken, Umschläge, Binden, Tampons, Verbandsmull, Pflaster, medizinischen Geräte und Releasematerialien gefunden, die mindestens eine erfindungsgemäße topische Zubereitungen enthält oder hieraus besteht und dem Folgenden als »erfindungsgemäße Produkte« bezeichnet werden. Not least the medical and decorative cosmetics, care products, products for saunas and steam baths, powders, solids, gels, creams, ointments, lotions, drops, sprays, metered aerosols gargles, lozenges, enemas, enemas, suppositories, foams and toilet utensils, textile fabrics , Face masks, envelopes, bandages, tampons, gauze, plasters, medical devices and release materials, which contains or consists of at least one topical preparation according to the invention and the following are referred to as "products according to the invention".
Vorteile der Erfindung Im Hinblick auf den Stand der Technik war es überraschend und für den Fachmann nicht vorhersehbar, dass die Aufgabe, die der vorliegende Aufgabe zu Grunde lag, mittels der erfindungsgemäßen topischen Zubereitungen, des erfindungsgemäßen Verfahrens, der erfindungsgemäßen Verwendung und der erfindungsgemäßen Produkte gelöst werden konnte. Advantages of the invention In view of the prior art, it was surprising and unforeseeable for the skilled person that the object underlying the present task could be achieved by means of the topical preparations according to the invention, the method according to the invention, the use according to the invention and the products according to the invention.
Insbesondere war es überraschend, dass die medizinischen und dekorativen Kosmetika, Pflegeprodukte, Produkte für Saunen und Dampfbäder, Pulver, Festkörper, Gele, Cremes, Salben Lotionen, Tropfen, Sprays, Dosieraerosole Gurgellösungen, Lutschtabletten, Einläufe, Klistiere, Zäpfchen, Schäume Toilettenutensilien, textilen Gewebe, Gesichtsmasken, Umschläge, Binden, Tampons, Verbandsmull, Pflaster, medizinische Geräte und Releasematerialien hervorragend als Feuchtigkeitsregulator und/oder als Wasserspeicher fungierten, anorganische und/oder organische Stoffe, die sich auf, in und/oder unter der menschlichen oder tierischen Haut befinden, binden, absorbieren und/oder unschädlich machten, die Bildung unangenehmer Gerüche unterdrückten und/oder ungesunde Bakterien hemmten und gesunde Bakterien förderten. In particular, it was surprising that the medical and decorative cosmetics, toiletries, products for saunas and steam baths, powders, solids, gels, creams, ointment lotions, drops, sprays, metered aerosols gargle solutions, lozenges, enemas, enemas, suppositories, foams toilet utensils, textile Tissues, facemasks, envelopes, sanitary napkins, tampons, gauze, plasters, medical devices and release materials have functioned well as moisture regulators and / or water storages, inorganic and / or organic substances located on, in and / or under human or animal skin , bind, absorb and / or render harmless, suppress the formation of unpleasant odors and / or inhibit unhealthy bacteria and promote healthy bacteria.
Die erfindungsgemäßen Produkte konnten erfindungsgemäß mit Vorteil als medizinische, insbesondere onkologische und dermatologische, Kosmetika und Pflegeprodukte, Produkte für Saunen und Dampfbäder und zur Pflege von Haut, Schleimhäuten, insbesondere Schleimhäute im Mund, an und in den Genitalien und im Darm, Augen, Ohren, Mund, Lippen, Fingernägel, Zehennägel, Hornhaut, Warzen und Narben, bei Ausscheidungen von Noxen, Drogen, Toxinen, Medikamenten, Säuren und Basen über die Haut, bei Läsionen, Juckreiz, Brennen, Intertrigo, Infektionen und Rötungen, zum vorbeugenden Schutz, zur Unterstützung von Heilungsprozessen bei bestehenden Infektionen, Wunden oder Verbrennungen, in der dekorativen Kosmetik, in der kosmetischen Gesichtspflege, in der Haarpflege und in der Körperpflege von Mensch und Tier verwendet werden. According to the invention, the products according to the invention could advantageously be used as medical, in particular oncological and dermatological, cosmetics and care products, products for saunas and steam baths and for the care of skin, mucous membranes, in particular mucous membranes in the mouth, on and in the genitals and in the intestine, eyes, ears, Mouth, lips, fingernails, toenails, cornea, warts and scars, in excretions of noxa, drugs, toxins, medicines, acids and bases over the skin, in lesions, itching, burning, intertrigo, infections and redness, for preventive protection, for Assist healing processes in existing infections, wounds or burns, in decorative cosmetics, in cosmetic facial care, in hair care and in the personal care of humans and animals.
Des Weiteren konnten die erfindungsgemäßen topischen Zubereitungen und die erfindungsgemäßen Produkte in einfacher und sehr gut reproduzierbarer Weise nach dem erfindungsgemäßen Verfahren hergestellt werden. Furthermore, the topical preparations according to the invention and the products according to the invention could be prepared in a simple and very reproducible manner by the method according to the invention.
Insbesondere überraschte, dass bei der Herstellung der erfindungsgemäßen Produkte und der erfindungsgemäßen topischen Zubereitungen weitgehend oder ausschließlich nachwachsende, kompostierbare, toxikologisch unbedenkliche, biologisch abbaubare und/oder recycelbare Rohstoffe genutzt werden konnten, sodass die Herstellung und die Verwendung der erfindungsgemäßen topischen Zubereitungen und der erfindungsgemäßen Produkte besonders umweltschonend waren und als Kohlendioxidsenke fungieren konnten. In particular, it was surprising that in the production of the products according to the invention and the topical preparations according to the invention, it was possible to use largely or exclusively renewable, compostable, toxicologically acceptable, biodegradable and / or recyclable raw materials, so that the production and the Use of the topical preparations according to the invention and the products according to the invention were particularly environmentally friendly and could act as a carbon dioxide sink.
Besonders überraschend war die Bindung und/oder die Aufnahme von Schadstoffen von der Haut durch die erfindungsgemäßen topischen Zubereitungen und die erfindungsgemäßen Produkte. Insbesondere wurde durch die Haut und die Schleimhäute abgesonderte Arzneimittel, insbesondere Zytostatika, an der Rückresorption gehindert und unschädlich gemacht. Somit waren die erfindungsgemäßen topischen Zubereitungen und die erfindungsgemäßen Produkte für Allergiker und/oder für alle Hauttypen verträglich. Außerdem waren sie bakteriostatisch und besaßen eine antivirale, fungizide oder fungistatische und nematizide Wirkung. Particularly surprising was the binding and / or absorption of pollutants from the skin by the topical preparations according to the invention and the products according to the invention. In particular, drugs secreted by the skin and mucous membranes, especially cytostatics, were prevented from reabsorbing and rendering harmless. Thus, the topical preparations according to the invention and the products according to the invention were tolerable for allergy sufferers and / or for all skin types. In addition, they were bacteriostatic and had an antiviral, fungicidal or fungistatic and nematicidal action.
All diese vorteilhaften Wirkungen der erfindungsgemäßen topischen Zubereitungen und der erfindungsgemäßen Produkte wurden verstärkt durch ihre hervorragende Eindringtiefe in die Haut und in die Schleimhäute. Sie konnten deshalb auch als Carrier für Medikamente dienen. All these advantageous effects of the topical preparations according to the invention and of the products according to the invention were enhanced by their excellent penetration into the skin and into the mucous membranes. They could therefore serve as carriers for drugs.
Des Weiteren überraschte, dass die Herstellung der erfindungsgemäßen Produkte frei von polycyclischen aromatischen Verbindungen (PAH) erfolgen konnte. Furthermore, it was surprising that the preparation of the products according to the invention could be carried out free of polycyclic aromatic compounds (PAH).
Ausführliche Beschreibung der Erfindung Detailed description of the invention
Der erste erfindungsgemäß wesentliche Bestandteil der erfindungsgemäßen topischen Zubereitungen ist mindestens ein Typ, insbesondere ein Typ, von Kohlenstoffpartikeln (OH) einer mittleren Teilchengröße dso = 650 ± 200 nm, vorzugsweise 650 ± 150 nm und insbesondere 650 ± 100 nm. The first essential constituent of the topical preparations according to the invention is at least one type, in particular one type, of carbon particles (OH) having an average particle size d 50 = 650 ± 200 nm, preferably 650 ± 150 nm and in particular 650 ± 100 nm.
Die Kohlepartikel (A) können von Holzkohle und/oder deren Siebrückständen und/oder Holzasche, Aktivkohle, Steinkohle, Tierkohle, Tierabfallkohle, pyrogenem Kohlenstoff unterschiedlichen Pyrolysegrades, funktionalisiertem Kohlenstoff und/oder funktionalisierter Kohle, vorbehandelter Kohle, gewaschener Kohle, Kohle mit unterschiedlichen Verkohlungsgraden, extrahierter Kohle Koks, natürlichem Koks und unvollständig ausgegastem Koks stammen und/oder durch einen Pyrolyseprozess in einer mobilen oder stationären Pyrolyseanlage aus vorwiegend ligninreichen, organischen Materialien wie Holz, Pflanzenstängel, Blättern, Obstkernen, Nussschalen und/oder Knochen gewonnen werden. Knochen haben den Vorteil, dass sie besonders phosphorhaltig sind. Vorzugsweise wird der Pyrolyseprozess unter Sauerstoffabschluss bei etwa 1000 °C betrieben. Der Fachmann versteht es jedoch, die entsprechenden Pyrolysebedingungen an die jeweiligen Gegebenheiten, wie die Art der Pyrolyseanlage, dem Umgebungsdruck und/oder der Menge der Art und der Beschaffenheit des Pyrolysegutes anzupassen. Diese Materialien sind üblich und bekannt und gehen beispielsweise aus der deutschen Offenlegungsschrift DE 10 2015 010 041 A1 , Absätze [0055] bis [0064], hervor. The charcoal particles (A) may consist of charcoal and / or their screenings and / or wood ash, activated carbon, hard coal, animal charcoal, animal waste coal, pyrogenic carbon of different pyrolysis degree, functionalized carbon and / or functionalized coal, pretreated coal, washed coal, coal with different degrees of charring, Extracted coal coke, natural coke and incompletely outgassed coke and / or obtained by a pyrolysis process in a mobile or stationary pyrolysis of predominantly lignin-rich, organic materials such as wood, plant stems, leaves, fruit pits, nut shells and / or bones. Bones have the advantage that they are particularly phosphorus-containing. Preferably, the pyrolysis process is operated under oxygen exclusion at about 1000 ° C. However, the person skilled in the art understands how to adapt the pyrolysis conditions to the particular circumstances, such as the type of pyrolysis plant, the ambient pressure and / or the amount of the type and nature of the pyrolysis product. These materials are customary and known and are evident, for example, from German Patent Application DE 10 2015 010 041 A1, paragraphs [0055] to [0064].
Die durch diverse Verfahren hergestellte Kohle weist intramolekulare Kohlenstoffstrukturen auf, die z.B. durch die Pyrolysebedingungen beeinflusst werden können. Dadurch können die Eigenschaften des für das erfindungsgemäße Verfahren verwendeten Kohlenstoffs im Hinblick auf eine hohe Nährstoff- und Wasserspeicherkapazität angepasst werden. The coal produced by various processes has intramolecular carbon structures, e.g. can be influenced by the pyrolysis conditions. Thereby, the properties of the carbon used for the process according to the invention can be adapted in view of a high nutrient and water storage capacity.
Die Kohlepartikel (A) können die unterschiedlichsten Morphologien und geometrischen Formen aufweisen, sodass diese hervorragend den anderen Bestandteilen der erfindungsgemäßen topischen Zubereitungen angepasst werden können. The carbon particles (A) can have a wide variety of morphologies and geometric shapes, so that they can be excellently adapted to the other constituents of the topical preparations according to the invention.
So können sie kompakt sein, sowie mindestens einen Hohlraum und/oder eine Kern-Schale- Struktur aufweisen. Außerdem können diese Hohlräume auch unterschiedlich groß sein. Sie können auch unterschiedliche geometrische Formen, wie Kugeln, Ellipsoide, Würfel, Quader, Pyramiden, Kegel, Zylinder, Rhomben, Dodekaeder, abgestumpfte Dodekaeder, Mäander, Fraktale, Ikosaeder, abgestumpfte Ikosaeder, Hanteln, Tori, Plättchen, oder Nadeln mit kreisförmigen, ovalen, elliptischen, quadratischen, dreieckigen, viereckigen, fünfeckigen, sechseckigen, siebeneckigen, achteckigen oder sternenförmigen (drei-, vier-, fünf-, oder mehrzackig) Umriss haben. Dabei können gegebenenfalls vorhandene Kanten und Ecken abgerundet sein. Es können sich auch zwei oder mehr Kohlenstoffpartikel (A) unterschiedlicher Morphologie und/oder geometrischer Form zusammenlagern. Beispielsweise, aber nicht einschränkend, können kugelförmige Kohlenstoffpartikel (A) spitze Auswüchse in Kegelform haben. Des Weiteren kann ihre Oberfläche Vertiefungen aufweisen, sodass die Kohlenstoffpartikel (A) eine erdbeer- oder himbeerförmige Morphologie haben. Nicht zuletzt können die Hantel, Tori, Nadeln oder Plättchen in mindestens einer Richtung des Raumes gebogen sein. Sie können in jeglicher Form freiwählbar sein. Thus, they can be compact, and have at least one cavity and / or a core-shell structure. In addition, these cavities can be different in size. You can also use different geometric shapes, such as spheres, ellipsoids, cubes, cuboids, pyramids, cones, cylinders, rhombuses, dodecahedra, truncated dodecahedron, meander, fractal, icosahedron, truncated icosahedron, dumbbells, tori, platelets, or needles with circular, oval , elliptical, square, triangular, quadrangular, pentagonal, hexagonal, heptagonal, octagonal, or star-shaped (tri, tetra, pentagonal, or polygonal) outline. If necessary, existing edges and corners can be rounded. It is also possible for two or more carbon particles (A) of different morphology and / or geometric form to be combined. For example, but not by way of limitation, spherical carbon particles (A) may have pointed outgrowths in the form of cones. Furthermore, their surface may have depressions so that the carbon particles (A) have a strawberry or raspberry morphology. Last but not least, the dumbbell, tori, needles or plates can be bent in at least one direction of the room. They can be freely selectable in any form.
Die mittlere Teilchengröße dso der Kohlenstoffpartikel (A) variiert zwischen den vorstehend angegebenen Grenzen. Dabei können die Kohlenstoffpartikel (A) monodispers, oligodispers und/oder polydispers sein und daher hervorragend dem jeweiligen Verwendungszweck der erfindungsgemäßen topischen Zubereitungen angepasst werden. Die mittlere Teilchengröße c o kann mithilfe der Transmissionselektromikroskopie (TEM), Rasterelektronenmikroskopie (REM), Rastertransmissionselektromikroskopie (RTEM), Rasterkraftmikroskopie (AFM) oder Rastertunnelmikroskopie (TRM) gemessenen werden. Sie kann mithilfe üblicher und bekannter Sichtungsmethoden auf den gewünschten Wert eingestellt werden. The mean particle size dso of the carbon particles (A) varies between the limits given above. In this case, the carbon particles (A) may be monodisperse, oligodisperse and / or polydisperse and therefore be excellently adapted to the particular intended use of the topical preparations according to the invention. The mean particle size co can be measured by transmission electron microscopy (TEM), scanning electron microscopy (SEM), scanning transmission electron microscopy (RTEM), atomic force microscopy (AFM) or scanning tunneling microscopy (TRM). It can be set to the desired value using standard and well-known screening methods.
Vorzugsweise haben die Kohlenstoffpartikel (A) weitgehend freie oder völlig freie Oberflächen. Preferably, the carbon particles (A) have largely free or completely free surfaces.
Die verwendeten Mengen an Kohlenstoffpartikel (A) in den erfindungsgemäßen topischen Zubereitungen können sehr breit variieren und richten sich hauptsächlich nach deren Verwendungszweck. Vorzugsweise liegen die verwendeten Mengen bei 0,01 bis 20 Gew.-%, bevorzugt 0,05 bis 18 Gew.-% und insbesondere 0,1 bis 15 Gew.-%, jeweils bezogen auf die Gesamtmenge einer gegebenen erfindungsgemäßen topischen Zubereitungen. Für spezielle Anwendungszwecke können auch höhere Dosierungen angewandt werden. The amounts of carbon particles (A) used in the topical preparations according to the invention can vary very widely and depend mainly on their intended use. Preferably, the amounts used are from 0.01 to 20 wt .-%, preferably 0.05 to 18 wt .-% and in particular 0.1 to 15 wt .-%, each based on the total amount of a given inventive topical preparations. For special applications, higher dosages can also be used.
Besonders vorteilhafte erfindungsgemäße topische Zubereitungen enthalten Partikel (B) einer mittleren Teilchengröße dso gleich 10 nm bis <1000 pm, vorzugsweise 20 nm bis 1000 nm, bevorzugt 30 nm bis 800 nm und insbesondere 40 nm bis 600 nm. Die Partikel (B) enthalten und/oder bestehen aus mindestens einem, insbesondere einem, Typ von nanokristallinen und/oder mikrokristallinen natürlichen Wachsen und/oder halbsynthetischen Wachsen auf der Basis von natürlichen Wachsen und/oder biologisch abbaubarer Mikroplastik. Particularly advantageous topical preparations according to the invention comprise particles (B) having an average particle size dso equal to 10 nm to <1000 pm, preferably 20 nm to 1000 nm, preferably 30 nm to 800 nm and in particular 40 nm to 600 nm. Containing particles (B) and / or consist of at least one, in particular one, type of nanocrystalline and / or microcrystalline natural waxes and / or semi-synthetic waxes based on natural waxes and / or biodegradable microplastics.
Bei dem Begriff des Wachses handelt es sich um eine Phänomenologie Bezeichnung für eine Reihe natürlich oder künstlich bzw. synthetisch gewonnener Stoffe, die in der Regel folgende Eigenschaften aufweisen: bei 20 °C knetbar, fest bis brüchig-hart, grob bis feinkristallin, durchscheinend bis opak, nicht glasartig, über 40 °C ohne Zersetzung schmelzend, jedoch schon wenig oberhalb des Schmelzpunktes verhältnismäßig niedrigviskos und im allgemeinen oder vorteilhafterweise nicht fadenziehend, weisen eine stark temperaturabhängige Konsistenz und Löslichkeit auf und sind unter leichtem Druck polierbar. Ist mehr als eine der zuvor aufgeführten Eigenschaften nicht erfüllt, ist dieser Stoff nach der DGF (Deutsche Gesellschaft für Fettwissenschaften) kein Wachs (vgl. DGF-Einheitsmethode M-l 1 (75)). Wachse unterscheiden sich von ähnlichen synthetischen oder natürlichen Produkten wie Harzen, plastische Massen, Metallseifen usw. hauptsächlich darin, dass sie im Allgemeinen etwa zwischen 50 °C und 90 °C, in Ausnahmefällen auch bis etwa 200 °C, in den schmelzflüssigen, niedrigviskosen Zustand übergehen und praktisch frei von aschebildenden Verbindungen sind. Wachse bilden Pasten oder Gele und brennen in der Regel mit rußender Flamme. The term wax is a phenomenology term for a series of naturally or synthetically or synthetically obtained substances, which generally have the following properties: kneadable at 20 ° C, solid to brittle-hard, coarse to fine crystalline, translucent to opaque, non-glassy, melting above 40 ° C without decomposition, but already slightly above the melting point relatively low viscosity and generally or advantageously not stringy, have a strong temperature-dependent consistency and solubility and are polishable under light pressure. If more than one of the above-mentioned properties is not met, this substance is not wax according to the DGF (German Society for Fat Science) (see DGF unit method Ml 1 (75)). Waxes differ from similar synthetic or natural products such as resins, plastic masses, metal soaps, etc. mainly in that they generally in the molten, low-viscosity state between about 50 ° C and 90 ° C, in exceptional cases up to about 200 ° C. pass over and virtually free of ash-forming Connections are. Waxes form pastes or gels and usually burn with a sooting flame.
Weitere Einzelheiten zum Begriff der Wachse finden sich in Römpp Chemielexikon, 10. Auflage, Band 6,19 199, Georg Thieme Verlag Stuttgart/New York, Seite 4.9.2006, Stichwort: „Wachse“ sowie die dort referierte Literatur, insbesondere Cos. Toil. 101 ,49 (1986 sowie DGF- Einheitsmethoden, Abteilung M-Wachse und Wachsprodukte, 7. Ergänzungslieferung, 05/1999, Stuttgart. Further details on the concept of waxes can be found in Römpp Chemielexikon, 10th edition, Volume 6.1999, Georg Thieme Verlag Stuttgart / New York, page 4.9.2006, keyword: "waxes" and the literature reviewed there, especially Cos. Toil. 101, 49 (1986 and DGF unit methods, Department M-waxes and wax products, 7th supplement delivery, 05/1999, Stuttgart.
Erfindungsgemäß ist es bevorzugt, wenn ein Wachs (B) eingesetzt wird, welches polare funktionelle Gruppen, insbesondere Gruppen, die Heteroatome aus der Gruppe von Sauerstoff, Stickstoff und/oder Schwefel, bevorzugt Sauerstoff, enthalten, besonders bevorzugt Hydroxylgruppen, Polyethergruppen, insbesondere Polyethylenoxidgruppen, und/oder Carboxylgruppen. According to the invention, preference is given to using a wax (B) which contains polar functional groups, in particular groups which contain heteroatoms from the group of oxygen, nitrogen and / or sulfur, preferably oxygen, particularly preferably hydroxyl groups, polyether groups, in particular polyethylene oxide groups, and / or carboxyl groups.
Beispiele geeigneter natürlicher Wachse sind pflanzliche Wachse wie Candelillawachs, Carnaubawachs, Japanwachs, Espartograswachs, Korkwachs, Guarumawachs, Reiskeimölwachs, Zuckerrohrwachs, Ouricurywachs, Montanwachs, absolute Blütenwachse, Kuba-Palmenwachs, Baumwollwachs, Flachswachs, Torfwachs, Rosenwachs, Jasminwachs, Peethawachs, Myrtewachs und Wachsfeigenwachs. Examples of suitable natural waxes are vegetable waxes such as candelilla wax, carnauba wax, Japan wax, esparto wax wax, cork wax, guaruma wax, rice germ oil wax, sugarcane wax, ouricury wax, montan wax, absolute flower waxes, cuba palm wax, cotton wax, flax wax, peat wax, rose wax, jasmine wax, peethawax, myrtle wax and waxy wax ,
Beispiele geeigneter natürlicher Wachse sind tierische Wachse wie Walrat, Wollwachs, Schellack, Chinawachs, Bienenwachs und Bürzeldrüsenwachs. Examples of suitable natural waxes are animal waxes such as spermaceti, wool wax, shellac, china wax, beeswax and ragwort wax.
Beispiele geeigneter natürlicher Wachse sind Mineralwachse wie Ceresin undOzokerit. Examples of suitable natural waxes are mineral waxes such as ceresin and ozokerite.
Beispiele geeigneter modifizierter natürlicher Wachse sind Hartwachse, Montanesterwachse, Sasolwachse, hydrierte Jojobawachse, Wollwachsalkohole (Eucerit), und modifizierte Bienenwachse (Cerabellina). Examples of suitable modified natural waxes are hard waxes, montan ester waxes, Sasol waxes, hydrogenated jojoba waxes, wool wax alcohols (Eucerit), and modified beeswaxes (Cerabellina).
Besonders bevorzugt werden Bienenwachse, Cerabellina und absolute Blütenwachse verwendet. Bees waxes, Cerabellina and absolute flower waxes are particularly preferably used.
Vorzugsweise werden die Wachspartikel (B) aus natürlichen und halbsynthetischen Wachsen mithilfe des GAS-Verfahrens (Gas Antisolvent Recrystallization), des PCA- Verfahrens (Precipitation with a Compressed Fluid Antisolvent), des PGSS-Verfahrens (Particles from Gas Saturated Solutions) oder des RESS-Verfahrens (Rapid Expansion of Supercritical Solutions) hergestellt (vgl. zum Beispiel die amerikanischen Patentanmeldungen US 2012/0258150 A1 und US 2013/0259913 A1 ). Preferably, the wax particles (B) of natural and semi-synthetic waxes using the gas antisolvent recrystallization (GAS), the PCA (Precipitation with a Compressed Fluid Antisolvent) method, the PGSS method (Particles from Gas Saturated Solutions) or the RESS process (Rapid Expansion of Supercritical Solutions) (see, for example, US Patent Applications US 2012/0258150 A1 and US 2013/0259913 A1).
Anstelle der Wachspartikel (B) oder zusätzlich zu diesen können die erfindungsgemäßen topischen Zubereitungen biologisch abbaubare und nicht abbaubare Mikroplastik oder Microbeads enthalten, was indes erfindungsgemäß weniger bevorzugt ist. Sofern biologisch nicht abbaubare Mikroplastik verwendet wird, sollen ihre Menge möglichst gering gehalten werden. Instead of the wax particles (B) or in addition to these, the topical preparations according to the invention may contain biodegradable and non-degradable microplastics or microbeads, which, however, is less preferred according to the invention. If non-biodegradable microplastics is used, their amount should be kept as low as possible.
Geeignete biologisch abbaubare Microbeads (B) sind beispielsweise aus der amerikanischen Patentanmeldung 2014/0026916 A1 bekannt. Sie haben eine mittlere Teilchengröße dso <400 pm und bestehen aus Polyhydroxyalkanoaten. Polyhydroxyalkanoate (PHA) oder Polyhydroxyfettsäuren (PHF) sind natürlich vorkommende wasserunlösliche und lineare Polyester, die von vielen Bakterien als Reservestoffe für Kohlenstoff und Energie gebildet werden. In der Natur werden sie durch Gärung von Zucker oder Fetten hergestellt. Diese Biopolymere sind biologisch abbaubar und werden zur Herstellung von Biokunststoffen verwendet. Sie habe den Vorteil, dass sie im Wasser zu Boden sinken und biologisch abgebaut werden. Suitable biodegradable microbeads (B) are known for example from US patent application 2014/0026916 A1. They have a mean particle size dso <400 pm and consist of polyhydroxyalkanoates. Polyhydroxyalkanoates (PHA) or polyhydroxy-fatty acids (PHF) are naturally occurring water-insoluble and linear polyesters, which are formed by many bacteria as a reserve for carbon and energy. In nature, they are made by fermenting sugar or fats. These biopolymers are biodegradable and are used to make bioplastics. It has the advantage that they sink to the bottom in water and biodegrade.
Weitere geeignete biologisch abbaubare Microbeads (B) sind beispielsweise aus der amerikanischen Patentanmeldung US 2010/0278882 A1 bekannt. Sie bestehen aus vernetzten Proteinen, wie beispielsweise Seidenproteinen und haben eine mittlere Teilchengröße dso von 0, 1 pm bis 100 pm. Other suitable biodegradable microbeads (B) are known for example from US patent application US 2010/0278882 A1. They consist of cross-linked proteins, such as silk proteins, and have an average particle size d.sub.50 of from 0.1 .mu.m to 100 .mu.m.
Weitere geeignete biologisch abbaubare Microbeads (B) sind des Weiteren aus der europäischen Patentanmeldung EP 0 563 876 A2 bekannt. Sie werden hergestellt, indem man natürliche Proteine wie Gelatine, Albumin und Casein mit Glycerinaldehyd als Vernetzungsmittel vernetzt. Further suitable biodegradable microbeads (B) are furthermore known from European patent application EP 0 563 876 A2. They are made by cross-linking natural proteins such as gelatin, albumin and casein with glyceraldehyde as a cross-linking agent.
Die mittlere Teilchengröße dso der Wachspartikel (B) und/oder der biologisch abbaubaren Microbeads (B) kann breit variieren und so hervorragend den Erfordernissen des Einzelfalls angepasst werden. Vorzugsweise liegt die mittlere Teilchengröße dso zwischen 1 pm und < 1000 pm, bevorzugt 10 pm bis 700 pm, besonders bevorzugt 50 pm bis 500 pm und insbesondere 100 pm bis 300 pm. Die Wachspartikel (B) und/oder die biologisch abbaubaren Microbeads (B) können durch Schutzkolloide vor der Aggregation oder Agglomeration geschützt werden. Schutzkolloide sind meist wasserlösliche, vorzugsweise biologisch abbaubare, Polymere wie teilverseiftes Polyvinylacetat, Polyvinylalkohol, Polyvinylpyrrolidon, Celluloseether (Tylose) wie zum Beispiel Methylcellulose, Hydroxyethylcellulose, Hydroxypropylmethylcellulose, Stärke, Proteine, Alginate, Pektine und Gelatine. The average particle size dso of the wax particles (B) and / or of the biodegradable microbeads (B) can vary widely and thus be perfectly adapted to the requirements of the individual case. The average particle size d 50 is preferably between 1 μm and <1000 μm, preferably 10 μm to 700 μm, more preferably 50 μm to 500 μm and in particular 100 μm to 300 μm. The wax particles (B) and / or the biodegradable microbeads (B) can be protected by protective colloids from aggregation or agglomeration. Protective colloids are usually water-soluble, preferably biodegradable, polymers such as partially saponified polyvinyl acetate, polyvinyl alcohol, polyvinylpyrrolidone, cellulose ethers (Tylose) such as methylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, starch, proteins, alginates, pectins and gelatin.
Der Gehalt der erfindungsgemäßen topischen Zubereitungen an Wachspartikeln und/oder biologisch abbaubaren Microbeads (B) kann breit variieren und so hervorragend dem jeweiligen Verwendungszweck angepasst werden. Vorzugsweise enthält eine gegebene erfindungsgemäße topische Zubereitung, bezogen auf ihre Gesamtmenge, 0,1 Gew.-% bis 50 Gew.-%, 0,5 bis 45 Gew.-% und insbesondere 1 Gew.-% bis 40 Gew.-% Wachspartikel (B). The content of the topical formulations according to the invention on wax particles and / or biodegradable microbeads (B) can vary widely and can thus be adapted excellently to the respective intended use. Preferably, a given topical preparation according to the invention, based on its total amount, contains 0.1% by weight to 50% by weight, 0.5% to 45% by weight and in particular 1% by weight to 40% by weight of wax particles (B).
Weitere vorteilhafte erfindungsgemäße topische Zubereitungen enthalten Partikel (C) einer mittleren Teilchengröße dso von 10 nm bis <1000 nm, vorzugsweise 300 nm bis 900 nm, bevorzugt 650 ± 200 nm und insbesondere 650 ± 100 nm. Sie enthalten mindestens einen Typ und/oder bestehen aus mindestens einem Typ von nanokristallinen, nanofibrillären, mikrokristallinen und/oder mikrofibrillären Polysacchariden. Insbesondere werden Cellulosenanofasern (CNF), mikrofibrilläre Cellulosen (MFC), mikrokristalline Cellulosen (MCC), nanofibrilläre Polysaccharide (NFP), nanokristalline Cellulosen (CNC), bakterielle Nanocellulosen (BNC) und Abfall aus Papiermaischen der Papierherstellung und Fasern, und Partikel aus Alttextilien, verwendet. Further advantageous topical preparations according to the invention comprise particles (C) of an average particle size d 50 of from 10 nm to <1000 nm, preferably 300 nm to 900 nm, preferably 650 ± 200 nm and in particular 650 ± 100 nm. They contain at least one type and / or consist of at least one type of nanocrystalline, nanofibrillar, microcrystalline and / or microfibrillar polysaccharides. In particular, cellulose nanofibers (CNF), microfibrillar celluloses (MFC), microcrystalline celluloses (MCC), nanofibrillary polysaccharides (NFP), nanocrystalline celluloses (CNC), bacterial nanocelluloses (BNC) and papermaking paper pulp and fiber paper pulp and fiber debris, and waste textiles particles, used.
Der Gehalt der erfindungsgemäßen topischen Zubereitungen an Partikeln (C) kann breit variieren und so hervorragend dem jeweiligen Verwendungszweck angepasst werden. Vorzugsweise enthält eine gegebene erfindungsgemäße topische Zubereitung, bezogen auf ihre Gesamtmenge, 0,01 Gew.-% bis 10 Gew.-%, bevorzugt 0,02 Gew.-% bis 9 Gew.-% und insbesondere 0,03 bis 8 Gew.-%. The content of the topical preparations according to the invention on particles (C) can vary widely and can be adapted excellently to the respective intended use. Preferably, a given topical preparation according to the invention contains, based on its total amount, from 0.01% by weight to 10% by weight, preferably from 0.02% by weight to 9% by weight and in particular from 0.03 to 8% by weight. -%.
Noch weitere vorteilhafte erfindungsgemäße topische Zubereitungen enthalten (D): Heteropolysäuren und Isopolysäuren sowie ihre Isomere, Defektstrukturen und Teilstrukturen, zusammenfassend Polyoxometallate (POM) genannt, in der Form ihrer Moleküle mit einem größten Moleküldurchmesser ^ 2 nm, vorzugsweise < 1 ,5 nm und insbesondere < 1 nm, zusammenfassend POM-Moleküle genannt sowie in der Form von Mikropartikeln und Nanopartikeln einer mittleren Teilchengröße von 1 nm bis < 1000 pm, vorzugsweise 2 nm bis 500 pm, bevorzugt 5 nm bis 250 pm, besonders bevorzugt 5 nm bis 150 pm und insbesondere 5 nm bis 100 pm. Im Folgenden werden sie je nachdem als »POM-Mikropartikel oder POM- Nanopartikel« bezeichnet. Still further advantageous topical preparations according to the invention contain (D): heteropolyacids and isopolyacids and their isomers, defect structures and substructures, collectively called polyoxometalates (POM), in the form of their molecules having a largest molecular diameter ^ 2 nm, preferably <1, 5 nm and in particular <1 nm, collectively called POM molecules and in the form of microparticles and nanoparticles having an average particle size of 1 nm to <1000 pm, preferably 2 nm to 500 pm, preferably 5 nm to 250 pm, more preferably 5 nm to 150 pm and in particular 5 nm to 100 pm. In the following, they will be referred to as "POM microparticles or POM nanoparticles", respectively.
Es sei betont, dass die Angaben < 2 nm, < 1 ,5 nm und < 1 nm keinen Moleküldurchmesser von 0 nm umfassen, sondern dass die untere Grenze des Moleküldurchmessers gleich dem größten Durchmesser des kleinsten existierenden POM-Moleküls ist. It should be emphasized that the data <2 nm, <1, 5 nm and <1 nm do not include a molecular diameter of 0 nm, but that the lower limit of the molecular diameter is equal to the largest diameter of the smallest existing POM molecule.
Die mithilfe der Transmissionselektromikroskopie (TEM), Rasterelektronenmikroskopie (REM), Rastertransmissionselektromikroskopie (RTEM), Rasterkraftmikroskopie (AFM) oder Rastertunnelmikroskopie (TRM) gemessene mittlere Teilchengröße der erfindungsgemäß zu verwendenden POM-Mikropartikel und POM-Nanopartikel kann sehr breit variieren und hervorragend den Erfordernissen des Einzelfalls angepasst werden. The mean particle size of the POM microparticles to be used according to the invention and POM nanoparticles measured by transmission electron microscopy (TEM), scanning electron microscopy (SEM), scanning transmission electron microscopy (RTEM), atomic force microscopy (AFM) or scanning tunneling microscopy (TRM) can vary very widely and meet the requirements of the invention To be adjusted individually.
Die die POM-Mikropartikel und POM Nanopartikeln können die unterschiedlichsten Morphologien und geometrischen Formen aufweisen, so dass sie auch in dieser Hinsicht hervorragend den Erfordernissen des Einzelfalls angepasst werden können. The POM microparticles and POM nanoparticles can have a wide variety of morphologies and geometric shapes, so that they can also be perfectly adapted to the requirements of the individual case in this respect.
So können sie kompakt sein sowie mindestens einen Hohlraum und/oder eine Kern-Schale- Struktur, wobei der Kern und die Schale aus unterschiedlichen Materialien aufgebaut sein können, aufweisen. Sie können auch unterschiedliche geometrische Formen wie Kugeln, Ellipsoide, Würfel, Quader, Pyramiden, Kegel, Zylinder, Rhomben, Dodekaeder, abgestumpfte Dodekaeder, Ikosaeder, abgestumpfte Ikosaeder, Hanteln, Tori, Plättchen oder Nadeln mit kreisförmigem, ovalen, elliptischen, quadratischen, dreieckigen, viereckigen, fünfeckigen, sechseckigen, siebeneckigen, achteckigen oder sternförmigen (drei-, vier-, fünf- oder mehrzackig) Umriss haben. Dabei können gegebenenfalls vorhandene Kanten und Ecken abgerundet sein. Es können sich auch zwei oder mehr POM-Mikropartikel und/oder POM- Nanopartikel unterschiedlicher Morphologie und/oder geometrischer Form zusammenlagern. Beispielsweise können kugelförmige POM-Mikropartikel und/oder POM-Nanopartikel spitze Auswüchse in Kegelform haben. Oder zwei oder drei zylinderförmige POM-Mikropartikel und/oder POM-Nanopartikel können sich derart zusammenlagern, dass sie ein T-förmiges oder Y-förmiges Teilchen bilden. Des Weiteren kann ihre Oberfläche Vertiefungen aufweisen, so dass die POM-Mikropartikel und/oder POM-Nanopartikel eine erdbeer-, himbeer- oder brombeerförmige Morphologie haben. Nicht zuletzt können die Hanteln, Tori, Nadeln oder Plättchen in mindestens einer Richtung des Raumes gebogen sein. Der Durchmesser der POM-Mikropartikel und POM-Nanopartikel kann sehr breit variieren und daher hervorragend den Erfordernissen des Einzelfalls angepasst werden. Thus, they can be compact and have at least one cavity and / or a core-shell structure, wherein the core and the shell can be constructed of different materials. They may also have different geometric shapes such as spheres, ellipsoids, cubes, cuboids, pyramids, cones, cylinders, rhombuses, dodecahedra, truncated dodecahedra, icosahedra, truncated icosahedra, dumbbells, tori, platelets or needles with circular, oval, elliptical, square, triangular , quadrangular, pentagonal, hexagonal, heptagonal, octagonal, or star-shaped (tri-quad, quadrilateral, pentagonal, or polygonal) outline. If necessary, existing edges and corners can be rounded. It is also possible for two or more POM microparticles and / or POM nanoparticles of different morphology and / or geometric form to assemble together. For example, spherical POM microparticles and / or POM nanoparticles may have pointed outgrowths in the form of cones. Or, two or three cylindrical POM microparticles and / or POM nanoparticles may assemble to form a T-shaped or Y-shaped particle. Furthermore, their surface may have pits so that the POM microparticles and / or POM nanoparticles have a strawberry, raspberry or blackberry morphology. Last but not least, the dumbbells, tori, needles or plates can be bent in at least one direction of the room. The diameter of the POM microparticles and POM nanoparticles can vary widely and therefore be perfectly adapted to the requirements of the individual case.
Im Rahmen der vorliegenden Erfindung ist der Durchmesser der erfindungsgemäß zu verwendenden POM-Mikropartikel und/oder POM-Nanopartikel, die keine Kugelform aufweisen, gleich der längsten, durch die jeweiligen POM-Mikropartikel und POM-Nanopartikel gelegten Strecke. In the context of the present invention, the diameter of the POM microparticles and / or POM nanoparticles to be used according to the invention, which have no spherical shape, is equal to the longest distance traveled by the respective POM microparticles and POM nanoparticles.
Vorzugsweise liegt der Durchmesser erfindungsgemäß bevorzugten Nanopartikel bei 1 nm bis <1000 pm, vorzugsweise 2 nm bis 500 pm, bevorzugt 5 nm bis 250 pm, besonders bevorzugt 5 nm bis 150 pm und insbesondere 5 nm bis 100 pm. The diameter of the nanoparticles preferred according to the invention is preferably 1 nm to <1000 pm, preferably 2 nm to 500 pm, preferably 5 nm to 250 pm, more preferably 5 nm to 150 pm and in particular 5 nm to 100 pm.
Die elementare Zusammensetzung und die Struktur der POM können ebenfalls sehr breit variieren. The elemental composition and structure of the POM can also vary very widely.
Bekannt ist beispielsweise die Einteilung der POM in die folgenden Strukturen: For example, the classification of the POM into the following structures is known:
- das Lindquist-Hexamolybdatanion, MO6OI 9 2 , the Lindquist hexamolybdate anion, MO 6 O I 9 2 ,
- das Decavanadatanion, V10O286·, the decavanadate anion, V10O28 6 ,
- das Paratungstatanion B, H2W12O4210 , the Paratungstatanion B, H2W12O42 10 ,
- Mo36-Polymolybdate, Mo360n2(H20)8 , Mo36 polymolybddate, Mo 36 O 2 (H 2 O) 8 ,
- die Strandberg-Struktur, HP2M05O234 , - the Strandberg structure, HP2M05O23 4 ,
- die Keggin-Struktur, CMΐ2q4oh , - the Keggin structure, CM ΐ 2q4o h ,
die Dawson-Struktur, C2Mi8q62p , the Dawson structure, C 2 Mi 8 q62 p ,
- die Anderson-Struktur, CM6q24h , - the Anderson structure, CM 6 q24 h ,
- die Allman-Waugh-Struktur, Xi2Mi8032 n , the Allman Waugh structure, Xi 2 Mi 8 O 32 n ,
- die Weakley-Yamase- Struktur, XMio036 n , und - the Weakley-Yamase structure, XMio0 36 n , and
- die Dexter-Silverton-Struktur, CMi2q42h . - the Dexter-Silverton structure, CMi 2 q42 h .
Die Hochzahl n ist hier eine ganze Zahl von 3 bis 20 bezeichnet die Wertigkeit eines Anions, die in Abhängigkeit von den Variablen X und M variiert. The n-prime number here is an integer from 3 to 20 denoting the valence of an anion that varies depending on the variables X and M.
Als ein weiteres Ordnungsprinzip für POM können die Formeln I bis XIII dienen: As a further principle of order for POM the formulas I to XIII can serve:
(BW12O40)5- (I). (BW12O40) 5 - (I).
(W10O32)4" (II), (P2Wi8062)6- (III), (W10O32) 4 " (II) (P 2 Wi 8 0 62 ) 6 - (III),
(PWn039)7- (IV), (PWn0 39 ) 7 - (IV),
(SiWn039)8- (V), (SiWn0 39 ) 8 - (V),
(HSiW9034)9 (VI), (HSiW 9 0 34 ) 9 (VI),
(HPW9O34)8- (VII), (HPW 9 O 34 ) 8 - (VII),
(TM)4(PW9034)t· (VIII), (TM) 4 (PW 9 034) t (VIII),
(TM)4(P2Wl5056)2t· (IX), (TM) 4 (P2WI 5 056) 2 t · (IX),
(NaPsWsoOno)14- (X), (NaPsWsoOno) 14 - (X),
(TM)3(PW9034)212· (XI) und (TM) 3 (PW 9 03 4 ) 2 12 · (XI) and
(P2Wi806)6 (XII). (P 2 Wi 8 0 6 ) 6 (XII).
In den Formeln I bis XII steht TM für ein zweiwertiges oder dreiwertiges Übergangsmetallion wie Mn2+, Fe2+, Fe3+, Co2+, Co3+, Ni2+, Cu2+ und Zn2+. Die Hochzahl t ist eine ganze Zahl und bezeichnet die Wertigkeit eines Anions, die in Abhängigkeit von der Wertigkeit der Variable TM variiert. In formulas I to XII, TM is a divalent or trivalent transition metal ion such as Mn 2+ , Fe 2+ , Fe 3+ , Co 2+ , Co 3+ , Ni 2+ , Cu 2+ and Zn 2+ . The superscript t is an integer and denotes the valence of an anion, which varies depending on the significance of the variable TM.
Des Weiteren kommen POM der allgemeinen Formel XIII in Betracht: Furthermore, POM of general formula XIII come into consideration:
(AxGayNbaOb)z- (XIII). (A x Ga y NbaOb) z - (XIII).
In der Formel XIII steht die Variable A für Phosphor, Silicium oder Germanium und der Index x steht für 0 oder für eine ganze Zahl von 1 bis 40. Der Index y steht für eine ganze Zahl von 1 bis 10, der Index a steht für eine ganze Zahl von 1 bis 8 und der Index b ist eine ganze Zahl von 15 bis 150. Die Hochzahl z variiert in Abhängigkeit von der Natur und dem Oxidationsgrad der Variable A. Es kommen auch die Aquakomplexe und die aktiven Fragmente der POM XIII in Betracht. In the formula XIII the variable A stands for phosphorus, silicon or germanium and the index x stands for 0 or for an integer from 1 to 40. The index y stands for an integer from 1 to 10, the index a stands for one integer from 1 to 8 and the index b is an integer from 15 to 150. The z factor varies depending on the nature and the degree of oxidation of the variable A. The aqua complexes and the active fragments of the POM XIII are also suitable.
Wenn der Index x gleich 0 ist, ist y bevorzugt gleich 6-a, wobei der Index a gleich einer ganzen Zahl von 1 bis 5 ist und der Index b gleich 19 ist. When the index x is 0, y is preferably 6-a, where the index a is an integer of 1 to 5 and the index b is 19.
Wenn die Variable A gleich Silicium oder Germanium ist, ist der Index x gleich 2, der Index y gleich 18, der Index a gleich 6 und der Index b gleich 77. When the variable A is silicon or germanium, the index x is 2, the index y is 18, the index a is 6 and the index b is 77.
Wenn die Variable A gleich P ist, ist der Index x gleich 2 oder 4, der Index y gleich 12, 15, 17 oder 30, der Index a gleich 1 , 3 oder 6 und der Index b gleich 62 oder 123. Außerdem kommen die Isomere der POM in Betracht. So hat die Keggin-Struktur fünf Isomere, die alpha, beta, gamma, delta, und epsilon-Struktur. Des Weiteren kommen Defektstrukturen oder lacunare Strukturen sowie Teilstrukturen in Betracht. When the variable A is P, the index x is 2 or 4, the index y is 12, 15, 17 or 30, the index a is 1, 3 or 6 and the index b is 62 or 123. In addition, the isomers of POM come into consideration. Thus, the keggin structure has five isomers, the alpha, beta, gamma, delta, and epsilon structure. Furthermore, defect structures or lacunary structures as well as partial structures can be considered.
Vorzugsweise werden die Anionen I bis XIII in der Form von Salzen mit Kationen, die für die Reinigung und Körperpflege und die pharmazeutische Anwendung zugelassen sind, angewandt. Preferably, the anions I to XIII are applied in the form of salts with cations which are approved for cleansing and personal care and pharmaceutical use.
Beispiele geeigneter Kationen sind H+, Na+, K+ und NH4 +, Examples of suitable cations are H + , Na + , K + and NH 4 + ,
- Mono-, Di-, Tri- oder Tetra-(Ci-C2o-alkylammonium) wie Pentadecyldimethyl- ferrocenylmethylammonium, Undecyldimethylferrocenylmethylammonium, Mono-, di-, tri- or tetra- (C 1 -C 20 -alkylammonium) such as pentadecyldimethyl-ferrocenylmethylammonium, undecyldimethylferrocenylmethylammonium,
Hexadecyltrimethylammonium, Octadecyltrimethylammonium, Didodecyl- dimethylammonium, Ditetradecyldimethylammonium, Dihexadecyl- dimethylammonium, Dioctadecyldimethylammonium, Dioctadecylviologen, Trioctadecylmethylammonium und Tetrabutylammonium, Hexadecyltrimethylammonium, octadecyltrimethylammonium, didodecyldimethylammonium, ditetradecyldimethylammonium, dihexadecyldimethylammonium, dioctadecyldimethylammonium, dioctadecylviologen, trioctadecylmethylammonium and tetrabutylammonium,
- Mono-, Di-, Tri- oder Tetra-(Ci-C20-alkanolammonium) wie Ethanolammonium Diethanolammonium und Triethanolammonium - Mono-, di-, tri- or tetra- (Ci-C20-alkanolammonium) such as ethanolammonium diethanolammonium and triethanolammonium
- Monokationen natürlich vorkommender Aminosäuren wie Histidinium (HISH+), Argininium (ARGFT) oder Lysinium (LYSH+) oder Oligo- oder Polypeptide mit einem oder mehreren protonierten basischen Aminosäurerest(en). Monocations of naturally occurring amino acids such as histidinium (HISH + ), argininium (ARGFT) or lysinium (LYSH + ) or oligo- or polypeptides having one or more protonated basic amino acid residues.
[Vgl. US 6,020,369, Spalte 3, Zeile 6, bis Spalte 4, Zeile 29] [See. US 6,020,369, column 3, line 6, to column 4, line 29]
Es kommen auch natürliche, modifizierte natürliche und synthetische kationische Oligomere und Polymere, d.h. , Oligomere und Polymere, die primäre, sekundäre, tertiäre und quartäre Ammoniumgruppen, primäre, sekundäre und tertiäre Sulfoniumgruppen und/oder primäre, sekundäre und tertiäre Phosphoniumgruppen tragen. Synthetische Oligomere und Polymere sind üblich und bekannt und werden beispielsweise in Elektrotauchlacken verwendet. Beispiele für natürliche kationische Oligomere und Polymere sind Polyaminoaccharide wie Polyglucosamine, insbesondere Chitosan. There are also natural, modified natural and synthetic cationic oligomers and polymers, i. , Oligomers and polymers bearing primary, secondary, tertiary and quaternary ammonium groups, primary, secondary and tertiary sulfonium groups and / or primary, secondary and tertiary phosphonium groups. Synthetic oligomers and polymers are common and well known and are used, for example, in electrodeposition paints. Examples of natural cationic oligomers and polymers are polyamino-saccharides such as polyglucosamines, especially chitosan.
Beispiele geeigneter POM gehen aus der Tabelle 1 hervor. Examples of suitable POM are shown in Table 1.
Tabelle 1 : Summenformeln von geeigneten POM Table 1: Sum formulas of suitable POM
a) vgl. US 6,020,369, TABLE 1 , Spalten 3 bis 10; b) Tierui Zhang, Shaoquin Liu, Dirk G. Kurth und Charl F. J. Faul, »Organized Nanostructured Complexes of Polyoxometalates and Surfactants that Exhibit a) cf. US 6,020,369, TABLE 1, columns 3 to 10; b) Tierui Zhang, Shaoquin Liu, Dirk G. Kurth and Charl FJ Faul, Organized Nanostructured Complexes of Polyoxometalates and Surfactants that Exhibit
Photoluminescence and Electrochromism, Advanced Functional Materials, 2009, 19, Seiten 642 bis 652; n Zahl, insbesondere ganze Zahl, von 1 bis 50. Weitere Beispiele geeigneter POM sind aus dem amerikanischen Patent US 7,097,858 B2, Spalte 14, Zeile 56, bis Spalte 17, Zeile 19, sowie aus TABLE 8a, Spalte 22, Zeile 41 , bis Spalte 23, Zeile 28, Verbindungen Nummer 1-53, und TABLE 8b, Spalte 23, Zeile 30, bis Spalte 25, Zeile 34, Verbindungen Nummer 1 bis 150, bekannt. Photoluminescence and Electrochromism, Advanced Functional Materials, 2009, 19, pages 642 to 652; n number, in particular integer, from 1 to 50. Further examples of suitable POM are disclosed in US Pat. No. 7,097,858 B2, column 14, line 56, to column 17, line 19, and from TABLE 8a, col. 22, line 41, to col. 23, line 28, compounds number 1-53, and TABLE 8b, column 23, line 30, to column 25, line 34, compounds number 1 to 150.
Ganz besonders bevorzugt werden Very particularly preferred
- Ammoniumheptamolybdat-Tetrahydrat {(NH4)6Mo7q24] 4H2O, CAS-Nr.13106-76-8 (wasserfrei), CAS-Nr. 12054-85-2 (Tetrahydrat), AHMT}, - Ammonium heptamolybdate tetrahydrate {(NH4) 6Mo 7 q24] 4H2O, CAS No.13106-76-8 (anhydrous), CAS-No. 12054-85-2 (tetrahydrate), AHMT},
- Wolframatophosphorsäure-Hydrat {H3[P(W3OI O)4] xH20, CAS-Nr. 1343-93-7- tungstophosphoric hydrate {H 3 [P (W 3 O IO ) 4] xH 2 O, CAS-No. 1343-93-7
(wasserfrei), CAS-Nr. 12067-99-1 (Hydrat), Wo-Pho}, (anhydrous), CAS no. 12067-99-1 (hydrate), Wo-Pho},
Molybdatophosphorsäure-Hydrat, {H3P(MO3OI0)4] xH20, CAS-Nr.: 12026-57-2Molybdatophosphoric acid hydrate, {H 3 P (MO 3 O 10 ) 4] xH 2 O, CAS No .: 12026-57-2
(wasserfrei), CAS-Nr. 51429-74-4 (Hydrat), Mo-Pho} und/oder (anhydrous), CAS no. 51429-74-4 (hydrate), Mo-Pho} and / or
Wolframatokieselsäure {H4[Si(W3Oio)4] xH20, CAS-Nr. 12027-43-9, CAS-Nr. WKS} und/oder ihre Salze verwendet. Tungstosilicic acid {H 4 [Si (W 3 Oio) 4 ] xH 2 O, CAS no. 12027-43-9, CAS no. WKS} and / or their salts used.
Die erfindungsgemäß zu verwendenden molekularen POM können mithilfe üblicher und bekannter nasschemischer Verfahren wie zum Beispiel Fällungsverfahren hergestellt werden. The molecular POMs to be used according to the invention can be prepared by means of customary and known wet-chemical processes, such as, for example, precipitation processes.
Die erfindungsgemäß zu verwendenden POM-Mikropartikel und POM-Nanopartikel können mithilfe üblicher und bekannter nasschemischer Verfahren hergestellt werden. Es ist aber auch möglich, die POM in Wasser aufzulösen und die resultierende Lösung gegen einen warmen Luftstrom zu sprühen. Außerdem ist es möglich, die Lösung im Vakuum einzudampfen, wobei sie mit IR-Strahlung bestrahlt wird. Des Weiteren ist es möglich, Lösungen, insbesondere wässrige, Lösungen von POM auf kalte Oberflächen, wie tiefgekühlte, glatte Metalloberflächen, Trockeneis, tiefgekühlte organische Lösungsmittel und verflüssigte Gase, wie Methan, Ethan Propan, Butan, Methylcyclohexan oder Benzine, flüssigen Stickstoff oder flüssiges Helium aufzusprühen und das Trockeneis oder die flüssigen Substanzen zu verdampfen. The POM microparticles and POM nanoparticles to be used according to the invention can be prepared by customary and known wet-chemical processes. However, it is also possible to dissolve the POM in water and to spray the resulting solution against a warm stream of air. In addition, it is possible to evaporate the solution under vacuum, being irradiated with IR radiation. Furthermore, it is possible to prepare solutions, in particular aqueous, solutions of POM on cold surfaces, such as frozen, smooth metal surfaces, dry ice, cryogenic organic solvents and liquefied gases, such as methane, ethane propane, butane, methylcyclohexane or benzine, liquid nitrogen or liquid helium spray on and evaporate the dry ice or the liquid substances.
Die vorstehend beschriebenen molekularen POM, POM-Mikropartikel und/oder POM- Nanopartikel sind unverändert, sauerstoffersetzt, funktionalisiert, aggregiert, agglomeriert und/oder geträgert. Beispielsweise können sie funktionalisiert, agglomeriert und geträgert sein. Sie können aber auch nicht funktionalisiert und nicht aggregiert sein. Sie können als Säure, Salz, Soft-Oxometallat (SOMS), Beschichtung und/oder Polyoxometallat-Nanocomposit und/oder molekulardispers gelöst, suspendiert, lipophilisiert und/oder mit organischen Gruppen fluidisiert und/oder in und/oder auf kompakten und/oder porösen Partikeln, Folien, Fasern und/oder Schwämmchen, in Hydrogelen, in Micellen, in Vesikeln, in Mikrokapseln, in Gelen, in Pulvern, in und auf Beschichtungen, in und auf Kunststoffen, in und auf Tabletten, in Cremes, Lotions, Salben und/oder Schäumen und/oder in Mischungen und/oder in Verbindung mit funktionalen Materialien, Antibiotika und/oder bioziden Materialien vorliegt. The molecular POM, POM microparticles and / or POM nanoparticles described above are unchanged, oxygen-substituted, functionalized, aggregated, agglomerated and / or supported. For example, they may be functionalized, agglomerated and supported. But they can also not be functionalized and not aggregated. They may be dissolved, suspended, lipophilized and / or fluidized with organic groups and / or in and / or on compact and / or porous as acid, salt, soft oxometalate (SOMS), coating and / or polyoxometalate nanocomposite and / or molecular disperse Particles, films, fibers and / or sponges, in hydrogels, in micelles, in vesicles, in microcapsules, in gels, in powders, in and on coatings, in and on plastics, in and on tablets, in creams, lotions, ointments and / or foams and / or in mixtures and / or in conjunction with functional materials, antibiotics and / or biocidal materials.
Außerdem können sie in den POM-Präparationen, wie sie in den eingangs beschriebenen Dokumenten offenbart werden, vorliegen. In addition, they may be present in the POM preparations as disclosed in the documents described above.
Die unveränderten POM sind die POM, wie sie bei ihrer Herstellung ohne eine weitere Funktionalisierung oder Modifizierung entstehen. The unaltered POMs are the POMs that arise during their manufacture without further functionalization or modification.
Bei den sauerstoffersetzten POM sind terminale Oxidzentren durch andere Liganden wie Sulfidionen, Bromidionen, Aminogruppen, Nitrosylgruppen und/oder Alkoxygruppen ersetzt. Die schwefelhaltigen POM werden auch Polyoxothiometallate genannt. In the oxygen-displaced POM, terminal oxide centers are replaced by other ligands, such as sulfide ions, bromide ions, amino groups, nitrosyl groups, and / or alkoxy groups. The sulfur-containing POM are also called polyoxothiometalates.
Die Aggregate sind lockere Anhäufungen von Partikeln, die durch Kohäsion zusammengehalten werden und durch übliche und bekannte Dispergierverfahren nicht verteilt werden können. Ihre innere Oberfläche ist kleiner die Summe der Oberflächen der Primärteilchen. The aggregates are loose aggregates of particles that are held together by cohesion and can not be distributed by conventional and known dispersion methods. Their inner surface is smaller than the sum of the surfaces of the primary particles.
Die Agglomerate sind Zusammenballungen von Primärteilchen und deren Aggregate, die über Kanten und Ecken brückenartig verbunden sind. Ihre innere Oberfläche entspricht in etwa der Summe der Oberflächen der Primärteilchen. The agglomerates are aggregates of primary particles and their aggregates, which are bridged over edges and corners. Their inner surface corresponds approximately to the sum of the surfaces of the primary particles.
Die erfindungsgemäß zu verwendenden molekularen POM, POM-Mikropartikel und POM- Nanopartikel können „nackt“ vorliegen. D.h., dass ihre Oberfläche nicht von einer Hülle umgeben ist und/oder nichtfunktionalisiert ist. The molecular POM, POM microparticles and POM nanoparticles to be used according to the invention can be present "naked". That is, their surface is not surrounded by a shell and / or is not functionalized.
Des Weiteren können die erfindungsgemäß zu verwendenden molekularen POM, POM- Mikropartikel und POM-Nanopartikel von einer Hülle umgeben sein und/oder mindestens eine funktionelle Gruppe tragen. Dabei kann das Material der Hüllen die funktionellen Gruppen tragen oder aber die funktionellen Gruppen können direkt auf der Oberfläche der molekularen POM, der POM-Mikropartikel und der POM-Nanopartikel vorliegen. Furthermore, the molecular POM, POM microparticles and POM nanoparticles to be used according to the invention can be surrounded by a shell and / or carry at least one functional group. The material of the shells may be the functional groups or the functional groups may be present directly on the surface of the molecular POM, the POM microparticles, and the POM nanoparticles.
Das Material der Hülle und/oder die funktionellen Gruppen können so ausgewählt werden, dass sich die erfindungsgemäß zu verwendenden molekularen POM, POM-Mikropartikel und POM-Nanopartikel besonders rasch und homogen in einer organischen und/oder anorganischen, festen oder flüssigen Matrix, insbesondere einer organischen und/oder anorganischen polymeren Matrix oder anorganischen keramischen Matrix, die als Trägermaterial und/oder Bindemittel fungiert, verteilen und/oder die physikalischen und/oder chemischen Eigenschaften der molekularen POM, POM-Mikropartikel und POM-Nanopartikel in einer bestimmten gewünschten Weise modifizieren oder maskieren. The material of the shell and / or the functional groups can be selected so that the molecular POM, POM microparticles and POM nanoparticles to be used according to the invention are particularly rapidly and homogeneously in an organic and / or inorganic, solid or liquid matrix, in particular a distribute and / or modify the physical and / or chemical properties of the molecular POM, POM microparticles, and POM nanoparticles in a particular desired manner, and / or modify the physical and / or chemical properties of the organic and / or inorganic polymeric matrix or inorganic ceramic matrix acting as a support material and / or binder mask.
Die Hüllen und/oder die funktionellen Gruppen können über kovalente und/oder ionische Bindungen und/oder elektrostatische und/oder Van-der-Waalskräfte an die Oberfläche der molekularen POM, POM-Mikropartikel und POM-Nanopartikel gebunden sein. The shells and / or the functional groups may be attached to the surface of the molecular POM, POM microparticles and POM nanoparticles via covalent and / or ionic bonds and / or electrostatic and / or van der Waals forces.
Die Bindung zwischen der Oberfläche der molekularen POM, POM-Mikropartikel und POM- Nanopartikel und der Hülle und/oder der funktionellen Gruppen kann permanent oder reversibel, d.h. wieder lösbar, sein. The bond between the surface of the molecular POM, POM microparticles and POM nanoparticles and the shell and / or the functional groups can be permanently or reversibly, i. be solvable again.
Die Hüllen können von organischen, anorganischen und metallorganischen, polymeren, oligomeren und niedermolekularen Materialien oder von Kombinationen von mindestens zwei dieser Materialien aufgebaut sein. The shells may be constructed of organic, inorganic and organometallic, polymeric, oligomeric and low molecular weight materials or combinations of at least two of these materials.
Zu weiteren Einzelheiten sei auf die internationale Patentanmeldung WO 2016/1 16259 A1 , Seite 25, Zeile 1 1 , bis Seite 38, Seite 32, verwiesen. For further details, please refer to the international patent application WO 2016/1 16259 A1, page 25, line 11, to page 38, page 32.
Zusätzlich können die erfindungsgemäßen topischen Zubereitungen mindestens einen für topische Zubereitungen üblicherweise verwendeten Inhaltsstoff (E), ausgewählt aus der Gruppe, bestehend aus Wasser, Schichtsilikaten, gemahlenen Tonerden, Bolus Americus Tonerden, Heilerden, Nussschalen, Weidenrinden, Lapacho-Heilrinden, Kieselerden, Bimssteinen, Geopolymeren, Bernsteinen, Edelsteinen, Spurenelementen und neutralen anorganischen Salzen, beta-Glucanen, Glutathion, Albumin, Xylan, Phytaten, Komplexbildnern, Antioxidantien, Radikalscavengern, Menthol, Koffein, Teein, Papain, Esculinsemihydrat, Carotinoiden, Lecithinen, Abscinsäure, Cyanidin, Guanidin, Harnstoff, Thioharnstoff, Füllstoffen, Lösungsmitteln, Befeuchtungsmitteln, Lösungsvermittlern, nichtionischen Netzmitteln, Puffern, Verdickungsmitteln, Bindemitteln, Umhüllungsmitteln, Zerfallsbeschleunigern, Sprengmitteln, Gleitmitteln, Schmiermitteln, Formentrennmitteln, Fließregulierungsmitteln, Antioxidantien, Konservierungsstoffen, Süßungsmitteln, Geschmackskorrigentien, Resorptionsbeschleunigern, Alkalisierungsmitteln,In addition, the topical preparations according to the invention may contain at least one ingredient (E) commonly used for topical preparations, selected from the group consisting of water, phyllosilicates, ground clays, bolus americus clays, healing earth, nut shells, willow bark, lapacho healing cortices, siliceous earth, pumice stones, Geopolymers, amines, gemstones, trace elements and neutral inorganic salts, beta-glucans, glutathione, albumin, xylan, phytates, complexing agents, antioxidants, radical scavengers, menthol, caffeine, teein, papain, esculin hemihydrate, carotenoids, lecithins, abscinic acid, cyanidin, guanidine, Urea, thiourea, fillers, solvents, humectants, solubilizers, nonionic wetting agents, buffers, thickeners, binders, coating agents, disintegrants, disintegrants, lubricants, lubricants, mold release agents, flow regulators, antioxidants, preservatives, sweeteners, flavoring agents, absorption enhancers, alkalizing agents,
Säuerungsmitteln, Neutralisierungsmitteln, Schauminhibitoren und Entschäumer, Farbstoffen, Farbpigmenten, Oxidationsmitteln, Reduktionsmitteln, Stabilisatoren, Treibgasen, Trübungsmitteln, Perlglanzstoffen, Vergällungsmitteln, Weichmachern, Mineralstoffen, Vitaminen, Mizellen, Superabsorbern, rückfettenden Substanzen, Ölen, Duftstoffen, Aromastoffen, Parfümen, Moisturizern, Feuchtigkeitsspender, Wirkstoffen für die Hautpflege, desodorierende Wirkstoffen, Filmbildnern, Gelbildnern, Gerbstoffen, Gerbmitteln, Gerbextrakten, Bitterstoffen, Pflanzenextrakten, Honigen, Colostrum, Zytostatika, Antikörpern, Immunoglobulinen, essenziellen und nicht essenziellen Aminosäuren und Fetten, Hyaluronsäure, Aloe Vera Gel, Alkylenglykolen, Polyalykylenetherglykolen, Proteinen, Peptiden, Kohlenhydraten, Lipiden, Nukleinsäuren, Nukleinsäurefragmenten, antivirialen Verbindungen, entzündungshemmendne Verbindungen, Antibiotika,Acidulants, neutralizing agents, foam inhibitors and defoamers, colorants, color pigments, oxidizing agents, reducing agents, stabilizers, propellants, opacifiers, pearlescers, denaturants, emollients, minerals, vitamins, micelles, superabsorbents, moisturizing agents, oils, fragrances, flavors, perfumes, moisturizers, moisturizers , Skin care ingredients, deodorizing agents, film formers, gelling agents, tannins, tanning agents, tannin extracts, bittering agents, plant extracts, honeys, colostrum, cytostatics, antibodies, immunoglobulins, essential and non-essential amino acids and fats, hyaluronic acid, aloe vera gel, alkylene glycols, polyalkylene ether glycols , Proteins, peptides, carbohydrates, lipids, nucleic acids, nucleic acid fragments, antiviral compounds, anti-inflammatory compounds, antibiotics,
Zelldifferenzierungsreagenzien, Analgetika, Betäubungsmitteln, Anästhetika, Kontrastmitteln, Enzymen, Zytokinen, Antihistaminen, Immunomodulatoren, hämostatischen Reagenzien, Hormonen, angiogenischen und antiangiogenischen Mitteln, Neurotransmittern, therapeutischen Oligonukleotiden, Virenpartikeln, Wachstumsfaktoren, Retinoiden, Zelladhäsionsfaktoren, extrazellulären Matrixglycoproteinen, osteogenischen Faktoren, Antikörpern, Antigenen, Steroiden, Schmerzmitteln, Kaliumsulfat, Gelee Royal, Propolis, gekapselten Duftstoffen, Nährstoffen Hexahydroxycyclohexanhexaphosphorsäureestersalz- Nanopartikeln, insbesondere Salze der Phytinsäure, und Tensiden,, in wirksamen Mengen enthalten. Cell differentiation reagents, analgesics, anesthetics, anesthetics, contrast agents, enzymes, cytokines, antihistamines, immunomodulators, hemostatic reagents, hormones, angiogenic and antiangiogenic agents, neurotransmitters, therapeutic oligonucleotides, viral particles, growth factors, retinoids, cell adhesion factors, extracellular matrix glycoproteins, osteogenic factors, antibodies, antigens , Steroids, analgesics, potassium sulfate, royal jelly, propolis, encapsulated perfumes, nutrients hexahydroxycyclohexanehexaphosphoric acid ester salt nanoparticles, especially salts of phytic acid, and surfactants, in effective amounts.
Beispiele geeigneter Inhaltsstoffe sind insbesondere Schichtsilikate, die vorzugsweise als Nanopartikel und/oder Mikropartikel einer mittleren Teilchengröße dso von 1 nm bis <1000 pm, vorzugsweise 10 nm bis 900 pm, bevorzugt 300 nm bis 1000 nm, besonders bevorzugt 650 ± 200 nm, ganz besonders bevorzugt 650 ± 150 nm und insbesondere 650 ± 100 nm vorliegen Examples of suitable ingredients are in particular phyllosilicates, which are particularly preferred as nanoparticles and / or microparticles having an average particle size dso of 1 nm to <1000 pm, preferably 10 nm to 900 pm, preferably 300 nm to 1000 nm, particularly preferably 650 ± 200 nm preferably 650 ± 150 nm and in particular 650 ± 100 nm
Die elementare Zusammensetzung und die Struktur der Schichtsilikat-Mikro- und/oder Nanopartikel können ebenfalls sehr weit variieren. Bekannt ist beispielsweise die Einteilung der Silikate in die folgenden Strukturen: The elemental composition and the structure of the layered silicate micro- and / or nanoparticles can also vary widely. For example, the classification of the silicates into the following structures is known:
- Inselsilikate - island silicates
- Gruppensilikate - Ringsilikate - group silicates - Ring silicates
- Ketten- und Bandsilikate - Chain and tape silicates
- Übergangsstrukturen zwischen Ketten- und Schichtsilikaten - Transition structures between chain and layer silicates
- Schichtsilikate - phyllosilicates
- Gerüstsilikate - Framework silicates
Schichtsilikate sind Silikate, deren Silikationen aus Schichten eckenverknüpfter S1O4- Tetraeder bestehen. Diese Schichten und/oder Doppelschichten sind untereinander nicht weiter verknüpft. Die technisch wichtigen und in Sedimentgestein verbreiteten Tonminerale sind ebenfalls Schichtsilikate. Der schichtartige Aufbau dieser Minerale bestimmt die Form und die Eigenschaften der Kristalle. Sie sind meist tafelig bis blättrig mit guter bis perfekter Spaltbarkeit parallel zu den Schichten. Die Zähligkeit der Ringe, aus denen sich die Silikatschichten zusammensetzen, bestimmt oft die Symmetrie und Form der Kristalle. Zwischen den Schichten können sich Wassermoleküle, große Kationen und/oder Lipide einlagern. Phyllosilicates are silicates whose silicates consist of layers of corner-sharing S1O 4 tetrahedra. These layers and / or bilayers are not further linked to one another. The technically important and in sedimentary rocks widespread clay minerals are also phyllosilicates. The layered structure of these minerals determines the shape and properties of the crystals. They are usually tabular to leafy with good to perfect cleavage parallel to the layers. The number of rings that make up the silicate layers often determines the symmetry and shape of the crystals. Between the layers, water molecules, large cations and / or lipids can be stored.
Beispiele geeigneter Schichtsilikate gehen aus der nachfolgenden Tabelle 2 hervor. Die Aufzählung ist beispielhaft und nicht abschließend. Tabelle 2: Summenformeln von geeigneten Schichtsilikaten a> Examples of suitable sheet silicates are shown in Table 2 below. The list is exemplary and not exhaustive. Table 2: Sum formulas of suitable phyllosilicates a>
a) vgl. Mineralienatlas, Mineralklasse Vlll/H - Schichtsilikate (Phyllosilikate), Strunz 8 Systematik a) cf. Mineral atlas, mineral class VIII / H - phyllosilicates (phyllosilicates), Strunz 8 classification
Ganz besonders bevorzugt wird Bentonit aus der Gruppe der Montmorilloniten ((Na,Ca)o.3(AI,Mg)2Si40io(OH)2-nH20). Bentonit ist eine Mischung aus verschiedenen Tonmineralien und enthält als wichtigsten Bestandteil Montmorillonit. Natrium-Bentonit zum Beispiel, nimmt Wasser auf, es kann um eine Vielzahl seines eigenen Trockengewichtes aufnehmen. Des Weiteren kann Calciumbentonit Fette und/oder Öle aufnehmen. Very particularly preferred is bentonite from the group of montmorillonites ((Na, Ca) o .3 (Al, Mg) 2 Si 4 0io (OH) 2 -nH 2 0). Bentonite is a mixture of various clay minerals and contains montmorillonite as its main constituent. For example, sodium bentonite absorbs water, it can absorb a variety of its own dry weight. Furthermore, calcium bentonite can absorb fats and / or oils.
Die vorstehend beschriebenen Schichtsilikat-Mikro- und/oder -Nanopartikel sind funktionalisiert, nicht funktionalisiert, aggregiert, nicht aggregiert, agglomeriert, nicht agglomeriert, geträgert und/oder nicht geträgert. Beispielsweise können sie funktionalisiert, agglomeriert und geträgert sein. Sie können aber auch nicht funktionalisiert und aggregiert sein. The layered silicate micro- and / or nanoparticles described above are functionalized, non-functionalized, aggregated, non-aggregated, agglomerated, non-agglomerated, supported and / or unsupported. For example, they may be functionalized, agglomerated and supported. But they can also not be functionalized and aggregated.
Beispiele weiterer geeigneter Inhaltsstoffe (E) sind: Examples of other suitable ingredients (E) are:
• Lactose, Cellulose, Stärken, Saccharose (Tabletten) • lactose, cellulose, starches, sucrose (tablets)
• Paraffin (Salben); Hartfett (Zäpfchen) • paraffin (ointments); Hard fat (uvula)
• Polyethylenglykole (Macrogole, PEG); Polyethylenoxide (PEO) (Tabletten, Salben, Cremes); Polyethylene glycols (macrogols, PEG); Polyethylene oxides (PEO) (tablets, ointments, creams);
• Lösungsmittel und/oder Befeuchtungsmittel: vcWasser, Ethanol, Isopropanol (Granulierung, Filmsprühung) • solvent and / or humectant: vcwater, ethanol, isopropanol (granulation, film spray)
• Emulgatoren: Cetylstearylalkohol, Gylcerolmonostearat, Lecithin, Fettsäureester des Sorbitans, des Polyoxyethylensorbitans (Polysorbate), des Polyoxyethylens, Polyoxyethylenfettalkoholether (Emulsionen, Cremes), Methylglucose, Sesquistearate, Stearinsäure und deren Derivate, Emulgatoren auf Acrylat-Basis wie z.B. Acrylates/C 10-330 Alkyl Acrylate Crosspolymer Emulsifiers: cetylstearyl alcohol, glycerol monostearate, lecithin, fatty acid esters of sorbitan, polyoxyethylene sorbitan (polysorbates), polyoxyethylene, polyoxyethylene fatty alcohol ethers (emulsions, creams), methyl glucose, sesquistearates, stearic acid and derivatives thereof, acrylate-based emulsifiers, e.g. Acrylates / C 10-330 Alkyl Acrylate Crosspolymer
• Lösungsvermittler und/oder Netzmittel: Polyethylenglykole (PEG, Macrogole), Polyethylenoxide (PEO, PolyOx), Polysorbate (Lösungen, Suspensionen) • Puffer: Dikaliumhydrogenphosphat Natriumdihydrogenphosphat,Solubilizers and / or wetting agents: polyethylene glycols (PEG, macrogols), polyethylene oxides (PEO, PolyOx), polysorbates (solutions, suspensions) • buffer: dipotassium hydrogen phosphate sodium dihydrogen phosphate,
Natriumhydrogencarbonat, Calciumhydrogenphosphat, Trometamol (Lösungen, Cremes) Sodium bicarbonate, calcium hydrogen phosphate, trometamol (solutions, creams)
• Verdickungs- und Bindemittel: Stärken, Guaran, Xanthan, Alginat, Carrageen, Pektin, Traganth, Polyacrylsäuren, Polyvinylpyrrolidon (Granulate, Tabletten); hochdisperses Siliciumdioxid, substituierte Celluloseether (Methylcellulose, Ethylcellulose, Hydroxypropylcellulose, Hydroxypropylmethylcellulose, Carboxymethylcellulose) (Tabletten, Gele, viskose Lösungen), Butyrospermum Parkii Butter, MAGNESIUM SULFATE Thickeners and binders: starches, guar gum, xanthan gum, alginate, carrageenan, pectin, tragacanth, polyacrylic acids, polyvinylpyrrolidone (granules, tablets); fumed silica, substituted cellulose ethers (methylcellulose, ethylcellulose, hydroxypropylcellulose, hydroxypropylmethylcellulose, carboxymethylcellulose) (tablets, gels, viscous solutions), Butyrospermum Parkii Butter, MAGNESIUM SULFATE
• Umhüllungsmittel: Saccharose (Zuckerdragierung); Gelatine (Kapseln); • wrapping agent: sucrose (sugar dragee); Gelatin (capsules);
Gelatinepolysuccinat („Weichkapseln“), Polyacrylate, Ethylcellulose, Methylcellulose (Filmcoating: Filmkapseln, Filmtabletten, Pellets) Gelatin polysuccinate ("soft capsules"), polyacrylates, ethylcellulose, methylcellulose (filmcoating: film capsules, film-coated tablets, pellets)
• Zerfallsbeschleuniger und/oder Sprengmittel: Stärken (Tabletten, Tabs); • disintegrants and / or disintegrants: starches (tablets, tabs);
Croscarmellose (Tabletten, Kapseln, Granulate); Natriumhydrogencarbonat in Kombination mit Citronensäure (Brausetabletten) Croscarmellosis (tablets, capsules, granules); Sodium bicarbonate in combination with citric acid (effervescent tablets)
• Gleit- und Schmiermittel und/oder Formentrennmittel: Polyethylenglykole (PEG, Macrogole), Polyethylenoxide (PEO), Talkum, Magnesiumstearat (Tablettierung) Lubricants and / or mold release agents: polyethylene glycols (PEG, macrogols), polyethylene oxides (PEO), talc, magnesium stearate (tableting)
• Fließregulierungsmittel: Hochdisperses Siliciumdioxid (Pulver, Granulate) Flow control agent: fumed silica (powders, granules)
• Antioxidantien: Butylhydroxytoluol, all-rac-a-Tocopherol • Antioxidants: butylated hydroxytoluene, all-rac-a-tocopherol
• Konservierungsstoffe: PHB-Ester, Benzalkoniumchlorid, Benzylalkohol, Thiomersal • Preservatives: PHB esters, benzalkonium chloride, benzyl alcohol, thiomersal
• Süßungsmittel, Geschmackkorrigientien: Saccharose, Sorbit, Süßstoffe wie etwa Saccharin-Natrium und Cyclamat • Sweeteners, flavoring agents: sucrose, sorbitol, sweeteners such as saccharin sodium and cyclamate
• Aromen • flavors
• Resorptionsbeschleuniger: Dimethylsulfoxid (in topischen Zubereitungen) • absorption accelerator: dimethyl sulphoxide (in topical preparations)
Weitere Hilfsmittel sind unter anderem Other aids include
Alkalisierungsmittel/Säuren/Neutralisierungsmittel Alkalizing / acids / neutralizing agent
• ACETIC ACID • ACETIC ACID
Essigsäure acetic acid
• AMINOMETHYL PROPANOL • AMINOMETHYL PROPANOL
2-Amino-2-methylpropanol 2-amino-2-methylpropanol
• AMMONIA • AMMONIA
Ammoniak ammonia
• AMMONIUM BICARBONATE • AMMONIUM BICARBONATE
Ammoniumbicarbonat, Ammoniumhydrogencarbonat • AMMONIUM CARBONATE Ammonium bicarbonate, ammonium bicarbonate • AMMONIUM CARBONATE
Ammoniumcarbonat ammonium carbonate
CITRIC ACID CITRIC ACID
Zitronensäure, Citronensäure Citric acid, citric acid
DISODIUM PHOSPHATE DISODIUM PHOSPHATES
Dinatriumhydrogenphosphat disodium
DISODIUM PYROPHOSPHATE DISODIUM PYROPHOSPHATE
Dinatriumdihydrogenpyrophosphat disodium dihydrogen pyrophosphate
ETHANOLAMINE ETHANOLAMINE
Ethanolamin, 2-Aminoethanol Ethanolamine, 2-aminoethanol
HYDROCHLORIC ACID HYDROCHLORIC ACID
Salzsäure, Chlorwasserstoff Hydrochloric acid, hydrogen chloride
PHOSPHORIC ACID PHOSPHORIC ACID
Phosphorsäure phosphoric acid
POTASSIUM CITRATE POTASSIUM CITRATE
Kaliumcitrat potassium citrate
POTASSIUM PHOSPHATE POTASSIUM PHOSPHATE
Kaliumdihydrogenphosphat potassium
SODIUM ACETATE SODIUM ACETATE
Natriumacetat, Natriumsalz der Essigsäure Sodium acetate, sodium salt of acetic acid
SODIUM BICARBONATE SODIUM BICARBONATE
Natriumbicarbonat, Natron, Natriumhydrogencarbonat SODIUM CITRATE Sodium bicarbonate, sodium bicarbonate, sodium bicarbonate SODIUM CITRATE
Natriumcitrat (Natriumsalz der Citronensäure) Sodium citrate (sodium salt of citric acid)
SODIUM HYDROXIDE SODIUM HYDROXIDE
Natriumhydroxid, Natronlauge Sodium hydroxide, caustic soda
SODIUM METAPHOSPHATE SODIUM METAPHOSPHATE
Natriummetaphosphat sodium metaphosphate
SODIUM PHOSPHATE SODIUM PHOSPHATE
Natriumdihydrogenphosphat sodium
SODIUM TRIMETAPHOSPHATE SODIUM TRIMETAPHOSPHATE
T rinatriumtrimetaphosphat Trisodium trimetaphosphate
TETRAPOTASSIUM PYROPHOSPHATE Tetrapotassium pyrophosphate
Kaliumpyrophosphat potassium pyrophosphate
TETRASODIUM PYROPHOSPHATE Natriumpyrophosphat TETRASODIUM PYROPHOSPHATE sodium pyrophosphate
• TRI ETHANOLAMINE • TRI ETHANOLAMINE
Tris(2-hydroxyethyl)amin, Trihydroxytriethylamin Tris (2-hydroxyethyl) amine, trihydroxytriethylamine
Antioxidantien antioxidants
• ASCORBIC ACID • ASCORBIC ACID
Vitamin C, Ascorbinsäure Vitamin C, ascorbic acid
• ASCORBYL PALMITATE • ASCORBYL PALMITATE
Palmitinsäureascorbylester, L-Ascorbylpalmitat Ascorbyl palmitate, L-ascorbyl palmitate
• BHT • BHT
Butylhydroxytoluol, 2,6-Di-t-butyl-p-cresol Butylhydroxytoluene, 2,6-di-t-butyl-p-cresol
• CAROTENOIDS • CAROTENOIDS
Carotinoide carotenoids
• LYCOPENE • LYCOPENE
Lycopin lycopene
• TOCOPHEROL • TOCOPHEROL
alpha-Tocopherol, Vitamin E alpha-tocopherol, vitamin E
• TOCOPHERYL ACETATE • TOCOPHERYL ACETATE
alpha-Tocopherylacetat (Vitamin-E-Acetat) alpha tocopheryl acetate (vitamin E acetate)
• UBIQUINONE • UBIQUINONE
Q10, Coenzym Q10; Ubichinon-10 Q10, coenzyme Q10; Coenzyme Q10
• RUTIN • RUTIN
Bindemittel binder
• Alkydharze • Alkyd resins
• Emulsionen • emulsions
• Epoxidharze • epoxy resins
• gebrannter Kalk, Zement, Lehm und Kaliwasserglas • burned lime, cement, clay and potash water
• Gummi arabicum • Gum arabic
• Harze • Resins
• Honig • honey
• Kasein • Casein
• Kunststoffdispersionen • plastic dispersions
• Pflanzenöle (Leinöl, Avocadoöl, Weizenkeimöl, Mandelöl, Lavendelöl)) • vegetable oils (linseed oil, avocado oil, wheat germ oil, almond oil, lavender oil))
• Polyurethane • Polyurethanes
• Rosmarin • rosemary
• Silikonharz • Wachs • silicone resin • Wax
• Zelluloseleim (Kleister) • cellulose glue (paste)
Farbstoffe/Farbpigmente Dyes / pigments
• Natrium-4-[(4,5-dihydro-3-methyl-5-oxo-1 -phenyl-1 H-pyrazol-4-yl)azo]-3- hydroxynaphthalin-1 -sulfonat Sodium 4 - [(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl) azo] -3-hydroxynaphthalene-1-sulfonate
Dihydroxyaluminiumstearat Dihydroxyaluminiumstearat
Anthocyane (Cyanidin, Peonidin, Malvidin, Delphinidin, Petunidin, Pelargonidin) Anthocyanins (cyanidin, peonidin, malvidin, delphinidin, petunidin, pelargonidin)
Rote Bete; Rote Rübe; Zuckerrübe Beetroot; Red beet; sugar beet
Bromkresolgrün bromocresol
Bromthymolblau Bromthymolblau
Calciumstearat calcium stearate
Paprikaextrakt; Capsanthin, Capsorubin Paprika extract; Capsanthin, Capsorubin
Karamell, Zuckerkulör Caramel, caramel
1 ,4-Bis(p-tolylamino)anthrachinon 1, 4-bis (p-tolylamino) anthraquinone
Natrium-1 -amino-4-(cyclohexylamino)-9, 10-dihydro-9, 10-dioxoanthracen-2-sulfonat Indigo; 2-(1 ,3-Dihydro-3-oxo-2H-indazol-2-yliden)-1 ,2-dihydro-3H-indol-3-on Sodium 1-amino-4- (cyclohexylamino) -9,10-dihydro-9,10-dioxoanthracene-2-sulfonate indigo; 2- (1,3-dihydro-3-oxo-2H-indazol-2-ylidene) -1,2-dihydro-3H-indol-3-one
Dinatrium[29H,31 H-phthalocyanindisulfonato(4-)-N29,N30,N31 ,N32]cuprat(2-) Disodium [29H, 31H-phthalocyaninedisulfonato (4 -) - N29, N30, N31, N32] cuprate (2-)
Polychlorkupferphthalocyanin Polychlorkupferphthalocyanin
Guanin; 2-Amino-6-hydroxypurin; 2-Amino-1 ,7-dihydro-6H-purin-6-on guanine; 2-amino-6-hydroxypurine; 2-amino-1, 7-dihydro-6H-purin-6-one
Kurkumin, Curcumin; 1 ,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1 ,6-dien-3,5-dion Karmin; Karminsäure Curcumin, curcumin; 1, 7-bis (4-hydroxy-3-methoxyphenyl) hepta-1, 6-diene-3,5-dione carmine; carminic
Chlorophyll; Chlorophyll a/b; Trinatrium-(2S-trans)-[18-carboxy-20-(carboxymethyl)-13- ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21 H,23H-porphin-2-propionato(5-) chlorophyll; Chlorophyll a / b; Trisodium (2S-trans) - [18-carboxy-20- (carboxymethyl) -13-ethyl-2,3-dihydro-3,7,12,17-tetramethyl-8-vinyl-21H, 23H-porphine 2-propionato (5)
N21 ,N22,N23,N24]cuprat(3-) N21, N22, N23, N24] cuprate (3-)
Aluminium aluminum
Aluminiumoxidhydrat; Aluminiumhydroxid hydrated alumina; aluminum hydroxide
Wasserhaltiges Aluminiumsilicat Hydrous aluminum silicate
Lazurit; Ultramarin Lazurite; ultramarine
Aluminumsilicat, gefärbt durch Eisen(lll)oxid Aluminosilicate, colored by iron (III) oxide
Bariumsulfat barium sulfate
Bismutchloridoxid bismuth oxychloride
Calciumcarbonat; Kalziumkarbonat; Kreide calcium carbonate; Calcium carbonate; chalk
Calciumsulfat; Kalziumsulfat Calcium sulfate; calcium sulphate
Kohlenstoff; synthetischer Ruß;„Carbon Black“ • Kohlenstoff; synthetischer Ruß;„Carbon Black“ (nanoskalig) Carbon; synthetic carbon black "carbon black" • carbon; synthetic carbon black "carbon black" (nanoscale)
• Knochenkohle • Bone coal
• Pflanzenkohle • biochar
• Chrom(lll)oxid; Chromoxidgrün Chromium (III) oxide; Chrome Oxide
• Chrom(lll)oxid-Dihydrat; Chromoxidhydratgrün • Chromium (III) oxide dihydrate; Viridian
• Kobaltaluminiumoxid; Kobaltblau Cobalt-aluminum oxide; cobalt blue
• Kupfer • copper
• Gold • Gold
• Eisen(ll)oxid • Iron (II) oxide
• Eisen(lll)oxid • Iron (III) oxide
• Eisen(lll)oxid-Hydrat • Iron (III) oxide hydrate
• Eisen(ll,lll)oxid • Iron (II, III) oxide
• Preußisch Blau, Eisen(lll)hexacyanoferrat • Prussian blue, iron (III) hexacyanoferrate
• Magnesiumcarbonat • Magnesium carbonate
• Manganviolett; Ammoniummangan(lll)diphosphat • manganese violet; diphosphate ammonium manganese (III)
• Mangan(ll)phosphat-Heptahydrat • Manganese (II) phosphate heptahydrate
• Silber • silver
• Titandioxid • titanium dioxide
• Zinkoxid • zinc oxide
• LACTOFLAVIN • LACTOFLAVIN
Lactoflavin; Riboflavin lactoflavin; riboflavin
• MAGNESIUM STEARATE • MAGNESIUM STEARATE
Magnesiumdistearat magnesium distearate
• RIBOFLAVIN • RIBOFLAVIN
Riboflavin; Lactoflavin riboflavin; lactoflavin
• ZI NC STEARATE • ZI NC STEARATE
Zinkstearat zinc stearate
Feuchthaltemittel Humectants
• CYCLOMETHICONE • CYCLOMETHICONE
Cyclomethicon; besteht aus Octamethylcyclotetrasiloxan (D4), Decamethylcyclopentasiloxan (D5) und Dodecamethylcyclohexasiloxan (D6) cyclomethicone; Composed of octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5) and dodecamethylcyclohexasiloxane (D6)
• CYCLOPENTASILOXANE • CYCLOPENTASILOXANE
Decamethylcyclopentasiloxan decamethylcyclopentasiloxane
• GLYCERIN • GLYCERINE
Glycerin, Glycerol, 1 ,2,3-Propantriol GLYCOL Glycerol, glycerol, 1,2,3-propanetriol GLYCOL
Glykol, Ethylenglycol, Ethylenglykol Glycol, ethylene glycol, ethylene glycol
LACTIC ACID LACTIC ACID
Milchsäure; 2-Hydroxypropionsäure, 2-Hydroxypropansäure y-6 Lactic acid; 2-hydroxypropionic acid, 2-hydroxypropanoic acid y-6
Polyethylenglycol (durchschnittlich 6 Einheiten -CH2-CH2-0-) SODIUM LACTATE Polyethylene glycol (average 6 units -CH2-CH2-0-) SODIUM LACTATE
Natriumlactat (Natriumsalz der Milchsäure) Sodium lactate (sodium salt of lactic acid)
SODIUM HYALURONATE SORBITOL SODIUM HYALURONATE SORBITOL
Sorbit, Sorbitol, Glucitol Sorbitol, sorbitol, glucitol
PANTHENOL (Provitamin B5) PANTHENOL (provitamin B5)
CAMELLIA EURYOIDES LEAF EXTRACT CAMELLIA EURYOIDES LEAF EXTRACT
Harze resins
POLYMETHACRYLIC ACID POLYMETHACRYLIC ACID
Polymethacrylsäure polymethacrylic
POLYVINYL ACETATE POLYVINYL ACETATE
Polyvinylacetat polyvinyl acetate
TOSYLAMIDE/FORMALDEHYDE RESIN TOSYLAMIDE / FORMALDEHYDE RESIN
Toluolsulfonamid-Formaldehydharz Toluene sulfonamide-formaldehyde resin
Konservierungsmittel preservative
2-BROMO-2-NITROPROPANE-1 ,3-DIOL 2-BROMO-2-NITROPROPANE-1, 3-DIOL
2-Brom-2-nitropropan-1 ,3-diol, Bronopol 2-bromo-2-nitropropane-1,3-diol, Bronopol
4-HYDROXYBENZOIC ACID 4-HYDROXYBENZOIC ACID
4-Hydroxybenzoesäure 4-hydroxybenzoic acid
5-BROMO-5-NITRO-1 ,3-DIOXANE 5-BROMO-5-NITRO-1, 3-DIOXANE
5-Brom-5-nitro-1 ,3-dioxan 5-bromo-5-nitro-1,3-dioxane
AMMONIUM BENZOATE AMMONIUM BENZOATE
Ammoniumbenzoat, Ammoniumsalz der Benzoesäure AMMONIUM BISULFITE Ammonium benzoate, ammonium salt of benzoic acid AMMONIUM BISULFITE
Ammoniumbisulfit, Ammoniumhydrogensulfit Ammonium bisulfite, ammonium bisulfite
AMMONIUM PROPIONATE AMMONIUM PROPIONATE
Ammoniumpropionat, Ammoniumsalz der Propionsäure Ammonium propionate, ammonium salt of propionic acid
AMMONIUM SULFITE AMMONIUM SULFITE
Ammoniumsulfit BENZALKONIUM BROMIDEammonium BENZAL CONVENTION BROMIDE
Benzalkoniumbromid benzalkonium
BENZALKONIUM CHLORIDE BENZAL CONVENTION CHLORIDE
Benzalkoniumchlorid benzalkonium chloride
BENZETHONIUM CHLORIDE BENZETHONIUM CHLORIDE
Benzethoniumchlorid benzethonium
BENZOIC ACID BENZOIC ACID
Benzoesäure benzoic acid
BENZYL ALCOHOL BENZYL ALCOHOL
Benzylalkohol; Phenylmethanol benzyl alcohol; phenylmethanol
BROMOCHLOROPHENE BROMOCHLOROPHENE
Bromchlorophen bromchlorophene
BUTYL BENZOATE BUTYL BENZOATE
Benzoesäure-Butylester Benzoic acid ester
BUTYLPARABEN Butylparaben
Butylparaben; 4-Hydroxybenzoesäurebutylester CALCIUM BENZOATE Butylparaben; 4-hydroxybenzoic acid butyl ester CALCIUM BENZOATE
Calciumbenzoat, Calciumsalz der Benzoesäure CALCIUM PARABEN Calcium benzoate, calcium salt of benzoic acid CALCIUM PARABEN
4-Hydroxybenzoesäure, Calciumsalz 4-hydroxybenzoic acid, calcium salt
CALCIUM PROPIONATE CALCIUM PROPIONATE
Calciumpropionat, Calciumsalz der Propionsäure CALCIUM SALICYLATE Calcium propionate, calcium salt of propionic acid CALCIUM SALICYLATE
Calciumsalicylat, Calciumsalz der Salicylsäure CALCIUM SORBATE Calcium salicylate, calcium salt of salicylic acid CALCIUM SORBATE
Calciumsorbat, Calciumsalz der Sorbinsäure Calcium sorbate, calcium salt of sorbic acid
CETRIMONIUM CHLORIDE CETRIMONIUM CHLORIDE
Cetrimoniumchlorid cetrimonium
CHLORHEXIDINE CHLORHEXIDINE
Chlorhexidin chlorhexidine
CHLOROACETAMIDE Chloroacetamide
Chloracetamid chloroacetamide
CHLOROBUTANOL chlorobutanol
Chlorbutanol chlorobutanol
CHLOROPHENE Chlorophen, 4-Chlor-2-(phenylmethyl)phenol CHLOROPHENE Chlorophen, 4-chloro-2- (phenylmethyl) phenol
CHLORPHENESIN Chlorphenesin
Chlorphenesin, 3-(4-Chlorphenoxy)-1 ,2-propandiol Chlorphenesin, 3- (4-chlorophenoxy) -1, 2-propanediol
CLIMBAZOLE Climbazole
Climbazol, 1-(4-Chlorphenoxy)-1-(1 H-imidazol-1-yl)-3,3-dimethyl-2-butanon DEHYDROACETIC ACID Climbazole, 1- (4-chlorophenoxy) -1- (1H-imidazol-1-yl) -3,3-dimethyl-2-butanone DEHYDROACETIC ACID
Dehydracetsäure, 3-Acetyl-6-methyl-2H-pyran-2,4(3H)-dion Dehydroacetic acid, 3-acetyl-6-methyl-2H-pyran-2,4 (3H) -dione
DIAZOLIDINYL UREA DIAZOLIDINYL UREA
Diazolidinylharnstoff diazolidinyl
DMDM HYDANTOIN DMDM HYDANTOIN
1 ,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidin-2,4-dion 1, 3-bis (hydroxymethyl) -5,5-dimethylimidazolidine-2,4-dione
ETHYL BENZOATE ETHYL BENZOATE
Benzoesäure-Ethylester Benzoic acid ethyl ester
ETHYLPARABEN Ethylparaben
Ethylparaben; 4-Hydroxybenzoesäureethylester Ethylparaben; 4-hydroxybenzoate
FORMALDEHYDE FORMALDEHYDE
Formaldehyd, Methanal, Formalin Formaldehyde, methanal, formalin
FORMIC ACID FORMIC ACID
Ameisensäure formic acid
GLUTARAL GLUTARAL
Glutaral, Glutardialdehyd Glutaral, glutaric dialdehyde
HEXAMIDINE HEXAMIDINE
Hexamidin hexamidine
IMIDAZOLIDINYL UREA IMIDAZOLIDINYL UREA
Imidazolidinyl-Harnstoff Imidazolidinyl urea
IODOPROPYNYL BUTYLCARBAMATE IOPROPYNYL BUTYL CARBAMATE
3-lod-2-propinylbutylcarbamat 3-iodo-2-propynyl butyl carbamate
ISOBUTYL BENZOATE ISOBUTYL BENZOATE
Benzoesäure-Isobutylester Benzoic acid isobutyl ester
ISOPROPYL BENZOATE ISOPROPYL BENZOATE
Benzoesäure-Isopropylester Benzoic acid isopropyl ester
ISOPROPYL CRESOLS ISOPROPYL CRESOLS
4-lsopropyl-m-cresol 4-isopropyl-m-cresol
MAGNESIUM BENZOATE MAGNESIUM BENZOATE
Magnesiumbenzoat, Magnesiumsalz der Benzoesäure • MAGNESIUM PROPIONATE Magnesium benzoate, magnesium salt of benzoic acid • MAGNESIUM PROPIONATE
Magnesiumpropionat, Magnesiumsalz der Propionsäure Magnesium propionate, magnesium salt of propionic acid
• MAGNESIUM SALICYLATE • MAGNESIUM SALICYLATE
Magnesiumsalicylat, Magnesiumsalz der Salicylsäure Magnesium salicylate, magnesium salt of salicylic acid
• MEA-BENZOATE • MEA BENZOATE
Benzoesäure, (Mono-)Ethanolaminsalz Benzoic acid, (mono) ethanolamine salt
• METHYL BENZOATE • METHYL BENZOATE
Benzoesäure-Methylester Benzoic acid Methylester
• METHYLCHLOROISOTHIAZOLINONE • METHYLCHLOROISOTHIAZOLINONE
Chlormethylisothiazolinon, Methylchlorisothiazolinon; 5-Chlor-2-methyl-2H-isothiazol-3- on Chloromethylisothiazolinone, methylchloroisothiazolinone; 5-chloro-2-methyl-2H-isothiazol-3-one
• METHYLISOTHIAZOLINONE • METHYLISOTHIAZOLINONE
Methylisothiazolinon, 2-Methyl-2H-isothiazol-3-on Methylisothiazolinone, 2-methyl-2H-isothiazol-3-one
• METHYLPARABEN • METHYL PARKS
Methylparaben; 4-Hydroxybenzoesäuremethylester methyl paraben; 4-hydroxybenzoate
• O-PHENYLPHENOL • O-PHENYLPHENOL
o-Phenylphenol o-phenylphenol
• P-CHLORO-M-CRESOL • P-CHLORO-M-CRESOL
4-Chlor-3-methylphenol, p-Chlor-m-cresol 4-chloro-3-methylphenol, p-chloro-m-cresol
• PHENOXYETHANOL • PHENOXYETHANOL
2-Phenoxyethanol 2-phenoxyethanol
• PHENOXYISOPROPANOL • PHENOXYISOPROPANOL
Phenoxyisopropanol, 1 -Phenoxypropan-2-ol Phenoxyisopropanol, 1-phenoxypropan-2-ol
• PHENYL BENZOATE • PHENYL BENZOATE
Benzoesäure-Phenylester Benzoic acid phenyl ester
• PIROCTONE OLAMINE • PIROCTONE OLAMINE
Pirocton-Olamin Pirocton olamine
• POTASSIUM BENZOATE • POTASSIUM BENZOATE
Kaliumbenzoat, Kaliumsalz der Benzoesäure Potassium benzoate, potassium salt of benzoic acid
• POTASSIUM BUTYLPARABEN • POTASSIUM BUTYL PARKS
Butylparaben (Kaliumsalz); 4-Hydroxybenzoesäurebutylester (Kaliumsalz) Butyl paraben (potassium salt); 4-hydroxybenzoic acid butyl ester (potassium salt)
• POTASSIUM ETHYLPARABEN • POTASSIUM ETHYLPARABEN
Ethylparaben (Kaliumsalz); 4-Hydroxybenzoesäureethylester (Kaliumsalz) Ethyl paraben (potassium salt); 4-hydroxybenzoic acid ethyl ester (potassium salt)
• POTASSIUM METABISULFITE • POTASSIUM METABISULFITE
Dikaliumdisulfit POT ASSI UM METHYLPARABEN Dikaliumdisulfit POT ASSI TO METHYLPARABES
Methylparaben (Kaliumsalz); 4-Hydroxybenzoesäuremethylester (Kaliumsalz) Methylparaben (potassium salt); 4-hydroxybenzoic acid methyl ester (potassium salt)
POT ASSI UM PARABEN POT ASSI TO PARABEN
4-Hydroxybenzoesäure, Kaliumsalz 4-hydroxybenzoic acid, potassium salt
POTASSIUM PROPIONATE POTASSIUM PROPIONATE
Kaliumpropionat, Kaliumsalz der Propionsäure Potassium propionate, potassium salt of propionic acid
POTASSIUM PROPYLPARABEN POTASSIUM PROPYL PARKS
Propylparaben (Kaliumsalz); 4-Hydroxybenzoesäurepropylester (Kaliumsalz) Propylparaben (potassium salt); 4-hydroxybenzoic acid propyl ester (potassium salt)
POTASSIUM SALICYLATE POTASSIUM SALICYLATE
Kaliumsalicylat, Kaliumsalz der Salicylsäure Potassium salicylate, potassium salt of salicylic acid
POTASSIUM SORBATE POTASSIUM SORBATE
Kaliumsorbat, Kaliumsalz der Sorbinsäure Potassium sorbate, potassium salt of sorbic acid
POTASSIUM SULFITE POTASSIUM SULFITE
Kaliumsulfit potassium
PROPIONIC ACID PROPIONIC ACID
Propionsäure propionic
PROPYL BENZOATE PROPYL BENZOATE
Benzoesäure-Propylester Benzoic acid propyl
PROPYLPARABEN PROPYLPARABEN
Propylparaben; 4-Hydroxybenzoesäurepropylester propyl paraben; 4-hydroxybenzoate
SODIUM BENZOATE SODIUM BENZOATE
Natriumbenzoat, Natriumsalz der Benzoesäure Sodium benzoate, sodium salt of benzoic acid
SODIUM BISULFITE SODIUM BISULFITE
Natriumbisulfit, Natriumhydrogensulfit Sodium bisulfite, sodium bisulfite
SODIUM BUTYLPARABEN SODIUM BUTYLPARABEN
Butylparaben (Natriumsalz); 4-Hydroxybenzoesäurebutylester (Natriumsalz) SODIUM ETHYLPARABEN Butyl paraben (sodium salt); 4-Hydroxybenzoic acid butyl ester (sodium salt) SODIUM ETHYLPARABEN
Ethylparaben (Natriumsalz); 4-Hydroxybenzoesäureethylester (Natriumsalz) SODIUM FORMATE Ethyl paraben (sodium salt); 4-hydroxybenzoic acid ethyl ester (sodium salt) SODIUM FORMATE
Natriumformiat, Natriumsalz der Ameisensäure Sodium formate, sodium salt of formic acid
SODIUM METABISULFITE SODIUM METABISULFITE
Dinatriumdisulfit, Natriummetabisulfit Disodium disulfite, sodium metabisulfite
SODIUM METHYLPARABEN SODIUM METHYLPARABEN
Methylparaben (Natriumsalz); 4-Hydroxybenzoesäuremethylester (Natriumsalz) SODIUM PARABEN 4-Hydroxybenzoesäure, Natriumsalz Methylparaben (sodium salt); 4-Hydroxybenzoic acid methyl ester (sodium salt) SODIUM PARABEN 4-hydroxybenzoic acid, sodium salt
SODIUM PROPIONATE SODIUM PROPIONATE
Natriumpropionat, Natriumsalz der Propionsäure Sodium propionate, sodium salt of propionic acid
SODIUM PROPYLPARABEN SODIUM PROPYLPARABEN
Propylparaben (Natriumsalz); 4-Hydroxybenzoesäurepropylester (Natriumsalz) Propylparaben (sodium salt); 4-hydroxybenzoic acid propyl ester (sodium salt)
SODIUM SALICYLATE SODIUM SALICYLATE
Natriumsalicylat, Natriumsalz der Salicylsäure Sodium salicylate, sodium salt of salicylic acid
SODIUM SORBATE SODIUM SORBATES
Natriumsorbat, Natriumsalz der Sorbinsäure Sodium sorbate, sodium salt of sorbic acid
SODIUM SULFITE SODIUM SULFITE
Natriumsulfit sodium
SORBIC ACID SORBIC ACID
Sorbinsäure, 2,4-Hexadiensäure Sorbic acid, 2,4-hexadienoic acid
STEARALKONIUM CHLORIDE STEALALCONIUM CHLORIDE
Stearalkoniumchlorid stearalkonium
TRICLOCARBAN triclocarban
T riclocarban, 1 -(4-Chlorphenyl)-3-(3,4-dichlorphenyl)harnstoff Triclocarban, 1- (4-chlorophenyl) -3- (3,4-dichlorophenyl) urea
TRICLOSAN Triclosan
T riclosan, 5-Chlor-2-(2,4-dichlorphenoxy)phenol Triclosan, 5-chloro-2- (2,4-dichlorophenoxy) phenol
Oxidationsmittel oxidant
AMMONIUM PERSULFATE AMMONIUM PERSULFATE
Ammoniumperoxodisulfat, Ammoniumpersulfat Ammonium peroxodisulfate, ammonium persulfate
HYDROGEN PEROXIDE HYDROGEN PEROXIDE
Wasserstoffperoxid hydrogen peroxide
POTASSIUM PERSULFATE POTASSIUM PERSULFATE
Kaliumpersulfat, Kaliumperoxodisulfat Potassium persulfate, potassium peroxodisulfate
SODIUM PERSULFATE SODIUM PERSULFATE
Natriumpersulfat, Natriumperoxodisulfat Sodium persulfate, sodium peroxodisulfate
Reduktionsmittel reducing agent
AMMONIUM BISULFITE AMMONIUM BISULFITE
Ammoniumbisulfit, Ammoniumhydrogensulfit Ammonium bisulfite, ammonium bisulfite
AMMONIUM THIOGLYCOLATE AMMONIUM THIOGLYCOLATE
Ammoniumthioglycolat, Ammoniummercaptoacetat Ammonium thioglycolate, ammonium mercaptoacetate
SODIUM METABISULFITE SODIUM METABISULFITE
Dinatriumdisulfit, Natriummetabisulfit • THIOGLYCOLIC ACID Disodium disulfite, sodium metabisulfite • THIOGLYCOLIC ACID
Thioglykolsäure, Thioglycolsäure; Mercaptoessigsäure Thioglycolic acid, thioglycolic acid; mercaptoacetic
THIOLACTIC ACID THIOLACTIC ACID
Thiomlichsäure, 2-Mercaptopropionsäure Thiomic acid, 2-mercaptopropionic acid
Stabilisatoren stabilizers
ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER ACRYLATES / C10-30 ALKYL ACRYLATE CROSPOLYMER
Polymer aus Acrylsäurealkylestern (C10-C30), Acrylsäure, Methacrylsäure und/oder anderen Alkylacrylaten; kreuzverknpüft mit Propenyl-(allyl-)modifizierten Zuckern Polymer of alkyl acrylates (C10-C30), acrylic acid, methacrylic acid and / or other alkyl acrylates; cross-linked with propenyl (allyl) modified sugars
ASCORBYL PALMITATE ASCORBYL PALMITATE
Palmitinsäureascorbylester, L-Ascorbylpa Imitat Ascorbyl palmitate, L-Ascorbylpa Imitation
BENTONITE BENTONITES
Bentonit (Tonmineral) Bentonite (clay mineral)
BHT BHT
Butylhydroxytoluol, 2,6-Di-t-butyl-p-cresol Butylhydroxytoluene, 2,6-di-t-butyl-p-cresol
CARBOMER CARBOMER
Polyacrylsäure polyacrylic acid
CETEARYL ALCOHOL CETEARYL ALCOHOL
Cetearylalkohol, Mischung aus 1-Hexadecanol (Cetylalkohol) und 1-Octadecanol (Stearylalkohol) Cetearyl alcohol, mixture of 1-hexadecanol (cetyl alcohol) and 1-octadecanol (stearyl alcohol)
CETYL HYDROXYETHYLCELLULOSE CETYL HYDROXYETHYL CELLULOSE
2-Hydroxyethylcellulose-Cetyl-Ether 2-hydroxyethyl-cetyl ether
COCAMIDE MEA COCAMIDE MEA
N-(Hydroxyethyl)-Kokosfettsäureamid N- (hydroxyethyl) -Kokosfettsäureamid
DISODIUM EDTA DISODIUM EDTA
Ethylendiamintetraessigsäure, Dinatriumsalz Ethylenediaminetetraacetic acid, disodium salt
EDTA EDTA
Ethylendiamintetraessigsäure ethylenediaminetetraacetic
ETIDRONIC ACID ETIDRONIC ACID
Etidronsäure, 1 -Hydroxyethyliden-bis-phosphonsäure Etidronic acid, 1-hydroxyethylidene-bis-phosphonic acid
HYDROXYETHYLCELLULOSE HYDROXYETHYLCELLULOSE
Hydroxyethylcellulose hydroxyethyl
MICROCRYSTALLINE CELLULOSE MICROCRYSTALLINE CELLULOSE
Cellulose (mikrokristallin) Cellulose (microcrystalline)
PENTASODIUM PENTETATE PENTASODIUM PENTETATE
Pentanatrium(carboxylatomethyl)iminobis(ethylennitrilo)tetraacetat • POTASSIUM ALGINATE Pentasodium (carboxylatomethyl) iminobis (ethylenenitrilo) tetraacetate • POTASSIUM ALGINATE
Kaliumalginat (Kaliumsalz der Alginsäure) Potassium alginate (potassium salt of alginic acid)
• PVP • PVP
Polyvinylpyrrolidon polyvinylpyrrolidone
• SODIUM CARBOMER • SODIUM CARBOMER
Polyacrylsäure (Natriumsalze) Polyacrylic acid (sodium salts)
• SODIUM CITRATE • SODIUM CITRATE
Natriumcitrat (Natriumsalz der Citronensäure) Sodium citrate (sodium salt of citric acid)
• SODIUM GLUCONATE • SODIUM GLUCONATE
Natriumgluconat (Natriumsalz der Gluconsäure) Sodium gluconate (sodium salt of gluconic acid)
• TETRASODIUM EDTA • TETRASODIUM EDTA
Ethylendiamintetraessigsäure, Tetranatriumsalz Ethylenediaminetetraacetic acid, tetrasodium salt
• TOCOPHEROL • TOCOPHEROL
alpha-Tocopherol, Vitamin E alpha-tocopherol, vitamin E
• TRISODIUM EDTA • TRISODIUM EDTA
Ethylendiamintetraessigsäure, T rinatriumsalz Ethylenediaminetetraacetic acid, trisodium salt
• Polysaccharide • polysaccharides
Treibgase für Sprays Propellants for sprays
• Butan • butane
• Kohlendioxid • carbon dioxide
• Dimethylether • dimethyl ether
• Isobutan, 2-Methylpropan Isobutane, 2-methylpropane
• Stickstoff Nitrogen
• Propan rübungsmittel/Perlglanzstoffe • propane opacifier / pearlescent
• Calciumsulfat • calcium sulfate
• Cellulose • cellulose
• GLYCOL PALMITATE • GLYCOL PALMITATE
Palmitinsäure-Glycolester; 2-Hydroxyethylpalmitat Palmitic acid glycol esters; 2-Hydroxyethylpalmitat
• MICA • MICA
Glimmer (ein Silikatmineral) Mica (a silicate mineral)
• PEG-2 STEARATE • PEG-2 STEARATE
2-(2-Hydroxyethoxy)ethylstearat; Ester aus Stearinsäure und Diethylenglycol (1 :1) 2- (2-hydroxyethoxy) ethyl stearate; Esters of stearic acid and diethylene glycol (1: 1)
• PROPYLENE GLYCOL DISTEARATE Propylenglycol-Distearat; Ester aus Stearinsäure und Propylenglycol (2:1 )• PROPYLENE GLYCOL DISTEARATE Propylene glycol distearate; Esters of stearic acid and propylene glycol (2: 1)
• PROPYLENE GLYCOL STEARATE SE • PROPYLENE GLYCOL STEARATE SE
Propylenglycol-Stearat; Ester aus Stearinsäure und Propylenglycol (1 :1), enthält Natrium- oder Kaliumstearat * Propylene glycol stearate; Ester of stearic acid and propylene glycol (1: 1) containing sodium or potassium stearate *
Vergällungsmittel denaturant
Weichmacher softener
• BUTYL STEARATE • BUTYL STEARATE
Butylstearat, Stearinsäurebutylester Butyl stearate, stearic acid butyl ester
. CAMPHOR , CAMPHOR
Kampfer Fighter
• CETEARYL ISONONANOATE • CETEARYL ISONONANOATE
Cetearyl-Isononanoat, Ester aus Isononansäure und Cetearylalkohol Cetearyl isononanoate, esters of isononanoic acid and cetearyl alcohol
• DIBUTYL SEBACATE • DIBUTYL SEBACATE
Dibutylsebacat, Sebacinsäuredibutylester Dibutyl sebacate, Sebacic acid dibutyl ester
• DICAPRYLYL ETHER • DICAPRYLYL ETHER
Dicaprylylether, Dioctylether Dicaprylyl ether, dioctyl ether
• DIISODECYL ADIPATE • DIISODECYL ADIPATE
Diisodecyladipat, Adipinsäure-Diisodecylester Diisodecyl adipate, adipic acid diisodecyl ester
• ISOPROPYL CITRATE • ISOPROPYL CITRATE
Isopropylcitrat, Citronensäure-Isopropylester Isopropyl citrate, citric acid isopropyl ester
• ISOPROPYL MYRISTATE • ISOPROPYL MYRISTATE
Isopropylmyristat, Myristinsäure-Isopropylester Isopropyl myristate, myristic-isopropyl ester
• ISOPROPYL PALMITATE • ISOPROPYL PALMITATE
Isopropylpalmitat, Palmitinsäure-Isopropylester Isopropyl palmitate, palmitic acid isopropyl ester
• OCTYLDODECANOL • OCTYLDODECANOL
2-Octyldodecan-1 -ol 2-octyldodecane-1-ol
• SORBITOL • SORBITOL
Sorbit, Sorbitol, Glucitol Sorbitol, sorbitol, glucitol
• TOSYLAMI DE/FORMALDEHYDE RESIN • TOSYLAMI DE / FORMALDEHYDE RESIN
• Toluolsulfonamid-Formaldehydharz • toluenesulfonamide-formaldehyde resin
• Mineralstoffe • minerals
• Sand • Sand
• Essentielle Spurenelemente: Kobalt, Eisen, Jod, Kupfer, Mangan, Molybdän, Selen, Silicium, Zink, Arsen, Nickel, Rubidium, Zinn, Vanadium • Vitamine: Vitamin A, Vitamin B1 , Vitamin B2, Vitamin B3, Vitamin B4, Vitamin B5, Vitamin B6, Vitamin B7, Vitamin B8, Vitamin B9, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, Vitamin K • Essential trace elements: cobalt, iron, iodine, copper, manganese, molybdenum, selenium, silicon, zinc, arsenic, nickel, rubidium, tin, vanadium • Vitamins: Vitamin A, Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B4, Vitamin B5, Vitamin B6, Vitamin B7, Vitamin B8, Vitamin B9, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, Vitamin K
• Salz: Kochsalz, Himalayasalz, Hawaii-Salz, Salz vom Toten Meer • Salt: table salt, Himalayan salt, Hawaiian salt, Dead Sea salt
• Mizellen • micelles
Rückfettende Substanzen: Refatting substances:
Unter rückfettenden Substanzen, auch Rückfetter und/oder Rückfettungsmittel genannt, sind Substanzen, die meistens Tensidpräperaten hinzugefügt werden, um ihrem entfettenden Charakter entgegenzuwirken. Hierzu werden die folgenden rückfettenden Substanzen benutzt. Die nachstehende Liste ist beispielshaft und nicht vollständig aufgezählt. Der Fachmann kann auf Grund seines allgemeinen Fachwissens ohne weiteres, weitere mögliche rückfettende Substanzen benennen. Substances that are usually added to surfactant preparations in order to counteract their degreasing character are substances which are also called moisturizers and / or moisturizers. For this purpose, the following moisturizing substances are used. The list below is exemplary and not exhaustive. The person skilled in the art, on the basis of his general knowledge, can easily name further possible refatting substances.
• SQUALANE • SQUALANE
2.6.10.15.19.23-Hexamethyltetracosan 2.6.10.15.19.23-hexamethyltetracosane
• SQUALENE • SQUALEN
2.6.10.15.19.23-Hexamethyl-2,6, 10,14,18,22-tetracosahexaen 2.6.10.15.19.23-hexamethyl-2,6, 10,14,18,22-tetracosahexaene
• STEARETH-10 • STEARETH-10
Polyethylenglycolether des Stearylakohols (durchschnittlich 10 Einheiten -CH2-CH2-O-) Polyethylene glycol ethers of stearyl alcohol (average 10 units -CH2-CH2-O-)
• STEARYL ALCOHOL • STEARYL ALCOHOL
Stearylalkohol, 1-Octadecanol Stearyl alcohol, 1-octadecanol
• TRIMYRISTIN • TRIMYRISTINE
Glyceryl-Trimyristat; Veresterungsprodukt von Glycerin und Myristinsäure (1 :3) Glyceryl trimyristate; Esterification product of glycerine and myristic acid (1: 3)
• TRIPALMITIN • TRIPALMITINE
• Eucerit, Wollwachsalkohole • Eucerit, wool wax alcohols
Glyceryl-Tripalmitat; Veresterungsprodukt von Glycerin und Palmitinsäure (1 :3) Glyceryl tripalmitate; Esterification product of glycerol and palmitic acid (1: 3)
• WHEAT GERM GLYCERIDES • WHEAT GERM GLYCERIDES
Veresterungsprodukt von Glycerin und Fettsäuren aus Weizenkeimöl Esterification product of glycerol and fatty acids from wheat germ oil
Öle: oils:
Öle sind eine Sammelbezeichnung für unterschiedliche flüssige Fettstoffe. Hierzu zählen unteranderem Mineralöle, Silikonöle und/oder Öle natürlichen Ursprunges, wie beispielsweise Pflanzenöle und/oder ätherische Öle. Diese kennzeichnen sich oft durch ein- und/oder mehrfach ungesättigte Fettsäuren. Öle tierischer Herkunft werden meist als Fette bezeichnet. Außerdem werden viele in der Kosmetik eingesetzten Ölkomponenten auf Grundlage natürlicher Ausgangsstoffe synthetisch hergestellt. Genau wie die rückfettenden Stoffe verhindern Ölkomponenten das vorzeitige Austrocknen von Haut und/oder Haar. In der nachstehenden Liste werden die Öle beispielshaft und nicht abschießend aufgelistet. Der Fachmann kann auf Grund seines allgemeinen Fachwissens ohne weiteres, weitere mögliche Öle benennen. Oils are a collective term for different liquid fatty substances. These include, inter alia, mineral oils, silicone oils and / or oils of natural origin, such as vegetable oils and / or essential oils. These are often characterized by monounsaturated and / or polyunsaturated fatty acids. Oils of animal origin are usually referred to as fats. In addition, many oil components used in cosmetics are based on natural starting materials synthetically produced. Just like the lubricating substances, oil components prevent the premature drying of the skin and / or hair. In the list below, the oils are listed by example and not by definition. The person skilled in the art, on the basis of his general knowledge, can easily name further possible oils.
• BETULA ALBA BARK EXTRACT (Birke) • BETULA ALBA BARK EXTRACT (birch)
• CAPRYLIC/CAPRIC TRIGLYCERIDE • CAPRYLIC / CAPRIC TRIGLYCERIDE
Veresterungsprodukt von Glycerin und Caprinsäure sowie Caprylsäure (1 :3) Esterification product of glycerol and capric acid as well as caprylic acid (1: 3)
• CETEARYL ALCOHOL • CETEARYL ALCOHOL
Cetearylalkohol, Mischung aus 1-Hexadecanol (Cetylalkohol) und 1-Octadecanol (Stearylalkohol) Cetearyl alcohol, mixture of 1-hexadecanol (cetyl alcohol) and 1-octadecanol (stearyl alcohol)
• CYCLOMETHICONE • CYCLOMETHICONE
Cyclomethicon; besteht aus Octamethylcyclotetrasiloxan (D4), Decamethylcyclopentasiloxan (D5) und Dodecamethylcyclohexasiloxan (D6) cyclomethicone; Composed of octamethylcyclotetrasiloxane (D4), decamethylcyclopentasiloxane (D5) and dodecamethylcyclohexasiloxane (D6)
• DIBUTYL SEBACATE • DIBUTYL SEBACATE
Dibutylsebacat, Sebacinsäuredibutylester Dibutyl sebacate, Sebacic acid dibutyl ester
• DICAPRYLYL ETHER • DICAPRYLYL ETHER
Dicaprylylether, Dioctylether Dicaprylyl ether, dioctyl ether
• DIISODECYL ADIPATE • DIISODECYL ADIPATE
Diisodecyladipat, Adipinsäure-Diisodecylester Diisodecyl adipate, adipic acid diisodecyl ester
• DIMETHICONE • DIMETHICONE
Polydimethylsiloxan polydimethylsiloxane
• GLYCERYL STEARATE • GLYCERYL STEARATE
Glycerinstearat, Glycerinmonostearat, Stearinsäure-Glycerinester Glycerol stearate, glycerol monostearate, stearic acid-glycerol ester
• ISOPROPYL MYRISTATE • ISOPROPYL MYRISTATE
Isopropylmyristat, Myristinsäure-Isopropylester Isopropyl myristate, myristic-isopropyl ester
• ISOPROPYL PALMITATE • ISOPROPYL PALMITATE
Isopropylpalmitat, Palmitinsäure-Isopropylester Isopropyl palmitate, palmitic acid isopropyl ester
• KAKAO-BUTTER • COCOA BUTTER
• MACADAMIA INTEGRIFOLIA SEED OIL • MACADAMIA INTEGRIFOLIA SEED OIL
Macadamia; Macadamianuss, echte; Macadamianussöl Macadamia; Macadamia nut, genuine; macadamia nut oil
• MACADAMIA TERNIFOLIA SEED OIL • MACADAMIA TERNIFOLIA SEED OIL
Macadamia, dreiblättrige; Macadamianussöl Macadamia, trifoliate; macadamia nut oil
• OCTYLDODECANOL 2-Octyldodecan-1 -ol • OCTYLDODECANOL 2-octyldodecane-1-ol
• PARAFFIN • PARAFFIN
Hartparaffin, Mikrokristallines Wachs, Ozokerit, Ceresin, Vaselin Hard paraffin, microcrystalline wax, ozokerite, ceresin, vaseline
• PARAFFINUM LIQUIDUM • PARAFFINUM LIQUIDUM
Flüssiges Paraffin, Paraffinöl, Mineralöl Liquid paraffin, paraffin oil, mineral oil
• PERSEA GRATISSIMA OIL • PERSEA GRATISSIMA OIL
Avocado; Avocadoöl Avocado; avocado oil
• SHEA-BUTTER • SHEA BUTTER
• SIMMONDSIA CHINENSIS SEED OIL • SIMMONDSIA CHINENSIS SEED OIL
Jojobastrauch; Jojobaöl Jojoba; jojoba oil
• STEARIC ACID • STEARIC ACID
n-Octadecansäure, Octadecansäure, Stearinsäure n-octadecanoic acid, octadecanoic acid, stearic acid
Duft- und/oder Aromastoffe Fragrances and / or flavorings
Ätherische Öle, Aromen, Duftstoffe und Parfüms: Essential oils, flavors, fragrances and perfumes:
Ätherische Öle sind flüchtige, intensiv riechende Stoffgemische von ölartiger Konsistenz, die in Wasser schwer löslich sind. Sie werden in der Regel aus pflanzlichen Ausgangsstoffen durch Wasserdampfdestillation gewonnen. Sie können ebenfalls durch Synthese, Extraktion oder durch Auspressen gewonnen werden. Auch pflanzliche Reinstoffe wie Menthol, Cineol, Vanillin und/oder Thymol werden als ätherische Öle bezeichnet. In der Medizin werden sie je nach Öl zur Behandlung zahlreicher Beschwerden verwendet, u. a. bei Muskel- und Gelenkschmerzen, bei Infektionskrankheiten, Erkältungen und Beschwerden im Magen-Darm- Trakt. Des Weiteren werden sie in der Kosmetik vor allem zur Parfümierung eingesetzt. Essential oils are volatile, intense-smelling mixtures of oily consistency that are sparingly soluble in water. They are usually obtained from vegetable raw materials by steam distillation. They can also be obtained by synthesis, extraction or by squeezing. Herbal substances such as menthol, cineole, vanillin and / or thymol are also referred to as essential oils. In medicine, they are used depending on the oil for the treatment of numerous complaints, u. a. Muscle and joint pain, infectious diseases, colds and discomfort in the gastrointestinal tract. Furthermore, they are used in cosmetics especially for perfuming.
Aromen sind Erzeugnisse, die beispielsweise Lebensmitteln zugesetzt werden, um ihnen einen besonderen Geruch und/oder Geschmack zu verleihen. Ein Aroma kann aus zahlreichen Aromastoffen, Aromaextrakten, thermisch gewonnenen Reaktionsaromen, Raucharomen und/oder Aromavorstufen bestehen. Die meisten Aromen werden industriell bei der Lebensmittelherstellung eingesetzt, einige Aromen sind ebenfalls im Einzelhandel erhältlich. Aromastoffe sind chemisch definierte Stoffe mit Geschmack gebenden Eigenschaften (Aromaeigenschaften), die zur Herstellung von Aromen eingesetzt werden. Man unterscheidet natürliche, naturidentische und/oder künstliche Aromastoffe. Flavors are products that are added to foods, for example, to give them a special smell and / or taste. An aroma can consist of numerous flavors, aroma extracts, thermally derived reaction aromas, smoke flavors and / or aroma precursors. Most flavors are used industrially in food production, and some flavors are also available in retail stores. Flavorings are chemically defined substances with taste-giving properties (aroma properties), which are used for the production of flavors. There are different natural, nature-identical and / or artificial flavorings.
In der Kosmetik verwendete Duftstoffe sind zum einen organische Verbindungen aus dem Tier- und Pflanzenreich. Des Weiteren sind Duftstoffe Verbindungen, die synthetisch hergestellt werden können. Zweck der Duftstoffe in kosmetischen Erzeugnissen ist es, den Eigengeruch eines Präparates zu maskieren und weiterhin angenehme Empfindungen beim Verbraucher auszulösen. Parfüms im engeren Sinn sind Duftstoffe und Duftmischungen, die den Körpergeruch verändern oder überdecken sollen. On the one hand, fragrances used in cosmetics are organic compounds from the animal and plant kingdoms. Furthermore, fragrances are compounds that are synthetic can be produced. The purpose of the fragrances in cosmetic products is to mask the odor of a drug and continue to trigger pleasant sensations in the consumer. Perfumes in the narrower sense are fragrances and fragrance mixtures that are supposed to change or mask the body odor.
Die nachstehende Liste der Ätherischen Öle, Aromen, Duftstoffe und Parfüms ist beispielhaft und nicht vollständig aufgelistet. Der Fachmann kann auf Grund seines allgemeinen Fachwissens ohne weiteres, weitere mögliche Ätherischen Öle, Aromen und/oder Duftstoffe und/oder Parfüm benennen. The following list of essential oils, flavors, fragrances and perfumes is exemplary and not fully listed. The person skilled in the art, on the basis of his general knowledge, can easily name further possible essential oils, flavors and / or fragrances and / or perfume.
Ätherische Öle: Essential oils:
• CAMPHOR • CAMPHOR
Kampfer Fighter
• CINNAMOMUM ZEYLANICUM LEAF OIL • CINNAMOMUM ZEYLANICUM LEAF OIL
Ceylon-Zimtbaum; Zimtlorbeerbaum Cinnamomum verum; Zimtlorbeerbaum
• CITRUS LIMON PEEL OIL • CITRUS LIMON PEEL OIL
Zitronenbaum; Zitrone Lemon Tree; lemon
• EUCALYPTOL • EUCALYPTOL
Eucalyptol; 3,3-Trimethyl-2-oxabicyclo[2.2.2]octan, 1 ,8-Cineol eucalyptol; 3,3-trimethyl-2-oxabicyclo [2.2.2] octane, 1,8-cineole
• JASMINUM OFFICINALE FLOWER EXTRACT • JASMINUM OFFICINAL FLOWER EXTRACT
Jasmin jasmine
• LAVANDULA ANGUSTIFOLIA OIL • LAVANDULA ANGUSTIFOLIA OIL
Lavendel, echter Lavender, real
• MANDELÖL (Sweet Almond oil) • ALMOND OIL (Sweet Almond oil)
• MENTHOL • MENTHOL
Menthol; 5-Methyl-2-(1 -methylethyl)cyclohexanol Menthol; 5-methyl-2- (1-methylethyl) cyclohexanol
• PINUS SYLVESTRIS LEAF OIL • PINUS SYLVESTRIS LEAF OIL
Kiefer, gemeine Pine, mean
• VANILLIN • VANILLIN
Vanillin vanillin
Aromastoffe flavorings
• AROMA • AROMA
Aromastoff, Aromenmischung Flavoring, Flavor Blend
• MENTHOL Menthol; 5-Methyl-2-(1-methylethyl)cyclohexanol • MENTHOL Menthol; 5-methyl-2- (1-methylethyl) cyclohexanol
• VANILLIN • VANILLIN
Vanillin vanillin
Parfüms und/oder Duftstoffe Perfumes and / or fragrances
• ANISE ALCOHOL • ANISE ALCOHOL
Anisalkohol; Anisylalkohol, 4-Methoxybenzylalkohol anisalcohol; Anisyl alcohol, 4-methoxybenzyl alcohol
• BENZYL ALCOHOL • BENZYL ALCOHOL
Benzylalkohol; Phenylmethanol benzyl alcohol; phenylmethanol
• CINNAMOMUM ZEYLANICUM LEAF OIL • CINNAMOMUM ZEYLANICUM LEAF OIL
Zimtbaum; Zimtlorbeerbaum cinnamon; Zimtlorbeerbaum
• CITRUS LIMON PEEL OIL • CITRUS LIMON PEEL OIL
Zitronenbaum; Zitrone Lemon Tree; lemon
• EUCALYPTOL • EUCALYPTOL
Eucalyptol; 3,3-Trimethyl-2-oxabicyclo[2.2.2]octan, 1 ,8-Cineol eucalyptol; 3,3-trimethyl-2-oxabicyclo [2.2.2] octane, 1,8-cineole
• JASMINUM OFFICINALE FLOWER EXTRACT • JASMINUM OFFICINAL FLOWER EXTRACT
Jasmin jasmine
• METHYL PHENYLBUTANOL • METHYL PHENYLBUTANOL
2-Methyl-4-phenylbutan-2-ol 2-methyl-4-phenyl-butan-2-ol
• OCTYLDODECANOL • OCTYLDODECANOL
2-Octyldodecan-1 -ol 2-octyldodecane-1-ol
• PARFÜM • PERFUME
Parfüms, Duftstoffe und Duftstoffmischungen Perfumes, fragrances and perfume mixtures
• ROSA INDICA FLOWER EXTRACT • PINK INDICA FLOWER EXTRACT
Teerose tea rose
• ROSA CENTIFOLIA • PINK CENTIFOLIA
Rosenwasser Rose water
• LIMONENE • LIMONENE
Limonen, Carven, p-Mentha-1 ,8-dien, 1-Methyl-4-prop-1-en-2-yl-cyclohexen, 1-Methyl- 4-isopropenyl-1 -cyclohexen Limonene, carven, p-mentha-1, 8-diene, 1-methyl-4-prop-1-en-2-ylcyclohexene, 1-methyl-4-isopropenyl-1-cyclohexene
Moisturizer/Feuchtigkeitsspender: Moisturizer / moisturizer:
• ALOE BARBADENSIS LEAF JUICE • ALOE BARBADENSIS LEAF JUICE
Aloe Vera; Gel/Saft Aloe vera; Gel / Juice
• ALOE BARBADENSIS LEAF JUICE POWDER Aloe Vera • ALOE BARBADENSIS LEAF JUICE POWDER Aloe vera
• Collagen • collages
• GLYCERIN • GLYCERINE
Glycerin glycerin
• HYALURONIC ACID • HYALURONIC ACID
Hyaluronsäure hyaluronic acid
• LACTIC ACID • LACTIC ACID
Milchsäure; 2-Hydroxypropionsäure, 2-Hydroxypropansäure Lactic acid; 2-hydroxypropionic acid, 2-hydroxypropanoic acid
• SODIUM HYALURONATE • SODIUM HYALURONATES
Natriumhyaluronat (Natriumsalz der Hyaluronsäure) Sodium hyaluronate (sodium salt of hyaluronic acid)
• SODIUM LACTATE • SODIUM LACTATE
Natriumlactat (Natriumsalz der Milchsäure) Sodium lactate (sodium salt of lactic acid)
• UREA • UREA
Harnstoff urea
• ALGAE (Algen) • ALGAE (algae)
• ECHINACEA PURPUREA EXTRACT • ECHINACEA PURPUREA EXTRACT
Wirkstoffe für die Hautpflege: Active ingredients for skin care:
• ALLANTOIN • ALLANTOIN
Glyoxylsäurediureid, 5-Ureidohydantoin, N-(2,5-Dioxo-4-imidazolidinyl)harnstoff Glyoxylic acid diureide, 5-ureidohydantoin, N- (2,5-dioxo-4-imidazolidinyl) urea
• ALOE BARBADENSIS LEAF JUICE • ALOE BARBADENSIS LEAF JUICE
Aloe Vera; Gel/Saft Aloe vera; Gel / Juice
• ASCORBIC ACID • ASCORBIC ACID
Vitamin C, Ascorbinsäure Vitamin C, ascorbic acid
• BISABOLOL • BISABOLOL
alpha-Bisabolol, ®-6-Methyl-2-(®-4-methylcyclohex-3-enyl)hept-5-en-2-ol alpha-bisabolol, ®-6-methyl-2- (®-4-methylcyclohex-3-enyl) hept-5-en-2-ol
• C12-15 ALKYL BENZOATE • C12-15 ALKYL BENZOATE
Ester aus Benzoesäure und Fettalkoholen der Kettenlänge C12 bis C15 Esters of benzoic acid and fatty alcohols of chain length C12 to C15
• CAPRYLIC/CAPRIC TRIGLYCERIDE • CAPRYLIC / CAPRIC TRIGLYCERIDE
Veresterungsprodukt von Glycerin mit Caprinsäure und Caprylsäure (1 :3) Esterification product of glycerol with capric acid and caprylic acid (1: 3)
• CHAMOMILLA RECUTITA FLOWER EXTRACT • CHAMOMILLA RECUTITA FLOWER EXTRACT
Kamille, echte Chamomile, real
• DECYL OLEATE • DECYL OLEATE
Decyloleat; Veresterungsprodukt von Ölsäure mit Decylalkohol oleate; Esterification product of oleic acid with decyl alcohol
• DIETHYLHEXYL SYRINGYLIDENEMALONATE [(4-Hydroxy-3,5-dimethoxyphenyl)methylen]-Propandisäure, Bis(2-ethylhexyl)ester• DIETHYLHEXYL SYRINGYLIDENE MONALATE [(4-Hydroxy-3,5-dimethoxyphenyl) methylene] -propanedioic acid, bis (2-ethylhexyl) ester
• ETHYLHEXYL COCOATE • ETHYLHEXYL COCOATE
Veresterungsprodukt aus 2-Ethylhexanol und Kokosfettsäuren Esterification product of 2-ethylhexanol and coconut fatty acids
• ETHYLHEXYL STEARATE • ETHYLHEXYL STEARATE
Stearinsäure-2-ethylhexylester Stearic acid 2-ethylhexyl
• ETHYLHEXYLGLYCERIN • ETHYLHEXYLGLYCERINE
Ethylhexylglycerin; 3-(2-Ethylhexyloxy)-1 ,2-propandiol Ethylhexylglycerin; 3- (2-ethylhexyloxy) -1,2-propanediol
FAGUS SILVATICA (Buche) FAGUS SILVATICA (beech)
HYALURONIC ACID HYALURONIC ACID
Hyaluronsäure hyaluronic acid
NIACINAMIDE Niacinamide
Niacinamid, 3-Pyridincarboxamid, Pyridin-3-carbonsäureamid, Nicotinsäureamid, Nicotinamid Niacinamide, 3-pyridinecarboxamide, pyridine-3-carboxylic acid amide, nicotinic acid amide, nicotinamide
PANTHENOL Panthenol
Dexpanthenol, Provitamin B5 Dexpanthenol, provitamin B5
PERSEA GRATISSIMA OIL PERSEA GRATISSIMA OIL
Avocado; Avocadoöl Avocado; avocado oil
PPG-15 STEARYL ETHER PPG-15 STEARYL ETHER
Stearylalkohol, verethert mit Polypropylenglycol (durchschnittlich 15 Einheiten Propylenglycol) Stearyl alcohol, etherified with polypropylene glycol (average 15 units of propylene glycol)
PROPYLHEPTYL CAPRYLATE PROPYLHEPTYL CAPRYLATE
Veresterungsprodukt von 2-Propylheptanol mit Caprylsäure Esterification product of 2-propylheptanol with caprylic acid
SIMMONDSIA CHINENSIS SEED OIL SIMMONDSIA CHINENSIS SEED OIL
Jojobastrauch; Jojobaöl Jojoba; jojoba oil
SODIUM HYALURONATE SODIUM HYALURONATES
Natriumhyaluronat (Natriumsalz der Hyaluronsäure) Sodium hyaluronate (sodium salt of hyaluronic acid)
STEARYL DIMETHICONE STEARYL DIMETHICONE
Poly(dimethyl-methylstearyl)siloxan Poly (dimethyl-methylstearyl) siloxane
SUCROSE LAURATE SUCROSE LAURATE
Veresterungsprodukt von Laurinsäure mit Saccharose (Rohrzucker) Esterification product of lauric acid with sucrose (cane sugar)
TOCOPHEROL TOCOPHEROL
alpha-Tocopherol, Vitamin E alpha-tocopherol, vitamin E
UBIQUINONE Q10, UBIQUINONE Q10,
Coenzym Q10; Ubichinon-10 Coenzyme Q10; Coenzyme Q10
HELIANTHUS ANNUUS HYBRID OIL • ECHIUM PLANTAGINEUM SEED OIL HELIANTHUS ANNUUS HYBRID OIL • ECHIUM PLANTAGINEUM SEED OIL
• CARDIOSPERMUM HALICACABUM FLOWER/LEAF/VINE EXTRACT • CARDIOSPERMUM HALICACABUM FLOWER / LEAF / VINE EXTRACT
• RUTIN • RUTIN
• ARGININE • ARGININE
Desodorierende Wirkstoffe: Deodorising agents:
• FARNESOL • FARNESOL
Farnesol, 3,7, 11 -T rimethyl-2,6, 10-dodecatrien-1 -ol Farnesol, 3,7, 11-trimethyl-2,6,10-dodecatriene-1-ol
• PARFÜM • PERFUME
Parfüm; Duftstoffe und Duftstoffmischungen Perfume; Perfumes and perfume mixtures
• TRICLOSAN • TRICLOSAN
T riclosan, 5-Chlor-2-(2,4-dichlorphenoxy)phenol Triclosan, 5-chloro-2- (2,4-dichlorophenoxy) phenol
• TRI ETHYL CITRATE • TRI ETHYL CITRATE
T riethylcitrat; Citronensäure-T riethylester Triethyl citrate; Citric acid triethyl ester
• ZINC LACTATE • ZINC LACTATE
Zinklactat (Zinksalz der Milchsäure) Zinc lactate (zinc salt of lactic acid)
• ZINC RICINOLEATE • ZINC RICINOLEATE
Zinkricinoleat ricinoleate
Lösungsmittel: Solvent:
• 1 ,2-HEXANEDIOL • 1, 2-HEXANEDIOL
1.2-Hexandiol; 1 ,2-Dihydroxyhexan 1.2-hexanediol; 1, 2-dihydroxyhexane
• ACETONE • ACETONE
Aceton, Propanon Acetone, propanone
• ALCOHOL • ALCOHOL
Alkohol, Ethanol, Äthanol, Äthylalkohol Alcohol, ethanol, ethanol, ethyl alcohol
• ALCOHOL DENAT • ALCOHOL DENAT
vergällter Alkohol, denaturierter Alkohol denatured alcohol, denatured alcohol
• AQUA • AQUA
Wasser water
• BUTYL ACETATE • BUTYL ACETATE
Butylacetat, Essigsäurebutylester Butyl acetate, butyl acetate
• BUTYLENE GLYCOL • BUTYLENE GLYCOL
1.3-Butandiol, Butylenglykol 1,3-butanediol, butylene glycol
• CYCLOPENTASILOXANE Decamethylcyclopentasiloxan • CYCLOPENTASILOXANE decamethylcyclopentasiloxane
• ETHYL ACETATE • ETHYL ACETATE
Ethylacetat, Essigsäureethylester Ethyl acetate, ethyl acetate
• GLYCERIN • GLYCERINE
Glycerin, Glycerol, 1 ,2,3-Propantriol Glycerol, glycerol, 1,2,3-propanetriol
• GLYCOL • GLYCOL
Glykol, Ethylenglycol, Ethylenglykol Glycol, ethylene glycol, ethylene glycol
• ISOPROPYL ALCOHOL • ISOPROPYL ALCOHOL
Isopropylalkohol, Isopropanol, 2-Propanol Isopropyl alcohol, isopropanol, 2-propanol
• METHYLPROPANEDIOL • METHYLPROPANEDIOL
2-Methyl-1 ,3-propandiol 2-methyl-1,3-propanediol
• PROPYLENE GLYCOL • PROPYLENE GLYCOL
1 ,2-Propandiol, Propylenglykol 1, 2-propanediol, propylene glycol
• ECHIUM PLANTAGINEUM SEED OIL • ECHIUM PLANTAGINEUM SEED OIL
Filmbildner: film formers:
• ACRYLATES COPOLYMER • ACRYLATES COPOLYMER
Polymer aus Methacrylsäure, Ethylacrylat und Methylmethacrylat Polymer of methacrylic acid, ethyl acrylate and methyl methacrylate
• ACRYLATES/HYDROXYESTERS ACRYLATES COPOLYMER • ACRYLATES / HYDROXYESTERS ACRYLATES COPOLYMER
Copolymer aus Acrylsäure/Methacrylsäure und deren Estern sowie Hydroxyacrylsäureestern Copolymer of acrylic acid / methacrylic acid and its esters and hydroxyacrylates
• ACRYLATES/STEARETH-20 METHACRYLATE CROSSPOLYMER • ACRYLATES / STEARETH-20 METHACRYLATE CROSPOLYMER
Copolymer aus Steareth-20-Methacrylat und Acrylsäure/Methacrylsäure und deren Estern, kreuzverknüpft mit Pentaerythritol-Allylether. Steareth-20-Methacrylat ist ein Ester der Methacrylsäure mit Polyethylenglycol (durchschn. 20 Einheiten -CH2-CH2-O-) Copolymer of steareth-20-methacrylate and acrylic acid / methacrylic acid and their esters cross-linked with pentaerythritol allyl ether. Steareth-20-methacrylate is an ester of methacrylic acid with polyethylene glycol (avg. 20 units -CH 2 -CH 2 -O-)
• DIBUTYL SEBACATE • DIBUTYL SEBACATE
Dibutylsebacat, Sebacinsäuredibutylester Dibutyl sebacate, Sebacic acid dibutyl ester
• NITROCELLULOSE • NITROCELLULOSE
Nitrocellulose, Cellulosenitrat, Schießbaumwolle Nitrocellulose, cellulose nitrate, gun cotton
• PVP • PVP
Polyvinylpyrrolidon polyvinylpyrrolidone
• SODIUM CARBOMER • SODIUM CARBOMER
Polyacrylsäure (Natriumsalze) Polyacrylic acid (sodium salts)
• TOSYLAMI DE/FORMALDEHYDE RESIN • TOSYLAMI DE / FORMALDEHYDE RESIN
T oluolsulfonamid-Formaldehydharz • PHTHALIC ANHYDRIDE/TRIMELLITIC ANHYDRIDE/GLYCOLS COPOLYMER T ololsulphonamide-formaldehyde resin • PHTHALIC ANHYDRIDE / TRIMELLITIC ANHYDRIDE / GLYCOLS COPOLYMER
Gelbildner: gelling agent:
• AGAR • AGAR
Agar, Agar-Agar Agar, agar-agar
• ALGIN • ALGIN
Natriumalginat (Natriumsalz der Alginsäure) Sodium alginate (sodium salt of alginic acid)
• ALGINIC ACID • ALGINIC ACID
Alginsäure alginic acid
• CARBOMER • CARBOMER
Polyacrylsäure polyacrylic acid
• CARRAGEENAN • CARRAGEENAN
Moos, irländisches; Carrageen Moss, Irish; carrageenan
• HECTORITE • HECTORITE
Hectorit (Tonmineral) Hectorite (clay mineral)
• HYDROXYETHYLCELLULOSE • HYDROXYETHYL CELLULOSE
Hydroxyethylcellulose hydroxyethyl
• HYDROXYPROPYLCELLULOSE • HYDROXYPROPYLCELLULOSE
Hydroxypropylcellulose hydroxypropyl
• POLYVINYL ALCOHOL • POLYVINYL ALCOHOL
Polyvinylalkohol polyvinyl alcohol
• PVP • PVP
Polyvinylpyrrolidon polyvinylpyrrolidone
• SODIUM CARBOMER • SODIUM CARBOMER
Polyacrylsäure (Natriumsalze) Polyacrylic acid (sodium salts)
• STEARALKONIUM HECTORITE • STEARAL KONG HECTORITE
Gerbstoffe, Gerbmitten und/oder Gerbextrakte: Tanning agents, tanning agents and / or tannin extracts:
Es wird zwischen Gerbstoffen, Gerbmitteln und/oder Gerbextrakten unterschieden. Gerbstoffe sind chemische Stoffe, die zum Gerben von Tierhäuten verwendet werden. Durch die Behandlung mit Gerbstoffen werden die Tierhäute in Leder umgewandelt, was unter anderem die Fäulnis verhindert. Des Weiteren gibt es in der Natur vorkommende, also natürliche, sowie künstlich hergestellte, also synthetische Gerbstoffe. Gerbmittel sind Pflanzenteile und/oder Stoffgemische, die einen und/oder mehrere Gerbstoffe enthalten. Die Begriffe Gerbstoff und/oder Gerbmittel werden oft als Synonyme verwendet. Ein Gerbextrakt ist ein Extrakt eines Gerbmittels. Nach der Extraktion liegt der Gerbstoff in höherer Konzentration vor, ohne eventuell störende Bestandteile des Ausgangsmaterials. Pflanzliche Gerbstoffe, auch Tannine genannt, werden auch in der Medizin verwendet. Des Weiteren sind Tannine als Geschmackskomponenten von Wein und Tee bekannt. There is a distinction between tannins, tannins and / or tannin extracts. Tannins are chemicals used to tan animal skins. By treating with tannins the animal skins are converted into leather, which among other things prevents the rot. Furthermore, there are naturally occurring, ie natural, as well as artificially produced, ie synthetic tannins. Tanning agents are plant parts and / or mixtures containing one and / or more tannins. The terms tanning agent and / or tanning agent are often used as synonyms. A tannin extract is an extract of a Tanning agent. After extraction, the tanning agent is in a higher concentration, without any interfering constituents of the starting material. Vegetable tannins, also called tannins, are also used in medicine. Furthermore, tannins are known as taste components of wine and tea.
Beispiele geeigneter Gerbstoffe: Examples of suitable tannins:
• Gallotannine • Gallotannins
• Pyrocatechine • catechols
• Catechin • Catechin
• Mineralgerbstoffe, • mineral tannins,
• Aldehyde, • aldehydes,
• Aliphatische Paraffinsulfochloride, • aliphatic paraffin sulphochlorides,
• synthetische Gerbstoffe (Syntane) auf Basis von Phenolderivaten, • Synthetic tanning agents (Syntans) based on phenol derivatives,
• Polymer-Gerbstoffe (Harzgerbstoffe) • polymer tanning agents (resin tanning agents)
Bitterstoffe: Bitter substances:
Bitterstoffe bezeichnen alle chemischen Verbindungen, die einen bitteren Geschmack aufweisen. Sie sind keine chemisch einheitliche Gruppe, sondern zeichnen sich nur dadurch aus, dass sie bitter schmecken. Die nachstehenden Bitterstoffe sind nur beispielhaft und nicht vollständig aufgelistet. Der Fachmann kann auf Grund seines allgemeinen Fachwissens ohne weiteres, weitere mögliche Bitterstoffe benennen. Bittern refers to all chemical compounds that have a bitter taste. They are not a chemically unified group, but are characterized only by the fact that they taste bitter. The following bitter substances are only exemplary and not fully listed. The person skilled in the art, on the basis of his general knowledge, can easily name other possible bitter substances.
Beispiele geeigneter Bitterstoffe: Examples of suitable bitter substances:
• Lactucopikrin kommt in der Gemeinen Wegwarte und allen Lattichen vor. • Lactucopikrin occurs in the common chicory and all lattices.
• Cynarin kommt in Artischocken vor. • Cynarin is found in artichokes.
• Glucosinolate kommen im Rüböl vor. • Glucosinolates occur in rapeseed oil.
• Lactucin kommt in Eisbergsalat vor. • Lactucin occurs in iceberg lettuce.
• Prämarrubiin und Marrubiin • premarubiin and marrubiin
• Naringin in Grapefruits und Pomelos • Naringin in grapefruit and pomelos
Farbpigmente: Color pigments:
Farbstoffe, Buntpigmente, Weißpigmente, fluoreszierende Pigmente und phosphoreszierende Pigmente (Phosphor) können auf unterschiedlichste Weise den erfindungsgemäßen topischen Zubereitungen hinzugefügt werden. Bevorzugt wird Kreide, Talkum, Montmorillonit, Tonmineralien, Papiere, papierähnliche Materialien und/oder Titandioxid, auch schwarzes Titandioxid. Dyes, colored pigments, white pigments, fluorescent pigments and phosphorescent pigments (phosphorus) can be added in many different ways to the topical preparations according to the invention. Preference is given to chalk, talc, montmorillonite, Clay minerals, papers, paper-like materials and / or titanium dioxide, also black titanium dioxide.
Pflanzenextrakte: Plant extracts:
Pflanzenextrakte sind Extrakte aus Pflanzen die in der Kosmetik eingesetzt werden. Die nachstehende Liste der Pflanzenextrakte ist beispielhaft und nicht vollständig. Der Fachmann kann ohne weiteres, weitere mögliche Pflanzenextrakte benennen. Plant extracts are extracts of plants used in cosmetics. The following list of plant extracts is exemplary and not exhaustive. The person skilled in the art can easily name further possible plant extracts.
Beispiele geeigneter Pfianzenextrakte: Examples of suitable Pfianzenxtrakte:
• African Copal Rinden CC>2-se Extrakt • African Copal bark CC> 2-se extract
• Angelikawurzel CC se Extrakt • Angelica root CC se extract
• Antimikrobieller Blend • Antimicrobial blend
• Arnikablüten C02-to Extrakt, 4 % Sesquiterpenlaktone • Arnica flowers C0 2 -to extract, 4% sesquiterpenlactones
• Bartflechten CÜ2-to Extrakt, wasserdispergierbar, 4 % Usninsäuren • Beard lichen CÜ2-to extract, water-dispersible, 4% usnic acids
• Borretschsamen C02-to Extrakt • Borage C0 2 -to extract
• Butter CC>2-se Extrakt, Dest. Typ • Butter CC> 2-se Extract, Dest. Type
• Butter CC>2-se Extrakt, Krist. Typ • Butter CC> 2-se extract, Krist. Type
• Chili CC>2-to Extrakt, 10 % Capsaicinoide • Chili CC> 2-to extract, 10% capsaicinoids
• Chili C02-to Extrakt, 5 % Capsaicinoide • Chili C0 2 -to extract, 5% capsaicinoids
• Curcuma Xanthorrhiza CC>2-se Extrakt • Curcuma Xanthorrhiza CC> 2-se extract
• Dillsamen C02-se Extrakt, Carvon Typ • Dill Seed C0 2 -se extract, carvone type
• Dillsamen CC>2-se Extrakt, Dillapiol Typ • Dill Seed CC> 2-Se Extract, Dillapiol Type
• Erdnuß CC>2-se Extrakt • Peanut CC> 2-se extract
• Fenchel C02-se Extrakt, Bitterer Typ • Fennel C0 2 -se Extract, Bitter Type
• Flavoxan 14, Rosmarin Antioxidans Formulierung • Flavoxan 14, rosemary antioxidant formulation
Schauminhibitoren und Entschäumer: Foam inhibitors and defoamers:
• Silikonöle mit Kieselsäurepartikel • Silicone oils with silica particles
• Mono- und Diglyceride von Speisefettsäuren • mono and diglycerides of fatty acids
• Polydimethylsiloxan (Simethicone®, E900) Polydimethylsiloxane (Simethicone®, E900)
• Tri-n-butylphosphat • Tri-n-butyl phosphate
• Tri-isobutylphosphat • tri-isobutyl phosphate
• Thermooxidiertes Sojaöl mit MDG (Mono- und Diglyceride) verestert Beispiele für weitere geeignete Inhaltsstoffe (E) für die erfindungsgemäßen topischen Zubereitungen sind aus der amerikanischen Patentanmeldung US 2012/0258150 A1 , Seiten 4 bis 6, TABLE 1 , Seite 7, Absatz [0071], bis Seite 9, Absatz [00 88] Ende, • Thermooxidized soybean oil esterified with MDG (mono- and diglycerides) Examples of further suitable ingredients (E) for the topical preparations according to the invention are described in the US patent application US 2012/0258150 A1, pages 4 to 6, TABLE 1, page 7, paragraph [0071], to page 9, paragraph [00 88] end .
- der deutschen Patentanmeldung DE 10 2012 214 622 A1 , Seite 4, Absatz [0016], bis Seite 16, Absatz [0039], sowie aus - German Patent Application DE 10 2012 214 622 A1, page 4, paragraph [0016], to page 16, paragraph [0039], as well as from
dem europäischen Patent EP 1 235 546 B1 , Seite 7, Absatz [0016], bis Seite 9, Absatz [0025] Ende, Seite 9, Absätze [0027] bis [0030], Seite 9, Absatz [0033], bis Seite 14, [0055], bekannt. European Patent EP 1 235 546 B1, page 7, paragraph [0016], to page 9, paragraph [0025] end, page 9, paragraphs [0027] to [0030], page 9, paragraph [0033], to page 14 , [0055], known.
Die erfindungsgemäßen topischen Zubereitungen können übliche und bekannte ionische und/oder nicht ionische Tenside als Inhaltsstoffe (E) enthalten (vgl. Römpp Lexikon Lacke und Druckfarben, Georg Thieme Verlag, Stuttgart, 1998, Stichwort »Tenside«). Es ist indes ein besonderer Vorteil der erfindungsgemäßen topischen Zubereitungen, dass sie in den allermeisten Fällen ohne Tenside, insbesondere ohne ionische Tenside, auskommen. The topical preparations according to the invention may contain customary and known ionic and / or nonionic surfactants as ingredients (E) (cf., Rompp Lexikon Lacke and Druckfarben, Georg Thieme Verlag, Stuttgart, 1998, keyword "surfactants"). However, it is a particular advantage of the topical preparations according to the invention that in the vast majority of cases they manage without surfactants, in particular without ionic surfactants.
Der Anteil der Inhaltsstoffe (E) an den erfindungsgemäßen topischen Zubereitungen kann sehr breit variieren und so hervorragend dem jeweiligen Verwendungszweck angepasst werden. Vorzugsweise enthält eine gegebene topische Zubereitung, bezogen auf ihre Gesamtmenge, 0,01 Gew.-% bis 70 Gew.-%, bevorzugt 0,01 Gew.-% bis 60 Gew.-% und insbesondere 0,01 Gew.-% 50 Gew.-% an Inhaltsstoffen (E). The proportion of the ingredients (E) in the topical preparations according to the invention can vary very widely and are thus perfectly adapted to the respective intended use. Preferably, a given topical preparation contains, based on its total amount, from 0.01% to 70%, preferably from 0.01% to 60%, and most preferably 0.01%, by weight % By weight of ingredients (E).
Vorzugsweise haben die erfindungsgemäßen topischen Zubereitungen einen pH-Wert zwischen 3 und 7, bevorzugt zwischen 4,5 - 6,5 und insbesondere zwischen 5 - 5,5, insbesondere um den Säureschutz der Haut nicht zu schädigen. In speziellen Fällen können die erfindungsgemäßen topischen Zubereitungen auch einen pH-Wert >7 aufweisen. The topical preparations according to the invention preferably have a pH of between 3 and 7, preferably between 4.5 and 6.5 and in particular between 5 and 5.5, in particular in order not to damage the acidity of the skin. In special cases, the topical preparations according to the invention may also have a pH of> 7.
Die erfindungsgemäßen topischen Zubereitungen liegen vorzugsweise als Pulver, Festkörper, Granulate, Gele, Cremes, Salben, Lotionen, Tropfen, Sprays, Dosieraerosole Gurgellösungen, Lutschtabletten, Einläufe, Klistiere, und Beschichtungen auf und Bestandteile von Toilettenutensilien, textilen Geweben, Gesichtsmasken, Umschlägen, Binden, Tampons, Verbandsmull, Pflastern, medizinischen Geräten und Releasematerialien vor. Diese Aufzählung ist nur beispielhaft und nicht abschließend und es kommen, insbesondere für spezielle Anwendungen, noch andere Darreichungsformen in Betracht. The topical preparations according to the invention are preferably in the form of powders, solids, granules, gels, creams, ointments, lotions, drops, sprays, metered aerosols, gargles, lozenges, enemas, enemas, and coatings on and components of toilet utensils, textile fabrics, face masks, envelopes, sanitary napkins , Tampons, gauze, plasters, medical devices and release materials. These Enumeration is only an example and not exhaustive and there are, in particular for special applications, still other dosage forms into consideration.
Die erfindungsgemäßen topischen Zubereitungen werden vorzugsweise nach dem erfindungsgemäßen Verfahren hergestellt. Dabei werden mindestens einen Typ von Partikeln (A) mit mindestens einem Typ der Partikel (B) und/oder mindestens einem Typ der Partikeln (C) miteinander vermischt und die resultierende Mischung homogenisiert. Anschließend wird die resultierende homogenisierte Mischung (AB), (AC) oder (ABC) vorzugsweise zu Pulvern, Festkörpern, Granulaten, Gelen, Cremes, Salben, Lotionen, Tropfen, Sprays, Dosieraerosolen, Gurgellösungen, Lutschtabletten Einläufen, Klistieren, Zäpfchen oder Schäumen verarbeitet und/oder auf und/oder in textile Gewebe, Gesichtsmasken, Verbandsmull, Umschläge, Binden, Tampons, Pflaster, medizinische Geräte und/oder Releasematerialien appliziert. The topical preparations according to the invention are preferably prepared by the process according to the invention. In this case, at least one type of particles (A) with at least one type of particles (B) and / or at least one type of particles (C) are mixed together and the resulting mixture homogenized. Subsequently, the resulting homogenized mixture (AB), (AC) or (ABC) is preferably processed into powders, solids, granules, gels, creams, ointments, lotions, drops, sprays, metered aerosols, gargles, lozenges, enema, suppositories or foams and / or applied to and / or in textile fabrics, face masks, gauze, envelopes, bandages, tampons, plasters, medical devices and / or release materials.
In einer bevorzugten Ausführungsform werden mindestens einen Typ von Partikeln (A) mit mindestens einem Typ von Partikeln (B) und/oder mindestens einem Typ von Partikeln (C), mindestens einem Polyoxometallat (D) und/oder mindestens einem Inhaltsstoff (E) miteinander vermischt und die resultierende Mischung (ABC), (ABD), (ABE), (ACD), (ACE), (ADE), (ABCD), (ABCE) oder (ABCDE) homogenisiert, wonach die homogenisierte Mischung, wie vorstehend beschrieben, verarbeitet wird. In a preferred embodiment, at least one type of particle (A) is associated with at least one type of particle (B) and / or at least one type of particle (C), at least one polyoxometalate (D) and / or at least one ingredient (E) and homogenize the resulting mixture (ABC), (ABD), (ABE), (ACD), (ACE), (ADE), (ABCD), (ABCE) or (ABCDE), followed by the homogenized mixture as described above , is processed.
Wenn nach dem erfindungsgemäßen Verfahren wässrige erfindungsgemäße topische Zubereitungen hergestellt werden, erweist es sich als Vorteil, wenn kohlendioxidhaltiges Wasser verwendet wird, weil dadurch die Kohlenstoffpartikel (A) besser benetzt werden. Das Kohlendioxid kann dabei im Wasser gelöst vorliegen, wobei gegebenenfalls bei Überdruck gearbeitet wird, oder durch das Wasser hindurch geblasen oder geperlt wird. If aqueous topical preparations according to the invention are prepared by the process according to the invention, it proves to be an advantage if carbon dioxide-containing water is used, because in this way the carbon particles (A) are better wetted. The carbon dioxide can be present dissolved in water, which is optionally carried out at overpressure, or blown through the water or bubbled.
Für das erfindungsgemäße Verfahren werden die üblichen und bekannten Anlagen, Aggregate, Apparaturen, Dosiertechniken und Messtechniken verwendet, wie sie auf den Gebieten der Herstellung von Kosmetika, Pflegeprodukten, Pharmazeutika und medizinischen Hilfsmitteln und Geräten üblicherweise verwendet werden. The process according to the invention uses the customary and known systems, aggregates, apparatuses, metering techniques and measuring techniques commonly used in the fields of the production of cosmetics, care products, pharmaceuticals and medical aids and equipment.
Die erfindungsgemäßen topischen Zubereitungen sind vielseitig verwendbar. So können sie als Kosmetika, Pflegeprodukte und Produkte für Saunen und Dampfbäder und zur Pflege von Haut, insbesondere von Überlappungen an Brust, Bauch und Leiste, Schleimhäuten, Augen, Ohren, Mund, Lippen, Fingernägel, Zehennägel, Hornhaut, Warzen und Narben, bei Ausscheidungen von Noxen, Drogen, Toxinen, Medikamenten, Säuren, Basen und Geruchsstoffe über die Haut, bei Läsionen, Juckreiz, Intertrigo, Brennen, Infektionen und Rötungen, bei der Krebstherapie, Chemotherapie, Chondrokalzinose, Hautkrankheiten wie: Schuppenflechte, Neurodermitis, Akne, Ekzeme, atrophische Ekzeme, Warzen, Rosacea, Herpes, Gürtelrose, Masern, Mumps, Röteln, Windpocken, Hand-Mund-Fuß-Krankheiten, Hand- und Fuß-Syndrom, zum vorbeugenden Schutz, zur Unterstützung von Heilungsprozessen bei bestehenden Infektionen, Wunden oder Verbrennungen, in der dekorativen Kosmetik, in der kosmetischen Gesichtspflege, in der Haarpflege und in der Körperpflege von Mensch und Tier verwendet werden The topical preparations according to the invention are versatile in use. Thus, they can be used as cosmetics, care products and products for saunas and steam baths and for the care of skin, in particular overlaps on chest, abdomen and groin, mucous membranes, eyes, ears, mouth, lips, fingernails, toenails, cornea, warts and scars Excretions of noxa, drugs, toxins, medicines, acids, bases and odorants through the skin, lesions, itching, intertrigo, burning, infections and redness, in cancer therapy, chemotherapy, chondrocalcinosis, skin diseases such as: psoriasis, atopic dermatitis, acne, eczema , atrophic eczema, warts, rosacea, herpes, shingles, measles, mumps, rubella, chickenpox, hand-foot-and-mouth disease, hand and foot syndrome, for preventative protection, to aid in the healing of existing infections, wounds or burns , are used in the decorative cosmetics, in the cosmetic facial care, in the hair care and in the personal care of humans and animals
Vorzugsweise werden dafür die erfindungsgemäßen Produkte in der Darreichungsform von dekorativen Kosmetika, Pflegeprodukten, Produkten für Saunen und Dampfbäder, Pulvern, Festkörpern, Granulaten, Gelen, Cremes, Salben, Lotionen, Tropfen, Sprays, Dosieraerosolen, Gurgellösungen, Lutschtabletten, Einläufen, Klistieren, Zäpfchen, Schäumen und Toilettenutensilien, textilen Geweben, Gesichtsmasken, Umschläge, Binden, Tampons, Verbandsmull, Pflaster, medizinische Geräte und Releasematerialien, angewandt. Auch hier ist diese Aufzählung nicht abschließend, sondern beispielhaft. Es können, insbesondere in speziellen Fällen, auch noch andere Produktformen verwendet werden. Preferably, the products according to the invention in the dosage form of decorative cosmetics, care products, products for saunas and steam baths, powders, solids, granules, gels, creams, ointments, lotions, drops, sprays, metered aerosols, gargles, lozenges, enemas, enemas, suppositories , Foams and toilet utensils, textile fabrics, face masks, envelopes, sanitary napkins, tampons, gauze, plasters, medical devices and release materials. Again, this list is not exhaustive, but exemplary. In particular, in special cases, other product forms may also be used.
Beispielsweise können die erfindungsgemäßen Produkte in der jeweils geeigneten Darreichungsform For example, the products of the invention in the appropriate dosage form
• zur Hygiene • for hygiene
• zur Desinfektion • for disinfection
• bei Infektionsgefahr • at risk of infection
• bei Pilzinfektion, auch im Genitalbereich • in fungal infections, even in the genital area
• bei Bindehautentzündungen • in conjunctivitis
• beim Gerstenkorn • with barley grain
• bei trockenen Augen • with dry eyes
• bei Hautausschlag • with rash
• bei Juckreiz, wie z.B. Neurodermitis, Schuppenflächte, Gürtelrose usw. For itching, such as Eczema, scales, shingles, etc.
• zur Geruchsbeseitigung (wie bspw. Schweiß) • for odor removal (such as sweat)
• zur Belebung der Haut • to invigorate the skin
• zur Beruhigung der Haut • to soothe the skin
• zur Kühlung der Haut • bei geröteter, juckender, brennender oder geschwollener Haut • to cool the skin • with reddened, itchy, burning or swollen skin
• bei rissiger, spröder Haut (Schrunden) • with cracked, rough skin (Schrunden)
• zum Infektionsschutz vor Bakterien, Viren, Pilzen etc • for infection protection against bacteria, viruses, fungi etc
• nach jeder Rasur • after every shave
• nach Insektenstichen • after insect bites
• vorbeugend • preventive
• zur Unterstützung des Heilungsprozesses bei bestehenden Infektionen, Wunden oder Verbrennungen • to support the healing process of existing infections, wounds or burns
• für Schleimhäute, Augen, Ohren und Mund • for mucous membranes, eyes, ears and mouth
Als Dekorative Kosmetik As a decorative cosmetics
• als Abdeckprodukte • as cover products
• als Augen-Make-up-Produkte (sonstige) • as eye make-up products (other)
• als Eyeliner • as eyeliner
• als Kajalstift • as a kohl pencil
• als Körperfarben • as body colors
• als Lidschatten • as eye shadow
• als Lippen-Make-up-Produkte (sonstige) • as lip make-up products (other)
• als Lippenstift-Versiegelung • as a lipstick sealer
• als Lippenstifte • as lipsticks
• als Make-up • as a make-up
• als Make-up-Entferner • as a make-up remover
• als Nagel-Bleichmittel • as a nail bleach
• als Nagelhaut-Pflege/-Entferner • as a cuticle care / remover
• als Nagelhärter • as a nail hardener
• als Nagelkleber-Entferner • as nail glue remover
• als Nagellack-Entferner • as a nail polish remover
• als Nagellack-Verdünner • as a nail polish thinner
• als Nagellacke/Nagel-Make-up • as nail polish / nail make-up
• als Nagelmodelliermittel • as a nail modeling agent
• als Wimperntusche • as mascara
• als After- und Pre-Shave-Produkte • as after- and pre-shave products
• als Augenpflegeprodukte • as eye care products
• als Gesichtsmasken • as face masks
• als Gesichtspflegeprodukte • als Lippenpflegeprodukte • as facial care products • as lip care products
• als Peeling-Produkte (chemisch) • as exfoliating products (chemical)
• als Peeling-Produkte (mechanisch) • as exfoliating products (mechanical)
• als Peeling-Produkte (enzymatisch) • as exfoliating products (enzymatic)
• als Rasiermittel (Nass- und Trockenrasur) As a shaving agent (wet and dry shave)
• als Rinse-off Produkte • as rinse-off products
Zur Haarpflege For hair care
• als Antischuppen-Produkte • as anti-dandruff products
• als Bleichmittel für Körperbehaarung • as a bleaching agent for body hair
• als Dauerwell-Produkte • as permanent wave products
• als Haarbleich-/Entfärbungsmittel As a hair bleaching / decolorizing agent
• als Haarfarben (nicht oxidativ) • as hair colors (not oxidative)
• als Haarfarben (oxidativ) • as hair colors (oxidative)
• als Haarfestiger (Pflege) • as a hair conditioner (care)
• als Haarfestiger (Styling) • as a hairstylist (styling)
• Haarglättungsmittel • hair straightener
• als Haarreinigungs- und Haarpflege-Produkte (sonstige) • as hair cleansing and hair care products (other)
• als Haarstyling-Produkte (sonstige) • as hairstyling products (other)
• als Produkte gegen Haarausfall • as products against hair loss
• als Produkte zur Pflege von Kopfhaut und Haarwurzeln • as products for the care of scalp and hair roots
• als Shampoos • as shampoos
• als Sonnenschutzprodukte für das Haar • as sunscreen products for the hair
Zur Körperpflege For body care
• als Antitranspirantien • as antiperspirants
• als Bade- und Duschprodukte, wie unteranderem ein Moorbad • as bath and shower products, as well as a moor bath
• als Bleichmitel für Körperbehaarung • as a bleaching agent for body hair
• als Depilations-Produkte • as depilation products
• als Desodorantien (Deodorants) • as deodorants (deodorants)
• als Duftprodukte (sonstige) • as fragrance products (other)
• als Epilations-Produkte • as epilation products
• als Fußpflegeprodukte • as foot care products
• als Handpflegeprodukte • as hand care products
• als Hautbleichmittel • as a skin bleaching agent
• als Hautpflegeprodukte (sonstige) • als Hautreinigungsprodukte (sonstige) • as skin care products (other) • as skin cleansing products (other)
• als Intimpflegeprodukte • as personal care products
• als Körperpflegeprodukte • as personal care products
• als Nagelpflegeprodukte • as nail care products
• als Parfüms und Duftwässer • as perfumes and perfume waters
• als Peeling-Produkte (chemisch) • as exfoliating products (chemical)
• als Peeling-Produkte (mechanisch) • as exfoliating products (mechanical)
• als Pre- und Aftersun-Produkte • as pre and aftersun products
• als Rasiermittel (Nass- und Trockenrasur) As a shaving agent (wet and dry shave)
• als Seifen und Syndets • as soaps and syndets
• als Selbstbräunungsmittel • as a self-tanning agent
• als Massageöl • as massage oil
• als Alternativprodukt zu Parfüm • as an alternative to perfume
• als Selbstbräunungsmittel • as a self-tanning agent
• als Sonnenschutz-Produkte • as sunscreen products
• als Sonnenschutzprodukte für das Haar • as sunscreen products for the hair
Zur Zahn- und Mundpflege For dental and oral care
• Mundsprays • mouth sprays
• Mundwässer • mouthwashes
• Zahn-Bleichmittel • tooth bleach
• Zahncremes verwendet werden. • Tooth creams are used.
Ein weiteres erfindungsgemäßes Anwendungsgebiet sind Anwendungen bei Hautproblemen wie durch Radikale ausgelöstem oxidativem Stress. Des Weiteren können verschiedene Cremes hergestellt werden, die am Tag, beispielsweise mit einem UV-Filter und zur Nacht mit Lipiden, angereichert werden. Außerdem kann ein Regenerationsbalsam hergestellt werden. Es kann außerdem eine Schleimhautpflege und/oder ein Kopfhautvlies hergestellt werden. Besonders bevorzugt werden Saunacremes verwendet. Des Weiteren werden besonders Cremes bevorzugt, die bei der Chemotherapie eingesetzt werden können. Des Weiteren lösen die erfindungsgemäßen Produkte keine Allergien aus und können sogar bestehende Allergien reduzieren. Außerdem kann die Haut durch die erfindungsgemäßen Produkte verjüngt bzw. der Alterungsprozess der Haut verlangsamt werden. Im Folgenden wird die Erfindung anhand von Beispielen näher erläutert. Die Beispiele sind nicht einschränkend, sondern sollen die Ausführbarkeit der Erfindung glaubhaft machen. A further field of application according to the invention are applications in the case of skin problems such as oxidative stress caused by radicals. Furthermore, different creams can be produced, which are enriched during the day with, for example, a UV filter and at night with lipids. In addition, a regeneration balm can be made. In addition, mucosal care and / or scalp nonwoven can be made. Particular preference is given to using sauna creams. Furthermore, creams are particularly preferred that can be used in chemotherapy. Furthermore, the products according to the invention do not trigger allergies and can even reduce existing allergies. In addition, the skin can be rejuvenated by the products according to the invention or the aging process of the skin can be slowed down. In the following the invention will be explained in more detail by means of examples. The examples are not limiting but are intended to make the feasibility of the invention believable.
Beispiele Examples
Beispiel 1 example 1
Herstellung und Anwendung einer Salbe zur Absorption und/oder Zersetzung von Chemotherapeutika, die über die Haut abgeschieden wurden Preparation and use of an ointment for the absorption and / or decomposition of chemotherapeutic agents deposited via the skin
Es wurde eine Salbe zur onkologischen Anwendung hergestellt, indem man An ointment for oncological application was prepared by
- 1 Gewichtsteil molekulardisperser Wolframatophosphorsäure-Hydrat {H3[P(W3OIO)4]0 · XH20, CAS-Nr. 1343-93-7 (D), 1 part by weight of molecularly dispersed tungstophosphoric acid hydrate {H 3 [P (W 3 O 10 ) 4 ] 0 · XH 2 O, CAS no. 1343-93-7 (D),
- 0,5 Gewichtsteile Dikaliumhydrogenphosphat als Puffer (D) und - 0.5 parts by weight of dipotassium hydrogen phosphate as buffer (D) and
- 0,05 Gewichtsteile Simethicone® E900 Schauminhibitor (D) in 52,45 Gewichtsteilen Wasser (E) unter sterilen Bedingungen und Durchperlen von Kohlendioxid dispergierte. Die resultierende pastöse Salbe wurde unter leichtem Rühren und Unterdrück entgast und in sterile Spender abgefüllt. - 0.05 parts by weight of Simethicone® E900 foam inhibitor (D) dispersed in 52.45 parts by weight of water (E) under sterile conditions and bubbled with carbon dioxide. The resulting pasty ointment was degassed with gentle stirring and suppression and filled into sterile dispensers.
Bei Krebspatienten, die sich einer Chemotherapie unterziehen mussten, gelangten sehr starke Medikamente in den Körper. Diese Medikamente und ihre Metaboliten wurden zum Teil wieder ausgeschieden. Dies geschah unter anderem über die Haut. Dies bedeutete, dass nicht nur die Haut der Krebspatienten, sondern auch ihre Umgebung und das Pflegepersonal geschädigt wurden. In cancer patients who had to undergo chemotherapy, very strong drugs were absorbed into the body. Some of these drugs and their metabolites were excreted. This happened, among other things, via the skin. This meant that not only the skin of the cancer patients, but also their environment and the nursing staff were damaged.
Die Haut von Krebspatienten, die mit jeweils mindestens einem der folgenden Chemotherapeutika behandelt wurden: The skin of cancer patients treated with at least one of the following chemotherapeutic agents:
Chemotherapeutika auf der Basis von Platin: Chemotherapeutic agents based on platinum:
Carboplatin carboplatin
Cisplatin cisplatin
Alkylierende Chemotherapeutika auf der Basis von Senfgas: Nitrosoharnstoffderivate: Alkylating chemotherapeutic agents based on mustard gas: nitrosourea derivatives:
Carmustin (BCNU) Carmustine (BCNU)
Antimetabolite: Antimetabolites:
Methotrexat methotrexate
Purinanaloge Metabolite Purine-analogous metabolites
Pyrimidinanaloge Antimetabolite: Pyrimidine analog antimetabolites:
Fluorouracil (5-FU) Fluorouracil (5-FU)
Gemcitabin gemcitabine
Hormonale antineoplastische Verbindungen: Hormonal antineoplastic compounds:
Goselerin Goselerin
Leuprolid leuprolide
Temoxifen Temoxifen
Natürliche antineoplastische Verbindungen: Natural antineoplastic compounds:
Taxane taxanes
Doclitaxel Doclitaxel
Paclitaxel paclitaxel
Leukine: Leukine:
Aldesleukin aldesleukin
lnterleukin-2 interleukin-2
Etoposid (VP-16) Etoposide (VP-16)
Interferon alfa Interferon alfa
Tretinoin (ATRA) Tretinoin (ATRA)
Antibiotische natürliche neoplastische Verbindungen:Antibiotic natural neoplastic compounds:
Bleomycin bleomycin
Dactinomycin dactinomycin
Daunarubicin Daunarubicin
Doxorubicin doxorubicin
Mitomycin Vinca alkaloid natural antineoplasics: mitomycin Vinca alkaloid natural antineoplasics:
Vinblastin vinblastine
Vincristin vincristine
Weitere Medikamente: Other medicines:
Daunarubicin HCl Daunarubicin HCl
Docetaxel docetaxel
Doxorubicin HCl Doxorubicin HCl
Epoetin alpha Epoetin alpha
Ganciclovir Natrium Ganciclovir sodium
Gentamicinsulfat Gentamicin sulfate
Interferon alpha Interferon alpha
Leuprolidacetat leuprolide acetate
Meperidin HCl (Phetidin) Meperidine HCl (Phetidine)
Methadon HCl Methadone HCl
Ranitidin HCl Ranitidine HCl
Vinblastinsulfat vinblastine
Zidovudin (AZT) Zidovudine (AZT)
Fluorouracil + Epinephrin + Bovinecollagen. wurde mit der Salbe behandelt. Nach einer Einwirkung der Salbe von jeweils 10 Stunden, wurde sie abgewaschen. Es zeigte sich, dass die Haut der Krebspatienten nicht gereizt oder geschädigt worden war und dass keine Medikamente und Metaboliten mehr auf der Haut nachgewiesen werden konnten. Fluorouracil + epinephrine + bovine collagen. was treated with the ointment. After an ointment action of 10 hours each, it was washed off. It turned out that the skin of cancer patients had not been irritated or damaged and that no more drugs and metabolites could be detected on the skin.
Beispiel 2 Example 2
Die Herstellung und Anwendung einer Saunapaste zur Entschlackung des Körpers The production and application of a sauna paste for purification of the body
Zur Herstellung der Saunapaste wurden zunächst For the preparation of the sauna paste were initially
- 100 Gewichtsteile von Partikeln (A) aus pyrogenem Kohlenstoff einer mittleren Teilchengröße dsovon 650 ± 50 nm, 100 parts by weight of particles (A) of pyrogenic carbon of an average particle size dsovon of 650 ± 50 nm,
- 50 Gewichtsteile von Himalayasalz (D) einer mittleren Teilchengröße d5o von 100 pm und 20 Gewichtsteile Bienenwachs (B) einer mittleren Teilchengröße von 100 mhi unter sterilen Bedingungen bei 10 °C in einer Kugelmühle innig vermahlen. Das resultierende Pulver wurde von den Mahlkugeln abgetrennt. - 50 parts by weight of Himalayasalz (D) of an average particle size d 5 o of 100 pm and 20 parts by weight of beeswax (B) of an average particle size of 100 mhi under sterile conditions at 10 ° C in a ball mill intimately milled. The resulting powder was separated from the grinding balls.
Es wurde unter sterilen Bedingungen eine Wasser-in-ÖI-Emulsion aus It was under sterile conditions, a water-in-oil emulsion
- 300 Gewichtsteilen Eucerit (B), - 300 parts by weight of Eucerit (B),
- 300 Gewichtsteile Bienenwachs (B) einer mittleren Teilchengröße von 100 pm und 300 parts by weight of beeswax (B) with an average particle size of 100 μm and
- 100 Gewichtsteile Wasser (E) hergestellt. Die Emulsion war in der Lage größere Mengen an Wasser aufzunehmen. - 100 parts by weight of water (E) produced. The emulsion was able to absorb larger amounts of water.
Das Pulver wurde nun in die Wasser-in-ÖI-Emulsion eingearbeitet, sodass es darin gleichmäßig dispergiert war. The powder was now incorporated into the water-in-oil emulsion so that it was uniformly dispersed therein.
Zur Anwendung wird die Saunapaste vor, während und/oder nach einem Saunagang in die trockene oder schweißnasse Haut einmassiert und während der Ruhephase auf die Haut einwirken gelassen. Die Paste nahm den Schweiß und anderer Abscheidungsprodukte des Körpers rasch auf. Vor dem nächsten Saunagang konnte die Saunapaste abgewaschen werden. Der Vorgang konnte während eines Saunabesuchs mehrfach wiederholt werden und bewirkte eine nachhaltige Entschlackung des Körpers, und die Haut wirkte verjüngt und faltenfreier und war geruchsneutralisiert. For use, the sauna paste is massaged before, during and / or after a sauna session in the dry or sweaty skin and allowed to act on the skin during the resting phase. The paste quickly absorbed sweat and other body deposits. Before the next sauna session the sauna paste could be washed off. The process could be repeated several times during a sauna visit and caused a lasting purification of the body, and the skin seemed rejuvenated and wrinkle-free and was odor-neutralized.
Beispiel 3 Example 3
Die Herstellung und Anwendung einer Peelingpaste The preparation and application of a peeling paste
Zur Herstellung der Peelingpaste wurden To prepare the exfoliating paste were
- 50 Gewichtsteile von Partikeln (A) aus pyrogenem Kohlenstoff einer mittleren Teilchengröße dso von 650 ± 50 nm, 50 parts by weight of particles (A) of pyrogenic carbon of an average particle size d 50 of 650 ± 50 nm,
- 50 Gewichtsteile von Himalayasalz (E) einer mittleren Teilchengröße dso von 100 pm - 50 parts by weight of Himalayasalz (E) of an average particle size dso of 100 pm
- 50 Gewichtsteile Koridonkristalle einer mittleren Teilchengröße dso von 50 pm unter sterilen Bedingungen bei 10 °C in einer Kugelmühle innig vermahlen. Das resultierende Pulver wurde von den Mahlkugeln abgetrennt. - 50 parts by weight of Koridonkristalle a mean particle size dso of 50 pm Milled intimately under sterile conditions at 10 ° C in a ball mill. The resulting powder was separated from the grinding balls.
Es wurde unter sterilen Bedingungen eine Wasser-in-ÖI-Emulsion aus It was under sterile conditions, a water-in-oil emulsion
- 50 Gewichtsteilen Eucerit (B), - 50 parts by weight of Eucerit (B),
- 50 Gewichtsteile Bienenwachs (B) einer mittleren Teilchengröße von 100 miti und - 50 parts by weight of beeswax (B) having a mean particle size of 100 miti and
- 20 Gewichtsteile Wasser (E) hergestellt. Die Emulsion war in der Lage größere Mengen an Wasser aufzunehmen. - 20 parts by weight of water (E) produced. The emulsion was able to absorb larger amounts of water.
Das Pulver wurde nun in die Wasser-in-ÖI-Emulsion eingearbeitet, sodass es darin gleichmäßig dispergiert war. The powder was now incorporated into the water-in-oil emulsion so that it was uniformly dispersed therein.
Die resultierende Peelingpaste wurde die Gesichtshaut und in das Dekollete ein massiert und während 30 Minuten einwirken gelassen. Anschließend wurde die Peelingpaste mit einer lauwarmen Reinigungslösung abgewaschen. Der wohltuende Effekt des Peelings war deutlich sichtbar. Die Haut wirkte nach dem Peeling frischer und glatter. Die Partikel (A) bewirkten außerdem eine rasche Aufnahme von Abfallprodukten der Haut. The resulting exfoliating paste was massaged into the facial skin and into the décolleté and allowed to act for 30 minutes. Subsequently, the peeling paste was washed off with a lukewarm cleaning solution. The soothing effect of the peeling was clearly visible. The skin looked fresher and smoother after exfoliation. The particles (A) also caused a rapid uptake of waste products of the skin.
Beispiel 4 Example 4
Die Herstellung und die Anwendung einer fettfreien Feuchtigkeits- und Reinigungscreme The production and application of a non-greasy moisturizing and cleansing cream
Es wurde eine fettfreie Feuchtigkeits- und Reinigungscreme hergestellt, indem man A fat-free moisturizing and cleansing cream was prepared by adding
- 5 Gewichtsteile von Partikeln (A) aus pyrogenem Kohlenstoff einer mittleren Teilchengröße dso von 650 ± 50 nm, 5 parts by weight of particles (A) of pyrogenic carbon of an average particle size d 50 of 650 ± 50 nm,
- 10 Gewichtsteile nanokristalliner Cellulose (CNC) (C) einer mittleren Teilchengröße dso von 650 ± 100 nm, 10 parts by weight of nanocrystalline cellulose (CNC) (C) having an average particle size d 50 of 650 ± 100 nm,
- 5 Gewichtsteile beta-Glucan (D) und - 5 parts by weight of beta-glucan (D) and
- 10 Gewichtsteile Harnstoff (D) in 150 Gewichtsteilen Wasser (E) dispergierte. Dabei bildet sich ein leicht zu verreibendes Gel. Das Gel wurde rasch von der Haut aufgenommen und hielt die Haut nachhaltig feucht. Die Partikel (A) aus pyrogenem Kohlenstoff bewirkten wegen ihrer geringen Dosierung keine Verfärbung der Haut. - 10 parts by weight of urea (D) in 150 parts by weight of water (E) dispersed. This forms an easy-to-rub gel. The gel was quickly absorbed by the skin and kept the skin permanently moist. The particles (A) of fumed carbon caused no discoloration of the skin because of their low dosage.
Beispiel 5 Example 5
Die Herstellung eines Duschgels zur Reinigung und Regenerierung von belasteter Haut The production of a shower gel for the cleaning and regeneration of stressed skin
Bekanntermaßen ist bei starken Rauchern die Haut schlecht durchblutet und wirkt daher grau. Außerdem ist die Haut durch Ausscheidungsprodukte, die auf den Rauch zurückzuführen sind, verunreinigt. It is known that in heavy smokers the skin is poorly supplied with blood and therefore looks gray. In addition, the skin is contaminated by excreta due to smoke.
Zur Reinigung und besseren Durchblutung der Haut wurde daher ein Duschgel aus For cleaning and better blood circulation of the skin was therefore a shower gel
- 10 Gewichtsteilen von Partikeln (A) aus pyrogenem Kohlenstoff einer mittleren Teilchengröße dso von 650 ± 50 nm, 10 parts by weight of particles (A) of pyrogenic carbon of an average particle size dso of 650 ± 50 nm,
- 10 Gewichtsteilen nanokristalliner Cellulose (CNC) (C) einer mittleren Teilchengröße dso von 650 ± 100 nm, 10 parts by weight of nanocrystalline cellulose (CNC) (C) having an average particle size d 50 of 650 ± 100 nm,
- 5 Gewichtsteilen beta-Glucan (D) und - 5 parts by weight of beta-glucan (D) and
- 10 Gewichtsteilen Harnstoff (D), 10 parts by weight of urea (D),
- 40 Gewichtsteilen Cerabellina (B) einer mittleren Teilchengröße dso von 50 miti, 40 parts by weight of Cerabellina (B) having an average particle size dso of 50 miti,
- 40 Gewichtsteilen Eucerit (B), - 40 parts by weight of Eucerit (B),
- 0,5 Gewichtsteilen Pflanzenfarbstoffen und Farbpigmenten (D), - 0.5 parts by weight of vegetable dyes and color pigments (D),
- 0,5 Gewichtsteilen natürlicher Duftstoffen (D) - 0.5 parts by weight of natural fragrances (D)
- 10 Gewichtsteilen Bentonit (D), - 10 parts by weight of bentonite (D),
- 0,5 Gewichtsteilen eines Gemischs aus verschiedenen Vitaminen und Spurenelementen und - 0,5 parts by weight of a mixture of different vitamins and trace elements and
- 250 Gewichtsteilen Wasser hergestellt. Der pyrogene Kohlenstoff bewirkte eine rasche Aufnahme und den Abtransport von Schadstoffen aus der Haut. Die Nanocellulose besaß zusammen mit Cerabellina und Eucerit eine grenzflächenaktive Wirkung, sodass sich bei der Anwendung Schaum bildete. Das hautgängige beta-Glucan und die Vitamine und Spurenelemente trugen zur Ernährung und Regeneration der Haut bei. Cerabellina und Eucerit hatten eine einfettende Wirkung. Die Pflanzenfarbstoffe und Farbpigmente dienten der Tönung der Haut. Die Bentonit-Partikel hatten einen Peeling-Effekt. Die Duftstoffe überdeckten nachhaltig den typischen Rauchergeruch und der Harnstoff hielt die Haut länger feucht. - Made 250 parts by weight of water. The pyrogenic carbon caused a rapid uptake and the removal of pollutants from the skin. The nanocellulose, along with Cerabellina and Eucerit, had a surfactant effect, causing foam to form during use. The skin-friendly beta-glucan and the vitamins and trace elements contributed to the nutrition and regeneration of the skin. Cerabellina and Eucerit had a lipid effect. The plant dyes and color pigments served to tint the skin. The bentonite particles had a peeling effect. The fragrances lastingly covered the typical smell of smokers and the urea kept the skin moist for longer.
Beispiel 6 Example 6
Die Herstellung eines Schutzproduktes für das Pflegepersonal, welches mit Chemotherapeutika in Berührung kommt. The preparation of a protective product for the nursing staff, which comes into contact with chemotherapeutic agents.
Die Reinigungs-/Schutzpaste diente dem Schutz der Haut vor Chemikalien wie Chemotherapeutika, um sie zu absorbieren, so dass sie die Hautbarriere nicht durchdringen konnten. The cleansing / protective paste served to protect the skin from chemicals such as chemotherapeutic agents to absorb them so that they could not penetrate the skin barrier.
Es wurde eine pastöse Salbe als Schutzfilm hergestellt, indem man It was prepared a pasty ointment as a protective film by
- 6 Gewichtsteile von Partikeln (A) aus pyrogenem Kohlenstoff einer mittleren Teilchengröße dso von 650 ± 50 nm, 6 parts by weight of particles (A) of pyrogenic carbon of an average particle size d 50 of 650 ± 50 nm,
- 50 Gewichtsteile von Bienenwachspartikeln (D) einer mittleren Teilchengröße dso von 200 pm, 50 parts by weight of beeswax particles (D) of an average particle size d 50 of 200 μm,
- 2 Gewichtsteile nanokristalliner Cellulose (CNC) (C) einer mittleren Teilchengröße dso von 650 ± 100 nm, 2 parts by weight of nanocrystalline cellulose (CNC) (C) having an average particle size d 50 of 650 ± 100 nm,
- 1 Gewichtsteil molekulardisperser Wolframatophosphorsäure-Hydrat {H3[P(W30I O)4]0 XH20, CAS-Nr. 1343-93-7 (D), 1 part by weight of molecularly dispersed tungstophosphoric acid hydrate {H 3 [P (W 3 O 10 ) 4 ] 0 XH 2 O, CAS no. 1343-93-7 (D),
- 0,5 Gewichtsteile Dikaliumhydrogenphosphat als Puffer (D) und - 0.5 parts by weight of dipotassium hydrogen phosphate as buffer (D) and
- 0,05 Gewichtsteile Simethicone® E900 Schauminhibitor (D) in 40,45 Gewichtsteilen Wasser (E) unter sterilen Bedingungen und Durchperlen von Kohlendioxid dispergierte. Die resultierende pastöse Salbe wurde unter leichtem Rühren und Unterdrück entgast und in sterile Spender abgefüllt. - 0.05 parts by weight of Simethicone® E900 foam inhibitor (D) dispersed in 40.45 parts by weight of water (E) under sterile conditions and bubbled with carbon dioxide. The resulting pasty ointment was degassed with gentle stirring and suppression and filled into sterile dispensers.
Bei Krebspatienten, die sich wie in Beispiel 1 beschrieben einer Chemotherapie unterziehen mussten, gelangten sehr starke Medikamente in den Körper. Diese Medikamente und ihre Metaboliten wurden zum Teil wieder ausgeschieden. Dies geschah unter anderem über die Haut. Dies bedeutete, dass auch die Umgebung der Krebspatienten und speziell das Pflegepersonal bei Kontakt geschädigt wurden. Vor und/oder während der therapeutischen Intervention und während der Pflege der Patienten wurden die Hände des Pflegepersonals mit der Salbe behandelt. Die Salbe bildet einen Schutzfilm, der Medikamente und Metaboliten absorbierte. Nach der Pflege und/oder bei Unterbrechung der Pflege wurde sie abgewaschen. Es zeigte sich, dass die Haut des Pflegepersonals nicht gereizt oder geschädigt worden war und dass sich keine Medikamente und Metaboliten mehr auf der Haut nachgewiesen werden konnten. In cancer patients who had to undergo chemotherapy as described in Example 1, very strong drugs were absorbed into the body. Some of these drugs and their metabolites were excreted. This happened, among other things, via the skin. This meant that the environment of the cancer patients and especially the nursing staff were damaged in contact. Before and / or during the therapeutic intervention and during the care of the patients, the hands of the nursing staff were treated with the ointment. The ointment forms a protective film of drugs and metabolites absorbed. After the care and / or interruption of the care she was washed off. It turned out that the skin of the nursing staff had not been irritated or damaged and that no more drugs and metabolites could be detected on the skin.
Beispiel 7 Example 7
Bereitstellung und topische Anwendung einer Salbe bei der Behandlung von Calcinosis Cutis. Provision and topical application of an ointment in the treatment of Calcinosis Cutis.
Calcinosis cutis bezeichnet Ablagerungen innerhalb der Haut, bestehend aus Calciumphosphat mit Bildung von Kalksalzkristallen. Die resultierenden Schwellungen können mit lokalen Entzündungen, Schmerzen und/oder Plaquedurchbrüchen einhergehen. Als Behandlung werden die Plaques chirurgisch entfernt. Calcinosis cutis refers to deposits within the skin consisting of calcium phosphate with the formation of calcium salt crystals. The resulting swelling may be associated with local inflammation, pain and / or plaque breakthroughs. As a treatment, the plaques are surgically removed.
Zur Vermeidung von Entzündungen und gegen weitere Ablagerungen wurde eine Salbe aus To prevent inflammation and against further deposits was an ointment
- 6 Gewichtsteilen von Partikeln (A) aus pyrogenem Kohlenstoff einer mittleren Teilchengröße dso von 650 ± 50 nm, 6 parts by weight of particles (A) of pyrogenic carbon of an average particle size d 50 of 650 ± 50 nm,
- 50 Gewichtsteilen von Bienenwachspartikeln (D) einer mittleren Teilchengröße dso von 200 pm, 50 parts by weight of beeswax particles (D) having an average particle size d 50 of 200 μm,
- 2 Gewichtsteilen nanokristalliner Cellulose (CNC) (C) einer mittleren Teilchengröße dso von 650 ± 100 nm, 2 parts by weight of nanocrystalline cellulose (CNC) (C) having an average particle size d 50 of 650 ± 100 nm,
- 1 Gewichtsteil molekulardisperser Wolframatophosphorsäure-Hydrat {H3[P(W30I O)4]0 XH20, CAS-Nr. 1343-93-7 (D), 1 part by weight of molecularly dispersed tungstophosphoric acid hydrate {H 3 [P (W 3 O 10 ) 4 ] 0 XH 2 O, CAS no. 1343-93-7 (D),
- 0,5 Gewichtsteilen Dikaliumhydrogenphosphat als Puffer (D), 0.5 part by weight of dipotassium hydrogen phosphate as buffer (D),
- 0,05 Gewichtsteilen Simethicone® E900 Schauminhibitor (D), - 0.05 part by weight of Simethicone® E900 foam inhibitor (D),
- 10 Gewichtsteilen Hexahydroxycyclohexanhexaphosphorsäureestersalz-Nanopartikel (E) (Natriumsalz der Phytinsäure) einer mittleren Teilchengröße von 650 ± 150 nm und Hexahydroxycyclohexanhexaphosphorsäureestersalz nanoparticles (E) (sodium salt of phytic acid) of an average particle size of 650 ± 150 nm and
- 1 Gewichtsteil Polyethylenglykol (PEG) zur Öffnung der Hautporen in 40,0 Gewichtsteilen Wasser (E) unter sterilen Bedingungen und Durchperlen von Kohlendioxid dispergierte. Die resultierende pastöse Salbe wurde unter leichtem Rühren und Unterdrück entgast und in sterile Spender abgefüllt. Die Salbe wurde bei Patienten mit Calcinosis cutis auf und um betroffene Stellen aufgetragen und verhinderte wirksam Entzündungen und weitere Ablagerungen in der Haut. - 1 part by weight of polyethylene glycol (PEG) for opening the skin pores in 40.0 parts by weight of water (E) under sterile conditions and sparging of carbon dioxide dispersed. The resulting pasty ointment was degassed with gentle stirring and suppression and filled into sterile dispensers. The ointment was applied to patients with calcinosis cutis on and around affected areas and effectively prevented inflammation and other deposits in the skin.
Beispiel 8 Example 8
Die Herstellung und Anwendung einer Lotion zur Pflege der Kopfhaut und der The preparation and application of a lotion for the care of the scalp and the
Haarwurzeln hair roots
Zur Pflege der Kopfhaut und der Haarwurzeln wurde eine wässrige Lotion aus To care for the scalp and hair roots, an aqueous lotion was made
- 4 Gewichtsteilen von Partikeln (A) aus pyrogenem Kohlenstoff einer mittleren Teilchengröße dso von 650 ± 50 nm, 4 parts by weight of particles (A) of pyrogenic carbon of an average particle size dso of 650 ± 50 nm,
- 10 Gewichtsteilen von Cerabellina (B) einer mittleren Teilchengröße dso von 200 pm, 10 parts by weight of Cerabellina (B) having an average particle size d 50 of 200 μm,
- 1 Gewichtsteil nanokristalliner Cellulose (CNC) (C) einer mittleren Teilchengröße dso von 650 ± 100 nm, 1 part by weight of nanocrystalline cellulose (CNC) (C) having an average particle size d 50 of 650 ± 100 nm,
- 15 Gewichtsteilen Ethanol (E), 15 parts by weight of ethanol (E),
- 5 Gewichtsteilen Panethol, - 5 parts by weight of Panethol,
- 0,5 Gewichtsteile Cinnamomum Zeylanicum Leaf Oil, 0.5 part by weight of Cinnamomum Zeylanicum Leaf Oil,
- 0,1 Gewichtsteile Polyethylenglykol (PEG) und - 0.1 parts by weight of polyethylene glycol (PEG) and
- 100 Gewichtsteilen Wasser unter sterilen Bedingungen hergestellt und in Flaschen abgefüllt. Zur Anwendung wurde die Lotion in die behaarte Kopfhaut einmassiert und 15 Minuten lang einwirken gelassen. Danach wurde die Lotion mit lauwarmem Wasser abgespült. Die Behandlung wurde während einer Woche einmal täglich wiederholt. Dadurch wurde die Behaarung sichtbar dichter, weil auch kleinere Härchen durch den Reinigungseffekt wieder stärker wuchsen und noch funktionsfähige Haarwuchsfollikel wieder zum Haarwachstum angeregt wurden. - 100 parts by weight of water produced under sterile conditions and bottled. For application, the lotion was massaged into the hairy scalp and allowed to act for 15 minutes. Thereafter, the lotion was rinsed with lukewarm water. The treatment was repeated once a day for one week. As a result, the hair became visibly denser, because even smaller hairs grew stronger again by the cleaning effect and still functional hair follicles were stimulated to hair growth again.
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18830134.5A EP3713647A1 (en) | 2017-11-25 | 2018-11-22 | Topical preparations |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102017010930.3A DE102017010930A1 (en) | 2017-11-25 | 2017-11-25 | Topical preparations |
DE102017010930.3 | 2017-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019101357A1 true WO2019101357A1 (en) | 2019-05-31 |
Family
ID=64959267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2018/000527 WO2019101357A1 (en) | 2017-11-25 | 2018-11-22 | Topical preparations |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP3713647A1 (en) |
DE (1) | DE102017010930A1 (en) |
WO (1) | WO2019101357A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115297823A (en) * | 2020-04-23 | 2022-11-04 | 德玛普吉有限责任公司 | Products and methods for skin decontamination to remove nanoparticles |
DE102021004905A1 (en) | 2021-09-29 | 2023-03-30 | Smart Material Printing B.V. | Mechanochemically pretreated, heavy metal-free activated carbon particles A |
DE102021004906A1 (en) | 2021-09-29 | 2023-03-30 | Smart Material Printing B.V. | Heavy metal-free topical medical devices and cosmetics, processes for their preparation and their use |
DE102021004907A1 (en) | 2021-09-29 | 2023-03-30 | Smart Material Printing B.V. | Mechanochemically pretreated, heavy metal-free activated carbon particles A for use in medicine |
WO2023052393A1 (en) | 2021-09-29 | 2023-04-06 | Smart Material Printing B.V. | Mechanochemically pre-treated, heavy-metal-free activated carbon particles a, topical medications, medicinal products and cosmetics, production method, and uses |
Citations (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0563876A2 (en) | 1992-04-01 | 1993-10-06 | Inverni Della Beffa S.P.A. | Biodegradable microbeads for the pharmaceutical and cosmetic uses |
US5824706A (en) | 1994-09-26 | 1998-10-20 | Schinazi; Raymond F. | Method, compositions, and apparatus for treating and preventing respiratory viral infections |
US5904734A (en) | 1996-11-07 | 1999-05-18 | S. C. Johnson & Son, Inc. | Method for bleaching a hard surface using tungsten activated peroxide |
EP1081216A1 (en) * | 1999-08-20 | 2001-03-07 | Kisho Co., Ltd. | Soap |
US6210694B1 (en) * | 1998-12-24 | 2001-04-03 | Nesura Cosmetic Co., Ltd. | Cosmetic composition containing charcoal and process for the preparation thereof |
CN1306825A (en) | 2000-01-31 | 2001-08-08 | 陈军 | Adsorbed burn ointment |
DE69704925T2 (en) | 1996-12-11 | 2001-09-06 | L'oreal S.A., Paris | Cosmetic composition containing the combination of a film-forming polymer and a wax dispersion and use of this combination |
US6723349B1 (en) | 1999-10-12 | 2004-04-20 | Emory University | Polyoxometalate materials, metal-containing materials, and methods of use thereof |
EP1235546B1 (en) | 1999-12-04 | 2005-03-30 | Cognis Deutschland GmbH & Co. KG | Use of nanoscale waxes |
US6911470B1 (en) | 1988-09-22 | 2005-06-28 | Raymond F. Schinazi | Polyoxometalate compounds as antiviral agents |
JP2005281299A (en) | 2004-03-01 | 2005-10-13 | Paratex Japan:Kk | Antibacterial/mildewproofing agent and coating material composition using the same |
US20090004124A1 (en) | 2007-06-27 | 2009-01-01 | L'oreal | Cosmetic composition comprising fluidized particles |
US20090012204A1 (en) | 2007-07-06 | 2009-01-08 | Lynntech, Inc. | Functionalization of polymers with reactive species having bond-stabilized decontamination activity |
US20090022645A1 (en) | 2005-01-12 | 2009-01-22 | Nippon Shokubai Co., Ltd. | Bleaching activator and detergent composition comprising the same |
DE102008021007A1 (en) | 2008-04-25 | 2009-11-12 | Byk-Chemie Gmbh | Dispersions of waxes and inorganic nanoparticles and their use |
US20100278888A1 (en) * | 2008-08-25 | 2010-11-04 | Byung-Ho Park | Composition for cosmetic raw material containing cellulose dyed with natural coloring matter having improved photostability, and visual carrier system comprising the same |
US20100278882A1 (en) | 2006-01-20 | 2010-11-04 | Burghard Liebmann | Use of protein microbeads in cosmetics |
DE69917690T3 (en) | 1998-02-09 | 2011-06-22 | L'oreal | Use of a microdispersion of wax in a cosmetic or dermatological composition |
US20120258150A1 (en) | 2011-04-11 | 2012-10-11 | Holly Balasubramanian Rauckhorst | Particles comprising volatile materials and particle gas saturated solution processes for making same |
US20130259913A1 (en) | 2012-03-29 | 2013-10-03 | Holly Balasubramanian Rauckhorst | Particles and particle gas saturated solution processes for making same |
US20140026916A1 (en) | 2012-07-25 | 2014-01-30 | College Of William And Mary | Method for Reducing Marine Pollution Using Polyhydroxyalkanoate Microbeads |
DE102012214662A1 (en) | 2012-08-17 | 2014-02-20 | Henkel Ag & Co. Kgaa | Delayed release cosmetic compositions |
US20140083416A1 (en) | 2010-03-19 | 2014-03-27 | Upm-Kymmene Corporation | Process for preparing micro- and nanocrystalline cellulose |
DE202014010286U1 (en) | 2014-12-05 | 2015-05-27 | Beiersdorf Ag | Cleaning preparations containing activated carbon |
JP2015189707A (en) * | 2014-03-28 | 2015-11-02 | 株式会社ファンケル | Cosmetic skin pack clay sheet |
US20150367024A1 (en) | 2013-02-22 | 2015-12-24 | Upm-Kymmene Corporation | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
DE102015000813A1 (en) | 2015-01-21 | 2016-07-21 | Smart Material Printing B.V. | Method of destroying drugs and toxins and their metabolites using polyoxometalate micro and / or nanoparticles |
DE102015000812A1 (en) | 2015-01-21 | 2016-07-21 | Smart Material Printing B.V. | Hydrous cleaning and personal care products with biocidal activity |
US20170000903A1 (en) | 2013-11-28 | 2017-01-05 | University Of Saskatchewan | Crystalline cellulose gel-based cryptands, surface active agents, emulsions and vesicles |
US20170027168A1 (en) | 2015-07-27 | 2017-02-02 | Stephan HEATH | Methods, products, and systems relating to making, providing, and using nanocrystalline (nc) products comprising nanocrystalline cellulose (ncc), nanocrystalline (nc) polymers and/or nanocrystalline (nc) plastics or other nanocrystals of cellulose composites or structures, in combination with other materials |
EP2493975B1 (en) | 2009-10-30 | 2017-03-29 | Stichting Kennis Exploitatie RB | Starch-based biodegradable polymer; method of manufacture and articles thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006017827A1 (en) * | 2004-08-06 | 2006-02-16 | The Procter & Gamble Company | Personal cleansing composition containing wax particles and platelet, spherical, or irregularly shaped particles |
DE102012214622A1 (en) | 2012-08-17 | 2014-02-20 | Robert Bosch Gmbh | Actuator and axial piston machine |
EP3247210A1 (en) | 2015-01-21 | 2017-11-29 | Smartmaterialprinting B.V. | Biocidal treatment of objects and water-containing cleaning and body-care products with polyoxometalate microparticles and/or nanoparticles |
DE102015010041A1 (en) | 2015-08-01 | 2017-02-02 | WindplusSonne GmbH | Terra Preta Humanidade, process for its preparation and its use |
DE102016004570B3 (en) * | 2016-04-19 | 2017-10-05 | Wind Plus Sonne Gmbh | Panel materials, composites and composite materials on the basis of separated manure or wood and separated manure |
DE102016207569A1 (en) * | 2016-05-03 | 2017-11-09 | Henkel Ag & Co. Kgaa | Solids-stabilized color creams and kit for dyeing hair |
-
2017
- 2017-11-25 DE DE102017010930.3A patent/DE102017010930A1/en active Pending
-
2018
- 2018-11-22 EP EP18830134.5A patent/EP3713647A1/en active Pending
- 2018-11-22 WO PCT/EP2018/000527 patent/WO2019101357A1/en active Application Filing
Patent Citations (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6911470B1 (en) | 1988-09-22 | 2005-06-28 | Raymond F. Schinazi | Polyoxometalate compounds as antiviral agents |
EP0563876A2 (en) | 1992-04-01 | 1993-10-06 | Inverni Della Beffa S.P.A. | Biodegradable microbeads for the pharmaceutical and cosmetic uses |
US5824706A (en) | 1994-09-26 | 1998-10-20 | Schinazi; Raymond F. | Method, compositions, and apparatus for treating and preventing respiratory viral infections |
US6020369A (en) | 1994-09-26 | 2000-02-01 | Schinazi; Raymond F. | Method compositions and apparatus for treating and preventing respiratory viral infections |
US5904734A (en) | 1996-11-07 | 1999-05-18 | S. C. Johnson & Son, Inc. | Method for bleaching a hard surface using tungsten activated peroxide |
DE69704925T2 (en) | 1996-12-11 | 2001-09-06 | L'oreal S.A., Paris | Cosmetic composition containing the combination of a film-forming polymer and a wax dispersion and use of this combination |
DE69917690T3 (en) | 1998-02-09 | 2011-06-22 | L'oreal | Use of a microdispersion of wax in a cosmetic or dermatological composition |
US6210694B1 (en) * | 1998-12-24 | 2001-04-03 | Nesura Cosmetic Co., Ltd. | Cosmetic composition containing charcoal and process for the preparation thereof |
EP1081216A1 (en) * | 1999-08-20 | 2001-03-07 | Kisho Co., Ltd. | Soap |
US7097858B2 (en) | 1999-10-12 | 2006-08-29 | Emory University | Polyoxometalate materials, metal-containing materials, and methods of use thereof |
US6723349B1 (en) | 1999-10-12 | 2004-04-20 | Emory University | Polyoxometalate materials, metal-containing materials, and methods of use thereof |
US20080187601A1 (en) | 1999-10-12 | 2008-08-07 | Hill Craig L | Polyoxometalate materials, metal-containing materials, and methods of use thereof |
EP1235546B1 (en) | 1999-12-04 | 2005-03-30 | Cognis Deutschland GmbH & Co. KG | Use of nanoscale waxes |
CN1306825A (en) | 2000-01-31 | 2001-08-08 | 陈军 | Adsorbed burn ointment |
JP2005281299A (en) | 2004-03-01 | 2005-10-13 | Paratex Japan:Kk | Antibacterial/mildewproofing agent and coating material composition using the same |
US20090022645A1 (en) | 2005-01-12 | 2009-01-22 | Nippon Shokubai Co., Ltd. | Bleaching activator and detergent composition comprising the same |
US20100278882A1 (en) | 2006-01-20 | 2010-11-04 | Burghard Liebmann | Use of protein microbeads in cosmetics |
US20090004124A1 (en) | 2007-06-27 | 2009-01-01 | L'oreal | Cosmetic composition comprising fluidized particles |
US20090012204A1 (en) | 2007-07-06 | 2009-01-08 | Lynntech, Inc. | Functionalization of polymers with reactive species having bond-stabilized decontamination activity |
DE102008021007A1 (en) | 2008-04-25 | 2009-11-12 | Byk-Chemie Gmbh | Dispersions of waxes and inorganic nanoparticles and their use |
US20100278888A1 (en) * | 2008-08-25 | 2010-11-04 | Byung-Ho Park | Composition for cosmetic raw material containing cellulose dyed with natural coloring matter having improved photostability, and visual carrier system comprising the same |
EP2493975B1 (en) | 2009-10-30 | 2017-03-29 | Stichting Kennis Exploitatie RB | Starch-based biodegradable polymer; method of manufacture and articles thereof |
US20140083416A1 (en) | 2010-03-19 | 2014-03-27 | Upm-Kymmene Corporation | Process for preparing micro- and nanocrystalline cellulose |
US20120258150A1 (en) | 2011-04-11 | 2012-10-11 | Holly Balasubramanian Rauckhorst | Particles comprising volatile materials and particle gas saturated solution processes for making same |
US20130259913A1 (en) | 2012-03-29 | 2013-10-03 | Holly Balasubramanian Rauckhorst | Particles and particle gas saturated solution processes for making same |
US20140026916A1 (en) | 2012-07-25 | 2014-01-30 | College Of William And Mary | Method for Reducing Marine Pollution Using Polyhydroxyalkanoate Microbeads |
DE102012214662A1 (en) | 2012-08-17 | 2014-02-20 | Henkel Ag & Co. Kgaa | Delayed release cosmetic compositions |
US20150367024A1 (en) | 2013-02-22 | 2015-12-24 | Upm-Kymmene Corporation | Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring |
US20170000903A1 (en) | 2013-11-28 | 2017-01-05 | University Of Saskatchewan | Crystalline cellulose gel-based cryptands, surface active agents, emulsions and vesicles |
JP2015189707A (en) * | 2014-03-28 | 2015-11-02 | 株式会社ファンケル | Cosmetic skin pack clay sheet |
DE202014010286U1 (en) | 2014-12-05 | 2015-05-27 | Beiersdorf Ag | Cleaning preparations containing activated carbon |
DE102015000813A1 (en) | 2015-01-21 | 2016-07-21 | Smart Material Printing B.V. | Method of destroying drugs and toxins and their metabolites using polyoxometalate micro and / or nanoparticles |
DE102015000812A1 (en) | 2015-01-21 | 2016-07-21 | Smart Material Printing B.V. | Hydrous cleaning and personal care products with biocidal activity |
US20170027168A1 (en) | 2015-07-27 | 2017-02-02 | Stephan HEATH | Methods, products, and systems relating to making, providing, and using nanocrystalline (nc) products comprising nanocrystalline cellulose (ncc), nanocrystalline (nc) polymers and/or nanocrystalline (nc) plastics or other nanocrystals of cellulose composites or structures, in combination with other materials |
Non-Patent Citations (5)
Title |
---|
DAN CHEN; JUN PENG; HAIJUN PANG; PENGPEG ZHANG; YUAN CHEN; YAN SHEN; CHANYUNG CHEN; HUIYUAN MA: "Fabrication and Characterization of Antibacterial-active Multilaer Films Based on Keggin Polyoxometalates and Methylene Blue", Z. NATURFORSCH, vol. 65b, 2010, pages 140 - 146 |
EUNYOUNG BAE; JAE WON LEE; BYEONG HEE WANG; JIMAN YEO; JECONG YOON; HYUNG JOON CHA; WONYONG CHOI: "Photocatalytic bacterial inactivation by polyoxometalates", CHEMOSPHERE, vol. 72, 2008, pages 174 - 181 |
H.-P. SCHMIDT: "55 Anwendungen von Pflanzenkohle", ITHAKA JOURNAL, January 2012 (2012-01-01), pages 92 - 102 |
J. LADEMANN; F. KNORR; H. RICHTER; S. JUNG; M. C. MEINKE; E. RÜHL; U. ALEXIEV; M. CALDERON; A. PATZELT: "Hair follicles as a target structure for nanoparticles", JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES, vol. 8, no. 4, 2015, pages 1530004 |
MIYAO INOUE; KEIKO SEGAWA; SAE MATSUNAGA; OBUHIRO MATSMOTO; MAYUMI ODA; TOSHIHIRO YAMASE: "Antibacterial activity of highly negative charged polyoxotungsstates, K (KAs W O ) and K (KSb W O ), and Keggin-structural polyoxotungstates against Heliobacter pylori", JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 99, 2005, pages 1023 - 1031 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115297823A (en) * | 2020-04-23 | 2022-11-04 | 德玛普吉有限责任公司 | Products and methods for skin decontamination to remove nanoparticles |
DE102021004905A1 (en) | 2021-09-29 | 2023-03-30 | Smart Material Printing B.V. | Mechanochemically pretreated, heavy metal-free activated carbon particles A |
DE102021004906A1 (en) | 2021-09-29 | 2023-03-30 | Smart Material Printing B.V. | Heavy metal-free topical medical devices and cosmetics, processes for their preparation and their use |
DE102021004907A1 (en) | 2021-09-29 | 2023-03-30 | Smart Material Printing B.V. | Mechanochemically pretreated, heavy metal-free activated carbon particles A for use in medicine |
WO2023052393A1 (en) | 2021-09-29 | 2023-04-06 | Smart Material Printing B.V. | Mechanochemically pre-treated, heavy-metal-free activated carbon particles a, topical medications, medicinal products and cosmetics, production method, and uses |
Also Published As
Publication number | Publication date |
---|---|
DE102017010930A1 (en) | 2019-05-29 |
EP3713647A1 (en) | 2020-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019101357A1 (en) | Topical preparations | |
US20070292459A1 (en) | Halloysite microtubule processes, structures, and compositions | |
US20050058672A1 (en) | Baby Care Skin Protectant Compositions for Diaper Rash | |
WO2010046291A2 (en) | Use of hydroxycinnamic acids and derivatives thereof and/or of plant extracts for treating body odor | |
JP2010132629A (en) | External composition for skin | |
JP2002205933A (en) | Cosmetic composition containing extract of orchidaceous plant | |
KR20180078564A (en) | Natural cosmetic formulation with excellent effect for skin soothing and moisturizing maintenance | |
DE202006019183U1 (en) | Sea buckthorn oil, useful for e.g. skin care, nourishment and cleaning dry skin, comprises oil from sea buckthorn pulp, vitamin E acetate, additional fats, vegetable base oil and/or waxes, and oil with active substance | |
DE69934307T2 (en) | USE OF A TOPICAL COMPOSITION | |
WO2023052393A1 (en) | Mechanochemically pre-treated, heavy-metal-free activated carbon particles a, topical medications, medicinal products and cosmetics, production method, and uses | |
US20150086522A1 (en) | Formulation containing herb infused aloe | |
DE102004037505A1 (en) | Prebiotic Intimate Care | |
DE19547991A1 (en) | Use of combinations of uricase and uric acid | |
EP2100593B1 (en) | Ternary mixtures with increased collagen synthesis | |
EP3256142A1 (en) | Immunologically active plant mixture and use thereof for prophylaxis and in a method for treating efflorescence | |
JP2001081037A (en) | Cosmetic composition | |
KR101894255B1 (en) | Method of Manufacturing for Cosmetic Natural Powder Coated Multiple with Essential Oil | |
JP2008247786A (en) | External preparation for skin | |
DE202013000377U1 (en) | Composition for topical application | |
CN106727249A (en) | A kind of mouthwash and preparation method thereof | |
JP5956122B2 (en) | Anti-acne fungicide | |
WO2009115216A1 (en) | Use of a component or extract from the baobab plant for skin diseases | |
DE102021004906A1 (en) | Heavy metal-free topical medical devices and cosmetics, processes for their preparation and their use | |
KR102024167B1 (en) | Skin temperature sensitive gel composition comprising bee venom and mask pack using the same | |
JP2001106619A (en) | Cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18830134 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2018830134 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2018830134 Country of ref document: EP Effective date: 20200625 |